Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

38 Pages (Click to Jump) V   1 2 3 4 > » 

nipper
Posted on: Yesterday, 05:10 PM


Group: Member
Posts: 7,511

QUOTE
What makes for a good commodity stew? A dollop of demand strength. A sprinkle of supply concerns. A rising cost curve. Minimal threats from alternatives.

We see all these ingredients and more for the copper sector and are thus more bullish than both consensus commodity forecasts and the forward curve.
Bernstein, US investment firm, September 2020
  Forum: Macro Factors

nipper
Posted on: Yesterday, 04:40 PM


Group: Member
Posts: 7,511

BHP and Encounter have entered into an Option Agreement covering the 4,500sq.km. Elliott Copper Project in the Northern Territory
• Option Agreement provides BHP with the right, following the completion of a jointly designed validation program, to enter an earn in and joint venture agreement to earn up to 75% interest in Elliott by spending up to $22 million over 10 years
• Elliott represents a compelling first mover copper opportunity in a high quality jurisdiction:
... Located at a major structural intersection on the southwestern margin of the Beetaloo Basin
... Contains the key conceptual criteria for the formation of sedimentary copper with the target sequence being undercover and untested
... Standout copper in groundwater anomaly which is supported by surface geochemical sampling at Elliott


• Elliott was first identified by analysing new datasets generated by Geoscience Australia, as part of the Federal Government’s Exploring for the Future Program
• Encounter retains 100% control of five other copper projects in the NT covering a further 10,300sq.km.
  Forum: By Share Code

nipper
Posted on: Yesterday, 01:29 PM


Group: Member
Posts: 7,511

Shares in Australian lithium producers have taken a hit after the Tesla Battery Day event tested investor conviction in the commodity class and among companies with exposure to the electric vehicle (EV) battery supply chain.

Tesla founder Elon Musk and co-presenter and engineering boss Drew Baglino offered fans a series of materials, process and product targets,
QUOTE
It is important to note that there is a massive amount of lithium on earth. Lithium is not like oil .... there is a massive amount of it pretty much everywhere, Musk said, explaining that all US vehicles could be replaced with EVs using lithium sourced in America alone.

Mr Baglino added: There really is enough lithium in Nevada alone to electrify the entire US fleet.

Investors responded by offloading shares in Australian lithium producers. That followed a 7 per cent fall for Tesla shares in after hours trading.

Galaxy Resources GXY plunged 11.6 per cent to $1.29; the following day saw them touch $1.15

Orocobre ORE shares dropped 6.5 per cent and continued to slide another 2% on Thursday.

Pilbara Minerals PLS gave up 6.8 per cent and a further 4% the next day.

Novonix NVX fell sharply after reported speculation that it may be revealed as a technology provider to Tesla failed to materialise. Its shares closed on the Wed some 11.6 per cent lower at $1.29, after erratic and speculative swings when it had surged to $2.40 at open. Come Thursday it went below $1.20.
  Forum: By Share Code

nipper
Posted on: Yesterday, 11:02 AM


Group: Member
Posts: 7,511

Element 25 Limited (E25, formerly Montezuma Mining Company Ltd) is an ASX listed mineral exploration and mining company exploring for manganese, copper and gold deposits in Western Australia.


The Company has a 100% interest in Yamarna Gold Project, Butcherbird Manganese Copper Project and Green Dam Project. Principal focus now seems to be on Butcherbird, where they are:
QUOTE
...building a globally significant, low cost, high purity manganese project turbocharged by early cashflow from a low capex concentrate export opportunity.
• Large resource, currently >260 Mt of manganese ore in Measured, Indicated and Inferred JORC resources • Maiden Proved and Probable Reserve of 50.6M tonnes at 10.3% Mn for 5.22t of contained manganese • Excellent local infrastructure (bitumen road and gas pipeline).
• 100% owned by Element 25 Limited.
• Located in WA, ranked as the #1 mining investment jurisdiction globally• Very simple geology, low strip ratio and free dig (no blasting) mining. • Measured and Indicated resources underpin the 42 year PFS.
• Simple beneficiation process.
• Pre Feasibility Study highlights outstanding economics.
  Forum: By Share Code

nipper
Posted on: Yesterday, 09:40 AM


Group: Member
Posts: 7,511

Euro Manganese (ASX: EMN) is a Canadian company focused on the development of a new high purity manganese production facility, based on the recycling of a tailings deposit located in the Czech Republic. Activities are conducted through the wholly owned subsidiary, Mangan Chvaletice sro, which holds a 100% interest to the Chvaletice Manganese Project.


Elon Musk is pushing the vehicle manufacture industry to seek out more high purity manganese to power its vehicles. As the world transitions to electric vehicle (EV) dominance, manganese will play a key role in EV production.
QUOTE
At the Tesla Battery Day 2020, held today, Musk said Tesla's next generation EV batteries will contain 1/3 manganese. It is relatively straight forward to do a cathode that's 2/3 Nickel 1/3 Manganese, which will allow us to make 50% more cell volume with the same amount of Nickel, Musk said.

A well located, ASX company could be one of the beneficiaries. Euro Manganese Inc (ASX: EMN) is sitting on the largest manganese resource in Europe, right in the thick of the action when it comes to battery markets in Europe, where there is no local manganese supply.

EMN has the largest manganese resource in Europe and will recycle waste to produce highly refined manganese metal and salts (no mining"involved). Furthermore, it is strategically located in the Czech Republic with 6+ large battery factories located just 200 to 500kms away.

Tesla will need to source its manganese from a local supplier to keep costs manageable. The Telsa Gigafactory under construction in Germany will be the most advanced high-volume electric vehicle production plant in the world and the company plans to produce 500,000 electric vehicles at the Grünheide site starting from the European summer of 2021.

Europe is at the heart of the EV revolution and Tesla's announcement today could prove to have a snowball effect on European manufacturers who are likely to follow in the US company's footsteps in seeking out a high-grade manganese product and localising cathode production.

Automakers like Volkswagen, General Motors, and Ford are already pouring billions of dollars into EV development and making a huge investment in this space as they fight over the growing consumer market. The changing landscape in Europe coincides with a scaling down of subsidies in China. Sales of EVs in Europe are projected to exceed one million units in 2020 and to grow rapidly in the years to come.

It comes as the EU prepares to 'recharge' its climate action plan and increase its climate targets to achieve a 55% reduction in greenhouse gas emissions by 2030, a move welcomed by clean transport group Transport & Environment (T&E).

EMN well placed
EMN intends to produce battery grade manganese by reprocessing tailings in the Czech Republic.

The following map illustrates the proliferation of battery plants and the extensive network of automotive and battery manufacturers in mainland Europe and the location of EMNs Chvaletice Manganese Project (CMP) in the Czech Republic, relative to the major European EV and battery manufacturing hub.



The company will be waste recycling from historic mines and delivering high purity manganese to EU battery makers. EMN plans to reprocess Europe's largest manganese deposit, which is hosted in historic mine tailings in the Czech Republic, in order to produce high purity manganese products (HPM) in an economically, socially and environmentally sound manner. EMN expect to become the only primary producer of high purity manganese in the EU, where 100% of manganese requirements are currently imported. Currently, the bulk of the world's production of manganese ore occurs in South Africa, China, Australia, Brazil, India and Gabon.

Several prospective customers have expressed interest in procuring high-purity manganese products from the project, and in conducting supply chain qualification of the products of the proposed Chvaletice demonstration plant.

Attracted by the strategic European position of Chvaletice, the incomparable low environmental footprint of the project (no mining or new solid waste generation), and the exceptional purity of the products that Euro Manganese has produced in previous pilot plant trials, five memorandums of understanding have been signed to date with major customers. These are intended to evolve into longterm offtake agreements.
  Forum: By Share Code

nipper
Posted on: Yesterday, 09:16 AM


Group: Member
Posts: 7,511

Brickworks has posted a 93.27 per cent lift in statutory net profit to $298.9m for 2020 as a one off profit was recognised from the merger of TPG and Vodafone via its sizeable investment portfolio and cross shareholding with Washington H Soul Pattinson.

The building products supplier said revenue for the 12 months to the end of July 2020 rose 4 per cent to $953m, with a strong contribution from its property business adding $94m in value for the year while its core brick operations in Australia and the US performed well despite the disruptions of COVID19.

Directors declared a fully franked final dividend of 39c per share, an increase of 1c on the prior year, bringing the full year dividend to 59c, up by 2c. The record date for the final dividend is October 15, with payment on November 25.

However, for the first time a dividend reinvestment plan will be offered to shareholders for the first time. Soul Pattinson will not participate in the DRP. The final dividend will be partially underwritten for an amount of $20m (representing approximately 34 per cent of the total dividend. Brickworks holds a 42.7 per cent of the shares in diversified investment company Soul Pattinson and Soul Pattinson, owns 44.23 per cent of Brickworks. The cross shareholding was created in 1969 via a share swap.

Brickworks has recently embarked on an expansion strategy into the US, buying up three brick operations in North America. For fiscal 2020 Brickworks’ US operations delivered earnings of $10m, up 63 per cent.

In Australia its flagship building products operations posted a 9 per cent fall in revenue to $687m as earnings fell 43 per cent to $33m. Despite the coronavirus pandemic disrupting operations the business has now seen sales grow strongly in September as government stimulus pumps up spending.
  Forum: By Share Code

nipper
Posted on: Sep 23 2020, 06:22 PM


Group: Member
Posts: 7,511

A couple more hopefuls.

EMN ... European Manganese

E25 .... Element 25. Self evident.
  Forum: By Share Code

nipper
Posted on: Sep 23 2020, 12:03 PM


Group: Member
Posts: 7,511

pushing higher.... $11.25
(missed this run up ; will not chase)
  Forum: By Share Code

nipper
Posted on: Sep 23 2020, 10:45 AM


Group: Member
Posts: 7,511

speaking at Tesla Battery day, Mr Musk said many things, especially about getting the cost of batteries down
QUOTE
To help reduce cost, Musk said Tesla planned to recycle battery cells at its Nevada gigafactory, while reducing cobalt, one of the most expensive battery materials, to virtually zero. It also plans to make its own battery cells at several highly automated factories around the world.

might even delete the Cobalt hopefuls watchlist
  Forum: Macro Factors

nipper
Posted on: Sep 23 2020, 10:06 AM


Group: Member
Posts: 7,511

speaking at the much hyped Battery Day, EM said a few things and TLSA shares fell heavily
Building an affordable electric car has always been our dream from the beginning of the company, Musk told an online audience of more than 270,000.

However, Musk described a new generation of electric vehicle batteries that will be more powerful, longer lasting and half as expensive than the company's current cells .

The new Tesla larger cylindrical cells, called 4680, will provide five times more energy, six times more power and 16 per cent greater driving range, Musk said, adding that full production is about three years away.

We do not have an affordable car. That's something we will have in the future. But we've got to get the cost of batteries down, Musk said.

To help reduce cost, Musk said Tesla planned to recycle battery cells at its Nevada gigafactory, while reducing cobalt, one of the most expensive battery materials, to virtually zero. It also plans to make its own battery cells at several highly automated factories around the world.

Tesla will produce the new battery cells initially on a new assembly line near its vehicle plant in Fremont, California, with planned output reaching 10 gigawatt hours a year by the end of next year. Tesla and partner Panasonic now have production capacity of about 35 gWh at the Nevada battery gigafactory.

Tesla aims to rapidly ramp up battery production over the next few years, to 3 terawatt hours a year, or 3000 gigawatt hours; .... roughly 85 times greater than the capacity of the Nevada plant.

The car maker plans to produce the new cells via a highly automated, continuous motion assembly process, according to Drew Baglino, Tesla senior vice president of powertrain and energy engineering.

Musk acknowledged that Tesla does not have its new battery design and manufacturing process fully complete.

  Forum: Investment Discussion

nipper
Posted on: Sep 22 2020, 09:11 PM


Group: Member
Posts: 7,511

The Future Super marketing strategy and target audience are obvious; the homepage, for example, is dominated by an image of hope filled Millennials jumping for joy in back to front caps in front of solar panels and clear blue sky. The fund has been found to charge relatively high fees despite being invested overwhelmingly in passive, low cost products (namely ETFs run by Betashares). Moreover, its large allocation to those products has raised questions about whether commercial ties to the manufacturer may be driving risky outcomes for members.

Its subfunds, Verve Super and Cruelty Free Super, another fund held by Diversa Trustees and to which Future Super is a sub promoter and sub investment manager, also adopt a marketing strategy designed to appeal to particular cohorts.


Verve Super advertises itself as for women, by women. Verve Super has adopted the World War II icon Rosie the Riveter as its logo and sponsored the podcast of feminist Clementine Ford.Along with a $93.60 annual membership fee, Future Super charges a combined administration and investment fee of 0.98 per cent per annum, made up of a 0.33 per cent direct and indirect investment fee, and a 0.65 per cent administration charge. Verve Super fees are higher, charging members the same flat annual membership but an administration and investment fee of 1.19 per cent a year.

On a balance of $50,000, Future Super would cost members $583.60 a year, while Verve Super members would pay $688.60, well above many other funds.


Cruelty Free Super promises superannuation with no nasties, aimed at the growing demographic of vegan Australians. Its website features a dreadlocked young woman hugging a donkey in the snow.
In a significant event notice letter sent to members, Cruelty Free Super said it would reduce overall fees from 01 October, with the investment fee falling from a flat 1.25 per cent per annum to 0.93 per cent a year. However, Cruelty Free has jacked up the administration fee from 0.64 per cent to 0.94 per cent a year.

This means the average member with a balance of $50,000 will be charged $992 a year, down from $997, a reduction of $5, and still around double the fees of major industry super funds.

- come on down,




( https://www.afr.com/companies/financial-ser...20200610-p5515x )
  Forum: Investment Discussion

nipper
Posted on: Sep 22 2020, 01:32 PM


Group: Member
Posts: 7,511

not sure how long that defence is going to hold, eb ... this will cannibalise the most lucrative bits. A thousand cuts...

QUOTE
NBN Co will slash wholesale enterprise broadband prices and invest $700 million over the next three years, as it ramps up its bid to challenge Telstra as the dominant wholesale business broadband provider.The announcement, a taster of the latest corporate plan to be released on Wednesday, will make its CBD prices available to 700,000 suburban and regional businesses.....

Under this plan, NBN Co will build fibre optic cable out to a business premises free of charge, and then provide its enterprise ethernet plan. All this must be done through a retailer, meaning NBN Co will rely on major providers such as Telstra, Optus and TPG getting on board.
One industry source said most providers apart from Telstra were likely to welcome the move, as it would break the TLS stranglehold on the sector.

QUOTE
Business telco provider Macquarie Telecom welcomed the announcement, calling it a complete turnaround from the detrimental journey tier one telcos had us on before the NBN was introduced and executed. Crucially, the availability of point to point fibre on demand to 85 regional zones will bring greater competition to regional Australia and be the final nail in the coffin for tier ones underserving and overcharging regional businesses that have not had choice of provider, group executive Luke Clifton said.
  Forum: By Share Code

nipper
Posted on: Sep 22 2020, 11:31 AM


Group: Member
Posts: 7,511

Hydrogen, batteries, green steel, carbon capture and storage, and soil carbon have been identified by the federal government as the five top priority, low emission technologies it will aim to develop over the next decade.

The long awaited technology road map, to be released on Tuesday by Energy Minister Angus Taylor, ranks energy efficiency, and electric and hydrogen vehicle recharging infrastructure as second level emerging technologies while nuclear power is delegated to a third order watching brief priority.

Mature technologies including coal, gas, wind and solar come fourth and last on the priority list.
QUOTE
Hydrogen, for example, will be deemed competitive when it can be produced for $2 a kilogram or less. It could then be used as a mainstream fuel for generating electricity to back up renewables, heavy transport and industrial applications such as producing ammonia or smelting steel...


... there is, as expected, a fair amount of pushback, especially where hydrogen production comes from non renewables
  Forum: By Share Code

nipper
Posted on: Sep 22 2020, 10:50 AM


Group: Member
Posts: 7,511

after a year of change and growth, including raising $2.3 million
QUOTE
.... with product/market fit now being established and the veracity of the underlying technology proven, there are many opportunities to continue growing the archTIS business in both public and private markets.

We expect growth to be organic and from selected merger and acquisition opportunities should they arise.
QUOTE
archTIS has also reduced its monthly operational expenditure by 32% since March 2020 as expenses shifted from software development to sales and marketing.
get out there and reel them in!
  Forum: By Share Code

nipper
Posted on: Sep 22 2020, 10:45 AM


Group: Member
Posts: 7,511

yep, slippery decimal point. Sorry about that
QUOTE
secured further funds by having utilised its Controlled Placement Agreement with Acuity Capital to raise $900,000 (inclusive of costs) by agreeing to issue 15 million LKE shares to Acuity Capital at an issue price of $0.06.

The issue price of $0.06 is marginally above the 15 trading day VWAP of $0.0593 to 21 September 2020 (inclusive).

The funds raised will be used, together with other funds on hand, towards accelerating the Definitive Feasibility Study for the development of Lake’s Kachi Lithium Brine Project, general exploration and working capital.

  Forum: By Share Code

nipper
Posted on: Sep 21 2020, 05:27 PM


Group: Member
Posts: 7,511

Hit a 50% rise and above 90c.. without any news. ASX will be in contact.
  Forum: By Share Code

nipper
Posted on: Sep 21 2020, 11:33 AM


Group: Member
Posts: 7,511

whoops
QUOTE
Market Update .... China accounting irregularities; audit investigation ongoing

Phoslock Environmental Technologies wishes to advise that an ongoing independent investigation initiated by the Chairman and Managing Director has revealed certain accounting irregularities relating to PET China Operations.
The investigation, being undertaken by the KPMG forensic accounting division, follows suspected accounting irregularities discovered during the audit process for the half year ended 30 June 2020. The company will seek to leave the current voluntary suspension of trading in place until the investigation and resulting KPMG report is completed and the impact of any irregularities is quantified...

too late. What steps should I take? BIG ones
  Forum: By Share Code

nipper
Posted on: Sep 21 2020, 10:58 AM


Group: Member
Posts: 7,511

another goldie waking up, made a placement, WA crowd in early i would suspect ....

from an announcement a week or 2 ago :
QUOTE
The Company has completed a low level detailed airborne magnetic survey over the entire tenement areas of Roberts Hill and Mt Berghaus. Thorough evaluation of the total magnetic intensity data will commence with a special focus on identification and delineation of special intrusive rock types within specific shear and lineament orientations. Anomalous locations will then be further evaluated by future drilling.

Following successful Heritage and Government approvals, the Company is optimistic that it will be able to conduct the first pass aircore drilling program at Roberts Hill before year end.

now these tenements are near the de Grey find.
QUOTE
Caeneus CEO Rob Mosig commented, the placement completed by the Company last week has provided an excellent treasury to conduct meaningful exploration on our Mallina Province Projects. It is with great excitement that we can now fast track activities at our Roberts Hill project which immediately abuts the De Grey Mining Limited tenements containing their exciting Hemi and Shaggy deposits. We look forward with much confidence to interpret the latest low level magnetic data as a prelude to the aircore drilling we expect to start later this year.

always hard to know whether to get on board, train looks like it may have left the station ..... 0.2c in June to 0.5c in July, then 1c by August and now 1.9c a share.

  Forum: By Share Code

nipper
Posted on: Sep 21 2020, 10:48 AM


Group: Member
Posts: 7,511

still going. At 70c today; was 32c a month ago.... The Lithium story has had its reset, and interest is rebuilding?
  Forum: By Share Code

nipper
Posted on: Sep 21 2020, 10:31 AM


Group: Member
Posts: 7,511

still running. got to 92c and that is alltime high (though some dilution along the way). Now pulling back a bit.
  Forum: By Share Code

nipper
Posted on: Sep 20 2020, 05:51 PM


Group: Member
Posts: 7,511

Yep, I would say Through to the keeper, but then, he probably has one.
  Forum: Off Topic Chat

nipper
Posted on: Sep 20 2020, 05:40 PM


Group: Member
Posts: 7,511

https://arichlife.com.au/brainchip-asx-brn-...-prices-higher/

.....

QUOTE
I think that the chances that the company can sustain a market capitalisation of $1b for long seem very low indeed. Of course, I might be wrong.

Whether it is deserved or not, Brainchip will certainly go down in history as one of the most hyped up stocks the ASX has ever seen as of September 2020. Certainly, I have never seen $1.3b in market cap for a company with $14,000 in half year revenue, before. But if dedicated Facebook groups, and meme generating Reddits remain as dedicated to promoting speculative stocks as they have been these past few months, we may well see other stocks rise just as high on the power of the dream


..
So, that is an Avoid then?
  Forum: By Share Code

nipper
Posted on: Sep 20 2020, 01:28 PM


Group: Member
Posts: 7,511

▪ Andromeda has one of the world's largest resources of halloysite kaolin
▪ This is a high value industrial mineral selling into a low volatility market

▪ Global demand is increasing and supply is decreasing
▪ Low capex project with a short timeline to operation
▪ Simple business model with low impact mining
▪ Andromeda is well positioned to become the world's leading producer of this mineral
▪ Huge potential in new application, high purity halloysite, nanotube technology and HPA
▪ Opportunities to build a diversified industrial minerals business

https://www.sharecafe.com.au/2020/09/14/and...r-presentation/
  Forum: By Share Code

nipper
Posted on: Sep 20 2020, 11:47 AM


Group: Member
Posts: 7,511

you make no sense, plastic. Clueless.
  Forum: Off Topic Chat

nipper
Posted on: Sep 20 2020, 11:46 AM


Group: Member
Posts: 7,511

it is funny how such diverse groups of people, that have come together and built a cohesive society, are now vilified as exemplars of white privilege.
  Forum: Off Topic Chat

nipper
Posted on: Sep 19 2020, 03:33 PM


Group: Member
Posts: 7,511

Tesla Battery Day is scheduled for September 22nd. Announcements on increased energy output, price and range advantage are expected as well as ....
QUOTE
a transformation in the core structural design of a vehicle ..…its quite a big thing, says Elon Musk. He has also teased it will … blow your mind. It blows my mind, and I know it!
https://www.sharecafe.com.au/2020/09/17/wil...at-battery-day/

.....New technology developments in the area of ESG and recycling include ASX listed CleanTeq (CLQ), Neometals (NMN) and Lithium Australia (LIX).

In the battery materials space stocks to watch could include Novonix (NVX), Pure Minerals (PM1) and Magnis Technologies (MNS).

Other clean technology companies could include EcoGraf (EGR) and Lakes Resources (LKE).

  Forum: Investment Discussion

nipper
Posted on: Sep 19 2020, 03:09 PM


Group: Member
Posts: 7,511

22 Sept.... Battery Day


https://www.sharecafe.com.au/2020/09/17/wil...at-battery-day/
  Forum: Investment Discussion

nipper
Posted on: Sep 19 2020, 12:25 PM


Group: Member
Posts: 7,511

Matthew Kidman (Livewire Markets) : Okay. Wake us up from our boredom. What is one stock that looks a bit boring, but it is actually a ripper?
QUOTE
Chris Stott (1851 Capital) : Generation Development Group, Matthew. GDG is the ticker. It is the best microcap opportunity in the market for us right now. So, they are in the investment bond space, which is really good from a tax effective standpoint, particularly for people rolling out of super. Their funds under management sits at $1.4 billion at the moment and is growing dramatically .... very, very quickly. They grew substantially through that pandemic period. Led by Grant Hackett, we think that it has certainly carved out a really good niche and got a really strong balance sheet with $12 million net cash. So, a high propensity to grow. So that's a buy for us.

and now Lonsec acquisition.
  Forum: By Share Code

nipper
Posted on: Sep 19 2020, 12:22 PM


Group: Member
Posts: 7,511

now renamed as Generation Development Group (GDG)


Generation Life is a specialist provider of investment bond product solutions; it established the first truly flexible investment bond product for Australia over 15 years ago.
Austock Financial Services provides administration services, including unit pricing, fund valuation, investment and fund accounting, fund administration and business registry services.

Generation Development Group will launch a $35 million equity raising via stockbrokers Morgans and Moelis to fund the acquisition of a stake in Lonsec, and investment research and consulting business. The raising is expected to be structured as an underwritten placement and rights issue, and done at a discount to the last close of 84¢.

Group chairman Rob Coombe earlier flagged the company was looking to make acquisitions:
QUOTE
As previously stated, we are attracted to businesses that we think will benefit from changes in the landscape in financial services or that are good value and need to be restructured to a more future proof business model.
Generation Development Group had $1.2 billion in funds under management as at 30 June, up from $1.07 billion one year earlier. The group recorded $15.3 million revenue in the 2020 financial year and posted a $2.8 million net profit after tax.
  Forum: By Share Code

nipper
Posted on: Sep 19 2020, 12:15 PM


Group: Member
Posts: 7,511

Matthew Kidman (Livewire Markets): Okay, when you travel, you have got somewhere to stay. Ingenia, accommodation: buy, hold, or sell?
QUOTE
Chris Stott (1851 Capital): Hold for us. So, again, very strong management team in that lifestyle space, which is a really good thematic over the medium term, but we think the stock has had a really strong performance in more recent times so I will hold for now.


Matthew Kidman (Livewire Markets): We all need a bit of value accommodation. It is a big market. Ingenia. Buy, hold, or sell?
QUOTE
Gary Rollo (Montgomery Markets): Ingenia is a buy for us. As Chris identified, that stock has got significant tourism assets, so it is a play on domestic tourism ... hard to find. There is lots of operational leverage when those parks get filled up, as you might imagine. It is all fixed cost. That stock had upgrades of about 12 per cent as a result of those good results that Chris mentioned. The stock has not really performed as a result. We think that the stock should do well once the domestic holiday season becomes apparent as a driver for earnings and this is a great way to play that. So, Ingenia is a buy.
  Forum: By Share Code

nipper
Posted on: Sep 19 2020, 12:11 PM


Group: Member
Posts: 7,511

Matthew Kidman (Livewire Markets): Now, Macquarie Telecom used to be really boring .... just sell your voice products. Now they build data centres. Buy, hold, or sell?
QUOTE
Gary Rollo (Montgomery Investments): Macquarie Telecom is a buy. This one has got everything for us. The top line over the course of the next four or five years is going to be driven by the data centre earnings power, and that is a great theme. You know, cloud is driving that market. The business can self fund the data centre development, so there is no need for extra capital. The stock is on 12 times EBITDA. You have got a management team that has delivered since it has been listed for about 12 or 13 years. It is a buy.



Matthew Kidman (Livewire Markets): Okay. You sound like you're falling in love, not picking a stock. Chris,: Macquarie Telecom. It's really changed itself over time. It might have been boring, but it has really got investor interest. Buy, hold, or sell?
QUOTE
Chris Stott (1851 Capital): Hold, Matthew. So, FY21 for Macquarie Telecom was an investment year, so they are deploying over $140 million of CapEx into a couple of new data centres at Macquarie Park and down in Canberra. So, again, David Tudehope, major shareholder, has done a terrific job with this business for well over a decade and continues to do so. But for now, it is an investment year, which will suppress their earnings in the second half of this financial year, so we'd look to review it around that stage, but for now, it's a hold.
  Forum: By Share Code

nipper
Posted on: Sep 19 2020, 12:04 PM


Group: Member
Posts: 7,511

Matthew Kidman (Livewire Markets): Gary, it has been around forever. Been a super stock ARB. Buy, hold, or sell?
QUOTE
Gary Rollo (Montgomery Investments): ARB is a sell for us. Look, it is super high quality. Whenever you mention quality in small caps, ARB jumps into mind, so it is a premier league type stock. The problem is opportunity. At 19 times EBITDA and a business model that is capable of delivering mid single digit type growth, you are paying a lot for that quality. So, Liverpool type quality, but Tranmere Rovers type of opportunity .... so pass that one on.


Matthew Kidman (Livewire Markets): Chris, while we're in lockdown in COVID, nothing better than ripping off the old bumper bar and putting on a new one, a few floodlights. ARB. Buy, hold, or sell?
QUOTE
Chris Stott (1851 Capital): Buy, Matthew. So, one of the strongest results we saw at reporting season, they called out a record order book in their history. They are actually struggling to keep up with demand at the moment out of their Thailand facility, and also Kilsyth and Melbourne. So, a really strong balance sheet, great management team, really leveraged to that interstate travel thematic over the next six to 12 months. So buy.
  Forum: By Share Code

nipper
Posted on: Sep 19 2020, 11:41 AM


Group: Member
Posts: 7,511

There is nothing yet on the ASX Upcoming Floats page
https://www.asx.com.au/prices/upcoming.htm

though things might change. This potential float is timely; some might even say opportunistic, especially as the potential raise amount has doubled.
QUOTE
Facemask maker CleanSpace to launch.

Street Talk understands the ASX aspirant, which manufactures respiratory masks for workers in the healthcare and industrial sectors, will launch its IPO bookbuild on Thursday next week, with help from its brokers Wilsons and Bell Potter. It is understood the company was looking to snare $131.4 million, after originally planning to raise up to $60 million. A raising of that size implied an enterprise value of $305 million and a market capitalisation of $340 million. The bookbuild would be launched after three days of marketing meetings with fund managers from Monday to Wednesday next week.

It is understood those meetings would be mainly aimed at the investors who had signed up to cornerstone the raising and cornerstone institutions were being sent a pathfinder prospectus on Friday. At those meetings, funds were told that the company posted $28 million in revenue for fiscal 2020 and exports its masks to more than 40 countries. Its clients include the likes of Ramsay Health Care, Sydney Childrens Hospital, Rio Tinto, Boral and Airbus.

Existing investors in the business include fund managers Acorn Capital and CVC.

Founded in 2009 by ResMed engineers, the company is helmed by ex PwC operative Dr Alex Birrell, who is supported by chief financial officer and former Macquarie director Elizabeth Harvey.

CleanSpace plans to hit the boards on 23 October.
https://www.afr.com/street-talk/medical-dev...20200918-p55wua

The respirators provide filtered air and utilise sensors to provide enough clean air depending on how deeply the user is breathing.
  Forum: Off Topic Chat

nipper
Posted on: Sep 19 2020, 11:23 AM


Group: Member
Posts: 7,511

Spotlight on CSL Revenue Targets

https://www.sharecafe.com.au/2020/09/14/spotlight-on-csl-revenue-targets/


  Forum: By Share Code

nipper
Posted on: Sep 18 2020, 07:23 PM


Group: Member
Posts: 7,511

QUOTE
A key trend is the dramatic reduction of air cargo capacity as a result of the significant loss of commercial airline capacity. Current estimates indicate that freighter capacity now accounts for 66% of total air capacity on the Transatlantic lane; 83% on the Trans Pacific; and 80% on the Europe to Asia lane. This compares to pre COVID freighter capacity of 33% for Transatlantic; 59% for Trans-Pacific and 50% for Europe to Asia.


QUOTE
Pre COVID, we projected that the US domestic market would hit 100 million packages per day by calendar year 2026. We now project that the US domestic parcel market will hit this mark by calendar year 2023, pulling volume projections forward by three years from the previous expectations. E-commerce fuelled substantially by this pandemic is driving the extraordinary growth

Brie Carere, Chief Marketing Officer, FedEx Corporation
  Forum: Off Topic Chat

nipper
Posted on: Sep 18 2020, 06:55 PM


Group: Member
Posts: 7,511

meantime
QUOTE
On Friday afternoon, 60 wharfies kickstarted the latest round of industrial action by walking off the DP World terminal for four hours and holding a meeting led by Maritime Union Australia Sydney secretary Paul McAleer.The MUA is striking in response to DP World push to change rosters and better deal with idle time as part of productivity offsets. It comes at the same time as action at the Patrick and Hutchison Port Botany terminals.

as a response, Maersk, the worlds largest shipping line has stopped imports arriving in Sydney, a strong response to the union industrial campaign that is stretching supply chains already under COVID19 pressure. Fashion wear, hand sanitiser, electrical products and furniture are inside some of the thousands of containers subject to 11 day delays, or forced to head instead to Melbourne as a result of action affecting all three major stevedores at Port Botany.


.... and who were the goons that went on strike when the Japanese were attacking at Milne Bay in 1942? ... Um ....
  Forum: Off Topic Chat

nipper
Posted on: Sep 18 2020, 06:50 PM


Group: Member
Posts: 7,511

that is the issue... the ethnicity. the cultural norm of clan loyalty
  Forum: Off Topic Chat

nipper
Posted on: Sep 18 2020, 03:51 PM


Group: Member
Posts: 7,511

delayed reaction, probably, to the notification from yesterday
QUOTE
... announce significant increases in the natural graphite mineral resources within its wholly owned Vittangi Graphite Project....
could even be Europe based buying? up nearly 20% to 75c
  Forum: By Share Code

nipper
Posted on: Sep 18 2020, 01:37 PM


Group: Member
Posts: 7,511

I am rereading A Fortunate Life by A B Facey.


Baby boomers got lucky !!
  Forum: Macro Factors

nipper
Posted on: Sep 18 2020, 01:29 PM


Group: Member
Posts: 7,511

like the ambition. 10 Full ones.

the market is throwing some startling run-ups in tech and exploration sectors
  Forum: By Share Code

nipper
Posted on: Sep 18 2020, 11:41 AM


Group: Member
Posts: 7,511

to and fro
QUOTE
RECOMMENDED 5GN OFF MARKET TAKEOVER BID

Webcentral today announces that:
... the Webcentral Board has determined that neither the Web.com Counterproposal nor the Revised Web.com Proposal (with the revised consideration of $0.18 per Webcentral share) would provide an equivalent or superior outcome for Webcentral shareholders as a whole compared with the 5GN Proposal;

... the Webcentral Board has determined that the 5GN Proposal is a Superior Proposal to the Web.com Counterproposal and the Revised Web.com Proposal, notwithstanding the increased headline cash offer of $0.18 by Web.com; and

... Webcentral has entered into a bid implementation deed with 5GN
  Forum: By Share Code

nipper
Posted on: Sep 18 2020, 11:30 AM


Group: Member
Posts: 7,511

Clover announced today. will pay 2.5c dividend. Some growth but impacted by Covid, in several ways.

Negatively, the new NZ plant taking longer to get going; finding it hard to build volumes with customers. The reaching into new markets impaired by travel restrictions. New products on hold.

on the plus side, home sales lifted with stocking of pantries, but this may be a one off.
  Forum: By Share Code

nipper
Posted on: Sep 18 2020, 11:23 AM


Group: Member
Posts: 7,511

buyers have given way to sellers for VOR.

down to 18c, but volume is off as well.
  Forum: By Share Code

nipper
Posted on: Sep 17 2020, 05:54 PM


Group: Member
Posts: 7,511

closed on its high... $1.195 (was 7c only six months)
  Forum: By Share Code

nipper
Posted on: Sep 17 2020, 04:54 AM


Group: Member
Posts: 7,511

I may look further, but my initial reaction when I see this headline is to think along the lines of Socialising losses and privatising profits


https://www.afr.com/companies/energy/cannon...20200916-p55w2t
QUOTE
Cannon-Brookes and Musk keen for big battery number two

The two billionaires chatted overnight, but Mike Cannon-Brookes says the Morrison government must clearly set out the rules of engagement before he backs a new investment.
.
  Forum: Macro Factors

nipper
Posted on: Sep 16 2020, 09:27 PM


Group: Member
Posts: 7,511

https://stockhead-com-au.cdn.ampproject.org...-rare-upside%2F
  Forum: Investment Discussion

nipper
Posted on: Sep 16 2020, 04:58 PM


Group: Member
Posts: 7,511

has been around since 2014 .... so it has been a long time coming. And evolving with a SaaS model of late.

Worldwide reach as Strata Title law seems to be following the Aust model ... might give an advantage?
  Forum: By Share Code

nipper
Posted on: Sep 16 2020, 04:39 PM


Group: Member
Posts: 7,511

Urbanise.com Limited (UBN) is a provider of industry specific cloud based software platforms designed and developed for the Strata, Facilities Management, Utilities and Insurance industries. The products offered by UBN include Urbanise Strata Platform, Urbanise Facilities Management Platform and Urbanise Utilities Platform.

Strata Managers
Primary use
• Manage apartment buildings, strata commercial towers and large housing communities
• Accounting and administration of strata bodies and funds
• Communicate with owners and residents
Benefits
• Integrated finance, banking and operations platform
• Compliance with local strata legislation
• Mobile app and e-services


Facilities Managers, Outsourcers, Asset Managers
Primary use
• Manage infrastructure, buildings, residential and commercial properties
• Asset Management
• Workforce Management
Benefits
• Reduce paperwork and administration costs
• Manage multiple assets & contracts from one place
• AI and machine learning
• Real time reporting and analytics
  Forum: By Share Code

nipper
Posted on: Sep 16 2020, 10:53 AM


Group: Member
Posts: 7,511

was going to put this in The banks thread, but here is probably more relevant
QUOTE
The coronavirus pandemic has of course thrown up lots of problems for business leaders, but senior bankers face a novel challenge in working out how to manage the tens of thousands of home loan borrowers who have decided to ghost them.

It's estimated that around one in five customers who opted to defer their home loan repayments are now ghosting their bankers: they are simply refusing to respond to phone calls, texts, letters and emails from the banks.

Now, this is not an insignificant number of would be ghosters. According to figures provided to the Australian Prudential Regulation Authority, the banks still had about 414,430 deferred home loans, with a total value of $167 billion, on their books as at the end of July.

Even if the banks have made some progress in whittling down the number of deferred home loans, it suggests that about 80,000 home loan borrowers, who owe a little more than $30 billion, have decided that their best financial strategy is to avoid having any sort of contact with their bankers.....
https://www.afr.com/companies/financial-ser...20200914-p55vil

so... where now?
QUOTE
[It has been]pointed out that although APRA has given them capital relief on deferred home loans until March next year, the prudential regulator does require banks to form a view as to whether the borrower will eventually be in a position to resume repayments. And this means that banks need to have conversations with their customers so that they can more accurately gauge their financial situation.
Indeed, bankers say that the clear message they are getting from APRA is that the prudential regulator does no want banks to give borrowers the impression that loans will be rolled indefinitely.
So where does that leave the tens of thousands of ghosters?

One senior banker explained that people were obviously not talking to the banks in the hope that the problem might simply go away. But, he added, this situation could not continue indefinitely. The notes will get a little bit sharper to get a response, he explained. He said that was why the banks were urging customers to talk to them before their six-month home loan deferral periods ran out. One month after, three months after, the letters will get more severe, he predicted.

But, he shrugged, then, of course, we'll get a bullying complaint.
and good luck to everyone
  Forum: Off Topic Chat

nipper
Posted on: Sep 15 2020, 09:57 AM


Group: Member
Posts: 7,511

as telegraphed
Offering SPP for up to $30,000 of ALI shares; open from 18 Sept and close on 09 Oct.

Price will be the LOWER of:
• $2.07 per new share (maximum price), which is a 2% discount to the volume weighted average price of ALI shares traded on the ASX on the Ex-dividend date; OR
• the volume weighted average price of ALI shares traded on the ASX over the last 3 days of the SPP Offer period (6 October to 8 October 2020 inclusive), rounded down to the nearest cent.
  Forum: By Share Code

nipper
Posted on: Sep 14 2020, 05:37 PM


Group: Member
Posts: 7,511

Hungry... Another under performer in his sights
QUOTE
A number of fellow shareholders of Contango Income Generator Limited (ASX: CIE) have called us asking how to lodge their vote against the Board of Director's illogical proposal at the upcoming Extraordinary General Meeting (EGM) on Friday, 18 September. We have also received numerous inquiries regarding the validity of CIE's distribution of pre-filled proxy forms, which is in breach of Listing Rule 14.2.1. We have material concerns about the challenging and intimidating tactics being used by CIE to solicit votes from shareholders for the EGM.

We thought it prudent to share with you clear instructions on how to lodge or change your vote. We consider it critical that shareholders are given a voice and are able to exercise their votes freely and validly.

Voting against the resolution on 18 September will allow Wilson Asset Management to continue to pursue our superior proposal for all CIE shareholders.

Your vote against the resolution can be submitted prior to the deadline of 10:00am (AEST) on Wednesday, 16 September 2020 ....

On 20 August 2020, CIE announced that it had received a notice under section 249D of the Corporations Act requesting that the company convene a meeting to consider resolutions to remove Mark Kerr and Don Clarke as directors of CIE and to appoint Geoff Wilson and Glen Burge. Wilson Asset Management has put forward additional resolutions requiring the Directors of CIE to call and arrange to hold a general meeting to consider the termination of the existing investment management agreement and the appointment of Wilson Asset Management (International) Pty Limited as manager.
  Forum: By Share Code

nipper
Posted on: Sep 14 2020, 04:53 PM


Group: Member
Posts: 7,511

thanks for updating on this. Angola sounds a challenge, the Lobito railway was upgraded by the Chinese and I suspect they will stick around, try and control production.


Now called Pensana Rare Earths. PM8

(I did not follow it subsequent to earlier posts)
  Forum: By Share Code

nipper
Posted on: Sep 14 2020, 03:21 PM


Group: Member
Posts: 7,511

Starpharma has completed additional antiviral testing for its SPL7013 COVID 19 nasal spray, with data generated at the Scripps Research Institute in the US showed the spray inactivating more than 99.9 per cent of SARS CoV 2, the virus that causes COVID 19.

The antiviral activity was evident both before and after exposure of cells to to the virus, meaning the spray could be used both before and after patients get infected.

QUOTE
We are delighted to be working with Professor Gallay to expedite the development of this important product, said Starpharma chief executive Jackie Fairley. This potent virucidal action is consistent with the activity seen for SPL7013 in other viruses, including HIV and HSV.


Starpharma said it was rapidly advancing development of the spray and with expedited approval, the product could be ready for market in the first half of 2021.
  Forum: By Share Code

nipper
Posted on: Sep 14 2020, 03:18 PM


Group: Member
Posts: 7,511

takeover

Pacific Equity Partners will buy enterprise software and services firm Citadel for $5.70 a share, giving the deal an enterprise value of $503.1 million and valuing Citadel's equity at $448.6 million. The purchase will take place via a scheme of arrangement, with the offer price representing a 43.2 per cent premium to Citadel's last closing price of $3.98 a share.

The Citadel board will declare a 15 cent per share special dividend, which will enable shareholders to receive up to 6.4 cents of franking credit benefits. The scheme will provide a scrip alternative to enable Citadel shareholders to retain an indirect interest in the business. The Citadel board unanimously recommends the deal in the absence of a superior proposal; directors intend to vote their Citadel shares in favour of the scheme.
QUOTE
"The scheme is an attractive transaction which provides an all-cash option for Citadel shareholders," said chairman Peter Leahy.
  Forum: By Share Code

nipper
Posted on: Sep 13 2020, 09:04 PM


Group: Member
Posts: 7,511

seems to be standard procedure. Cuff em when standing; if there is resistance, get em to the ground, immobilise then cuff.

Used to be called wallopers a while ago; much more sensitive and trained nowadays. outcome is similar.


  Forum: Off Topic Chat

nipper
Posted on: Sep 13 2020, 11:24 AM


Group: Member
Posts: 7,511

check out the clip on kabaddi in this article; great sport, should be in the Olympics (India, Pakistan, Nepal, Iran and a few of the 'stans)

https://www.abc.net.au/news/2020-09-13/indi...uccess/12648400
  Forum: Off Topic Chat

Poll: The Banks
nipper
Posted on: Sep 12 2020, 08:16 PM


Group: Member
Posts: 7,511

QUOTE
You could be forgiven for thinking ANZ, CBA, NAB and Westpac had abandoned wealth management. After a series of scandals culminating in the Hayne royal commission, the incumbents embarked on a series of big ticket asset sales, jettisoning troublesome divisions that caused them and their shareholders so much grief. But to suggest they have ceded the market to AMP and IOOF is not correct.

It is true to say they are no longer building, managing and selling everything from superannuation to insurance and managed funds. But wealthy bank customers still require advice and the big four are only too happy to oblige .... for a price.

The two giants of the wealth space, AMP and IOOF, have 3260 advisers between them. They manage about $200 billion on behalf of 1.5 million customers. The numbers will swell by 50 per cent after IOOF beds down the MLC purchase, with about 500 of its advisers expected to come across....

But as IOOF and AMP duke it out over the mass market, the big four have set their sights on a more lucrative prize; the 63,000 Australians classified as high networth individuals and estimated to be worth between $US5 million ($6.9 million) and $US10 million.

https://www.afr.com/wealth/personal-finance...20200908-p55tht

(but in reality, the cutoff is $A2.5mill,where sophisticated investor rules apply. No Statement of Advice, fewer protections and a lower compliance burden than those in place for retail investors.)
  Forum: Investment Discussion

nipper
Posted on: Sep 12 2020, 08:07 PM


Group: Member
Posts: 7,511

Westpac ... wealth management

Westpac, Australia's oldest bank, is pursuing the same model as the biggest bank, CBA. A model of wholesale only. Like NAB, however, it has moved the private bank into the business division.

It seems like a lifetime but it was only 18 months ago the bank said it was resetting its wealth strategy with the sale of its employed adviser arm to Viridian. Like the others, it has not turned its back on wealth entirely with about 500 staff at its private arm.

Ashley Stewart, managing director of Westpac Private Wealth, says it specialises in providing banking, lending and investment services to 10,000 customers.
QUOTE
Our global investment service for high net worth individuals is one of the market's fastest-growing propositions for sophisticated, wholesale investors with investable assets above $1 million, he adds.

On the investment side, Westpac will lend its expertise to help blend the right mix of equities, funds, property, debt, bonds, private credit and private equity. They also do execution and can discuss specific holdings.

If you have less than $1 million, Westpac is happy to give you the name of a good financial adviser. And they wont even take a commission. (aka forget about it, next, moving on quickly, get outa here, do not waste my time, I am not out of bed for less than $2mill, etc)
  Forum: By Share Code

nipper
Posted on: Sep 12 2020, 08:02 PM


Group: Member
Posts: 7,511

ANZ .. wealth management

As James Dunlop, ANZ Private head of investments and wealth, tells it, the bank selling of its insurance arm to Zurich and its advice arm to IOOF, was one of the best things that could have happened.

Freed from the shackles of vertical integration, the private bank and high net worth advice arm of ANZ has been able to pursue a best of breed model, installing the product agnostic Netwealth as a default platform (which costs just 15 basis points per annum) and concentrate on delivering for the client.
QUOTE
It creates a good environment for people to work in, they are not the distribution business they were historically, Dunlop adds.
Costs at ANZ Private start at $6000 for statement of advice and average about $12,000 per annum for ongoing advice. The business has about 6000 clients and 350 staff including 100 bankers and 35 advisers. It also draws on the expertise of 16 staff from the chief investment office within the bank.
QUOTE
If you are spending 75 per cent of your time talking to clients, you have to accept you are not the best stockpicker or fund selector, so having a robust chief investment office is really important, Dunlop says.

ANZ Private targets clients with investments and debt of $3 million. All members of the adviser team have completed the FASEA exams or will soon. Dunlop agrees that the wholesale or sophisticated investor classification reduces the compliance burden by as much as 75 per cent but says the bank doesn't have a preference for one over the other. We are of the view that just because you have a lot of money does not make you wholesale, he adds.
The division itself is not much of a rainmaker for the business either, Dunlop concedes. While describing what ANZ Private does for the bank customers as a core offering, its contribution to the bank bottom line is almost negligible, which should give clients some comfort they are not lining someone else's pockets. Delivery of advice is not a profitable section to be in; we are an ancillary service that probably breaks even, it is certainly not the game in town if you are looking to be making a huge amount of money, Dunlop says.
  Forum: By Share Code

nipper
Posted on: Sep 12 2020, 07:53 PM


Group: Member
Posts: 7,511

NAB - wealth management


The NAB high net worth advice business, private bank and self directed investor offerings were placed under the stewardship of Justin Greiner in May. Greiner has been CEO of the 180 year old JB Were since 2013 and is only the ninth chief executive in its history.
JB Were and NAB Private are the advice and private bank arms respectively. Clients may work with one or both arms. The two units have about 350 client facing staff and about 20,000 customers with $52 billion in funds under management.

At NAB the advice and private wealth businesses have been repatriated to the NAB business division from retail, the reverse of what has happened at CBA. This is an important distinction according to Greiner, who says retail is about volume and processes.
QUOTE
You are sitting in a retail business that wants simplicity, it wants one way, same way. The choice now is either basic banking or holistic, whole of balance sheet support and I don't think high net worth Australians have had the choice before, Greiner says.

JB Were targets customers with investable assets of $2.5 million and about half its client base are classified as wholesale or sophisticated investors. Despite the lower compliance burden, all JB Were advisers are undertaking their Financial Adviser Standards and Ethics Authority (FASEA) exams. FASEA is the new professional standard in Australia and must be completed by existing advisers by the end of 2021. We just believe in it. We want professionals in our industry, we need to lift, Greiner says.

The JB Were financial services guide says retail clients are charged a minimum $3300 for a statement of advice and a further $5500 for additional ongoing advice. Greiner says this is not set in stone. We have taken the view that today it comes down the conversation you have with the client; how much you have to invest and what the fees are, that is not the starting point. There is no minimum, tell us what is important to you, he explains.

JB Were operates a multi asset platform that allows customers to keep track of investments in cash, equities, fixed income and less liquid alternatives that are not readily tradeable such as private equity, hedge funds and the like.
  Forum: By Share Code

nipper
Posted on: Sep 12 2020, 06:59 PM


Group: Member
Posts: 7,511

Commonwealth Bank


Earlier this year Commonwealth Bank completed a small restructure that moved its private bank from its business bank to the retail bank (but more of that later). Commonwealth Private focuses exclusively on wholesale or sophisticated investors (defined as individuals with income of more than $250,000 or assets of more than $2.5 million).

The sophisticated investor regime comes with fewer protections and a lower compliance burden than those in place for retail investors while providing clients with priority entree to opportunities such as IPOs, capital raisings and hard to access investment vehicles.

Angus Sullivan, Commonwealth Bank's group executive of retail banking, says CBA sees a big opportunity with its private bank and plans to invest $100 million in staff and infrastructure over the next three years.

QUOTE
There are around twice as many customers of our retail bank who qualify than there are customers of our private bank. We see a huge opportunity here to grow the customer base and attract the best private bankers, Sullivan adds.


CBA is cagey about the numbers but Commonwealth Private is understood to have between 10,000 and 20,000 customers. The $100 million investment is earmarked for another 100 frontline staff, taking its staff numbers to 400 and a soon-to-be released Commonwealth Private-only mobile app.

Angus Sullivan says while many of the revelations from the Hayne royal commission were challenging, they were a wake-up call. Supplied

The move of private to the retail bank is a big plus, Sullivan says, because technology has long been one of CBA core strengths and the private bank can now leverage that.

QUOTE
We are going to have the best culture and the best technology. We've got a phenomenal franchise here– we are going to take what we have done on the lending front and apply it to the private bank.


Because Commonwealth Private deals only in wholesale clients, it doesn't need to provide customers with statements of advice. The cost of advice and management is on application, so it's difficult to line up against rivals.

As a client of Commonwealth Private (or indeed any of the private banks), you can expect the execution of domestic and international share trades, global fixed income, access to hedge funds, multi-currency accounts and all manner of lending services. But you will pay for it. Execution isn't cheap across any of the big four private banks.

The question is, will investors go for it? After the bollocking the big four banks received at the Hayne royal commission, why wouldn't an investor seek independent advice?

CBA is free of many of the conflicts it used to have. Insurance and global asset management have been sold. But it still retains the superannuation business and investment platforms. Sullivan says while many of the revelations from the Hayne royal commission were challenging, they were a wake-up call. You've got to do better than that, he adds.

  Forum: By Share Code

nipper
Posted on: Sep 12 2020, 06:04 PM


Group: Member
Posts: 7,511

Ha yes. One from the past.
  Forum: Off Topic Chat

nipper
Posted on: Sep 12 2020, 01:57 PM


Group: Member
Posts: 7,511

I reckon there is an App in this.....

Especially in these Covid times, instead of offering up the full plethora from the menu for each restaurant that then has to social distance its clientele, in some specific locations, suburbs oe where the concentration and range is sufficient, then a few or multiple restaurants (not talking fast food) get together and offer either tapas or degustation or equivalent, with their signature dishes available. Amblers and ramblers can stroll along and have a full dine out experience from multiple offerings.

I wonder if it would work? Though the punters would probably end up at the pub, looking for lubrication; ithe take up would not be evenly distributed!
  Forum: Off Topic Chat

nipper
Posted on: Sep 12 2020, 10:56 AM


Group: Member
Posts: 7,511

There was a LIC called Wealth Defender Equities WDE, run by one of the bigger houses. It traded at a discount and nothing the directors did to get it up to NTA worked. Quite like the predicament for a few newer LICs. Buybacks, boosting their holdings, and that sort of thing.

WAM took it over, and what happened then? The premium that WAM had disappeared as the former holders sold out. Bye, and thanks for all the fish!

LIC trading is low key. They attract the buy and hold crowd.

  Forum: By Share Code

nipper
Posted on: Sep 11 2020, 05:57 PM


Group: Member
Posts: 7,511

there is always a paradox with fund managers. .... low level of funds under management FUM allows for stock picking and potential outperformance, and hence reputation (bragging rights) .... Then, get the flow of money and then the fees that come with it make life comfortable, but it then becomes harder to deviate from the index.

So Geoff Wilson has a diversification strategy, lots of funds. Small cap, Leaders, Microcap, an overseas one. And now he has absorbed an Alternative Fund (BAF) that will be rebranded WMA
  Forum: By Share Code

nipper
Posted on: Sep 11 2020, 05:07 PM


Group: Member
Posts: 7,511

This is old school stock picking...

https://finfeed.com/stock-of-the-week/acrow...-out-investing/
  Forum: By Share Code

nipper
Posted on: Sep 11 2020, 04:47 PM


Group: Member
Posts: 7,511

the wind is coming out of the 5GN sails. ... since coming back on after the successful completion of the placement of 5GN shares to raise $27.5 million at an offer price of $1.80 per share.

(The Placement was completed with a broad range of new and existing institutional investors. 5GN notes that the 5GN Proposal [for WebCentral] is fully funded through the $27.5 million Placement), ... but there has been a steady sell down from $2.10 to close at $1.69 today.

DNH
  Forum: By Share Code

nipper
Posted on: Sep 11 2020, 03:39 PM


Group: Member
Posts: 7,511

there is another, lapsed, delisted company with BTH. This version has been around since 2017 and doing OK
QUOTE
Bigtincan Holdings Limited (BTH) is a provider of enterprise mobility software, that enables sales and service organizations to increase sales win rates, reduce expenditures and improve customer satisfaction through improved mobile worker productivity.

Bigtincan Hub is a secure, artificial intelligence powered solution for mobile workforces that enables sales and service organisations and their employees to better engage and win with customers. Bigtincan customers are located in over 50 countries and operate in diverse industries and market segments. Bigtincan has 300 paying customers with 150,000 users.

probably well suited to Covid times, and the SP is well above any March sell off
QUOTE
Matthew Kidman : Okay. Time to get ambitious. What is one stock you think is ambitious and taking on the world that we should know about?Gary Rollo: Our name today is Bigtincan. We think Bigtincan is a buy. It is a small cap technology stock, software as a service. Excellent business model. It is a company that has gone global. It has a client roster that ranges from Anheuser-Busch, through Nike, up to large tech companies.

What it does is it helps companies manage their sales enablement. That is a growing area of the market. It is growing its top line at 40 per cent. It is a $400 million market cap. It is one of these microcap stocks that are just about to get into that point where larger funds can take a look at it. So, we think the technology stacks it well and it's got a bright future.



  Forum: By Share Code

nipper
Posted on: Sep 11 2020, 03:03 PM


Group: Member
Posts: 7,511

they seem to like this one. Now it is in the 200
QUOTE
Matthew Kidman (Livewire Markets): Okay. Let's jump into an area you know well. Data centres, the cloud, Megaport, appropriate name. Taking on the world in that area. Buy, hold or sell?

Gary Rollo (Montgomery): Megaport is a buy. Look, this company has an interesting proposition, not just here in Australia, but globally. And, as the name suggests, it is solving a problem that was not around yesterday. Corporate computing networks were designed for the old age. In the new world of cloud, you don't know what you've got to connect to and when. Megaport solves that problem, and it solves it in an elegant way. It has got a huge addressable market. And for us, that is one of the most interesting tech stories on the ASX and globally today.

Matthew Kidman: Megaport: mega by name, mega by price. Went up about 120 per cent since the [March] bottom. Chris, buy, hold or sell?

Chris Stott (1851 Capital): Sell. So, really good company, Matthew, but the valuation is incredibly stretched to us. 26 times revenue, yet to be positive in terms of from an EBITDA perspective. So, we think it has certainly had a strong run, as you mentioned, off the lows in March. So, sell.

  Forum: By Share Code

nipper
Posted on: Sep 11 2020, 01:10 PM


Group: Member
Posts: 7,511

QUOTE
Labour has been the biggest issue through COVID. A lot of the work is done by backpackers and there are normally about 170,000 backpackers around and currently there are about 70,000, so getting workers is going to be an issue
David Schwartz, CEO, Vitalharvest Trust [owner of Costa Group farmland assets]
  Forum: By Share Code

nipper
Posted on: Sep 11 2020, 07:48 AM


Group: Member
Posts: 7,511

ASX futures down 79 points or 1.3% to 5830 near 6.25am AEST

AUD down 0.4% to 72.56 US cents
On Wall St: Dow -1.5%, S&P 500 -1.8%, Nasdaq -2%
In Europe: Stoxx 50 -0.4%, FTSE -0.2%, CAC -0.4%, DAX -0.2%
Spot gold: +0.2% to $US1950.19/oz at 2.25pm NY
Brent crude : down 1.5% to $US40.20 a barrel
US oil : down 1.5% to $US37.47 a barrel
Iron ore : down 0.4% to $US126.09 a tonne
2-year yield: US 0.14%, Australia 0.21%
5-year yield: US 0.26%, Australia 0.38%
10-year yield: US 0.68%, Australia 0.93%, Germany -0.44


lots of yoyoing for a while. And these debts; does anybody care?
  Forum: Investment Discussion

nipper
Posted on: Sep 10 2020, 07:44 PM


Group: Member
Posts: 7,511

On Tuesday, shareholders of Blue Sky Alternatives Access Fund Limited (ASX: BAF) overwhelmingly voted in favour of our proposal to see the Company join the Wilson Asset Management stable as WAM Alternative Assets Limited (ASX: WMA) at an Extraordinary General Meeting.

In managing WAM Alternative Assets, we will provide Australian retail shareholders with access to alternative investment opportunities managed by a strong team. We will engage with current shareholders and market to new shareholders with a plan to return the share price to a premium to net tangible assets (NTA). We look forward to announcing the Portfolio Manager responsible for WAM Alternative Assets in the coming days.

..... I do not think the premium is attainable, short term ... Too many stale holders. But the discount has shrunk, with BAF lifting to 90c or better, while NTA is about $1.08.

Also, getting extra funds under management will be interesting.... Capital raise or three, but how to massage that reality?
  Forum: By Share Code

nipper
Posted on: Sep 10 2020, 01:10 PM


Group: Member
Posts: 7,511

QUOTE
This massive market rally is due in large part to the measures taken up by the Fed since the pandemic began, Druckenmiller said. He noted that, while the central bank did a great job in March by cutting rates and launching unprecedented stimulus programs to sustain the economy, the follow-up market rally has been excessive.


the other side:
QUOTE
We never had in the past interest rates that have been this low, both in terms of the spread and the 30 year bond yield and the 10 year bond yield, said an analyst. He also argues that in a low growth, low rate world, companies that can deliver high free cash flow will be rewarded ... and that is exactly what capital lite tech companies do.

Between 1984 and 2009, the S&P 500 produced free cash flow as a percentage of sales of 4.7 per cent, but since 2009 this has doubled to 10 per cent.

The more cash you have in a slower-growing world, the more your assets are worth, he argues, adding that the relationship between free cash flow and returns (in the form of dividends and buybacks) is a strong one. Growth and technology will win versus value and old economy, he says
  Forum: Investment Discussion

nipper
Posted on: Sep 9 2020, 05:41 PM


Group: Member
Posts: 7,511

And in a halt. Raising money. Lot of trading beforehand.
  Forum: By Share Code

nipper
Posted on: Sep 9 2020, 01:35 PM


Group: Member
Posts: 7,511

today, the big riser is SBW. Off the bench and up 50%. But it is volatile, and thinly traded.
  Forum: By Share Code

nipper
Posted on: Sep 9 2020, 01:34 PM


Group: Member
Posts: 7,511

there are a lot of people similarly situated... multi baggers, and then the creeping worry what did I miss about this one? . I guess that keeps it interesting.
  Forum: By Share Code

nipper
Posted on: Sep 9 2020, 12:55 PM


Group: Member
Posts: 7,511

BRN has received several ASX Hallo hallo what is going on here missives recently. Not that these are slowing it down .... 135 million traded today, reached 97c before settling around 80c.


let me see, was it 30c at the start of this month? and 3c some five months ago? unsure.gif
  Forum: By Share Code

nipper
Posted on: Sep 9 2020, 09:26 AM


Group: Member
Posts: 7,511

bit of a Tech Selloff happening on the market. Among the biggest losers: Tesla down 21%; Apple down 6.7%; Microsoft down 5.4%; Amazon down 4.4%; Facebook down4.1%.

The Tesla plunge was its biggest daily loss ever, according to Bloomberg, and reflected both GM making an investment in electric truck maker Nikola as well as investor disappointment with Tesla failing to be added to the S&P 500, a decision announced after the market closed on Friday in the US. Now some 33% below its high of just a few weeks ago.
  Forum: Investment Discussion

nipper
Posted on: Sep 8 2020, 09:54 PM


Group: Member
Posts: 7,511

From the AFR

Chanticleer
QUOTE
The most important deal of the year just might involve two companies you’ve never heard of, and a superannuation fund determined to pull off an Australian first.

First State Super’s $600 million offer for junior telco Opticomm, which arrived just two days before shareholders were set to vote on a takeover bid from rival Uniti, is the first time a super fund has launched a direct bid for an ASX company.

First State Super, an industry fund with $130 billion of assets under management, is bidding on its own, without the involvement of an investment manager.

Which makes this a big deal. As super funds have grown ever larger, there has been intense speculation about the potential for them to take ASX-listed companies private. ...

First State was silent on the decision to use this strategy and its broader plans for Opticomm on Tuesday.

But Chanticleer understands the investment team, led by chief investment officer Damian Graham and the point man on this deal, head of income and real assets Damien Webb, see this as the continuation of a strategy that has seen them invest directly in a range of infrastructure assets....

To be clear, the First State team is excited about the deal and recognises its significance. But the internal view is that this is simply a good infrastructure business ... just one that happens to be listed.

What makes this deal even more dramatic is First State’s five minutes to midnight bidding strategy. The non-binding offer was handed to the Opticomm board on Monday and announced on Tuesday morning. Opticomm investors were set to vote on Uniti’s scheme of arrangement at a virtual meeting on Thursday.

Suffice to say, the Uniti team are perplexed at an offer that’s come out of nowhere. First State is not an investor in either Opticomm or Uniti.

Sources said First State began looking at Opticomm when Uniti first announced its bid on June 15.

Opticomm is Australia’s largest private provider of fibre optic cable, and has built a business around competing with NBN Co on putting networks in new housing estates and similar developments.

As the network owner, Opticomm gets paid three times; when the network is established, when a property is connected to it, and charging retail internet service providers to use it.

Uniti is run by two former directors of telco junior M2, Vaughan Bowen and Michael Simmons. The company only listed last year, and has since gone on an acquisition spree not unlike that which Bowen used to turn M2 from a $14 million minnow into a $2 billion empire.

Indeed, in a delicious bit of irony, one of its deals in August last year was to buy a fibre network operator called LBNCo from a consortium led by ROC Partners and , you guessed it, First State Super. It is also now a significant player in private fibre networks.

The Uniti offer for Opticomm was a mix of cash and script pitched at $5.10 a share, plus a 10¢ dividend if the deal got up.

While the $5.20-a-share package offered a premium of less than 4 per cent to Opticomm’s last closing price before the deal was announced on June 15, it eventually won the recommendation of the board.

A big selling point was the chance for Opticomm investors to take Uniti stock and enjoy the benefits of the $10 million in annual synergies that Uniti promised. About 30 per cent of Uniti’s investors are also investors in Opticomm.

But the party has been crashed by First State, which is offering $5.85 a share in cash.

Opticomm has delayed the shareholder vote, given First State 10 days for due diligence and a deadline of September 18 to make an offer.

The Uniti camp has been sideswiped by the First State offer, which is non-binding and conditional.

The Uniti team justifiably asks how First State will complete due diligence in just 10 days. And how can it assure members that it’s not overpaying, given it cannot extract synergies in the same way Uniti can?

But Uniti’s big problem is the pressure the First State bid has put on its share price; Uniti shares plunged 10.4 per cent on Tuesday. Given its bid involves script, a falling share price makes it even tougher to match the First State bid.

Uniti Group's Vaughan Bowen has helped the company's value rocket through a string of acquisitions. Still, Uniti was quick to say on Tuesday it can do so without raising capital.

There are even suggestions that First State may turn its sights on Uniti if it successfully buys Opticomm. That might be wishful thinking from interested parties, but it does go to the fascinating question of what First State would do with Opticomm.

What is clear is that First State does not see this as a chance to make a quick private equity style return, but rather a long term bet on a private infrastructure provider.

This fight has a long way to go. But should First State win, it will be an important moment for the market that underscores both the growing power of super funds and their agnostic approach to hunting returns ... private or public does not matter, a good investment is a good investment.

But boards and management teams will have a different view of the prospect that super funds can be stock pickers, takeover predators and rival bidders all at once.


(Bought SLC)
  Forum: By Share Code

nipper
Posted on: Sep 8 2020, 06:21 PM


Group: Member
Posts: 7,511

perhaps he could change his name to Karen?
QUOTE
Bill Shorten is among a growing number of federal Labor MPs frustrated with the situation in their home state and willing the lockdown to be faster than the timetable laid out by Mr Andrews on Sunday. "I had sort of hoped that maybe the restrictions would come off a bit quicker, I will be honest,'' he said on Tuesday, adding that Mr Andrews needed to do more to offer Victorians hope.

Mr Shorten said his office had been "inundated with complaints and concerns'' about Mr Andrews' road map.

"People have got two attitudes at the moment. One is they're angry. They're over this lockdown. I've been under restrictions for 69 days with my family. I'm over it. But people also just want to see it finished. They want to see that beaten."
  Forum: Off Topic Chat

nipper
Posted on: Sep 8 2020, 01:30 PM


Group: Member
Posts: 7,511

https://www.afr.com/ . ..From the garage to a COVID-19 vaccine lab
QUOTE
When local synthetic antibiotics developer Recce Pharmaceuticals announced they had entered into an antiviral Sars CoV 2 screening program in partnership with the CSIRO and the University of Melbourne Doherty Institute back in July, the news threatened to overshadow some of the other pioneering work being undertaken by the health company.

The company is a potential world leader in something much larger in the long term: helping us combat our growing resistance to antibiotics.

Recce executive director, James Graham, says the company story is a classic Australian innovation story. It started in a retired chemist's garage and as he tinkered away he realised carpentry was not his thing so he picked up his test tubes again, Graham says.

The retired chemist was Johnson & Johnson former head of research, Graham Melrose, and what he was endeavouring to uncover was a synthetic compound that would overcome the superbugs now mutating as the world develops antibiotic resistance. Fast forward a few years and besides the SarsCoV2 partnership the company's executive director of regulatory affairs & microbiology, Michele Dilizia, will deliver the opening R&D Address at the World Anti Microbial Resistance (AMR) Congress next month outlining the case for further developing synthetic antibiotics.

Graham says Australia punches well above its weight in medical technology because we "think outside the square". Moreover, we have an extraordinarily valuable R&D rebate scheme in Australia where we get 43.5 per cent back on every $1 we spend. So if we spend $5 million on R&D applicable research, that is about $7 million of true cash runway. That incentivises us to stay local, to build local knowhow and advance the technology for intended sale in international markets, he says.

Yet staying in Australia does present some challenges because Australia accounts for only 3 per cent of the global antibiotic market whereas the US accounts for 48 per cent. It is for this reason many local players move offshore but Graham says the company is committed to having its manufacturing base here.

Furthermore, beside the partnership with the CSIRO and Doherty Institute, who have chosen the Recce compounds RECCE® 327 and RECCE® 529 as their priority one test candidate against coronavirus, the company is the only one in the world that has a qualified infectious disease designation awarded by the US Food and Drugs Administration for sepsis. This designation provides us 10 years of market exclusivity above and beyond a patent position. So that i's a government backed 10 year market exclusivity only from time of approval, Graham says. And while that is incredibly unique, we also have a pending human application for dosing on wounds in a West Australian hospital in a burns department led by a very prominent burn specialist.

For Graham, medical technology is just one of many potential winners for Australia that will transition the economy away from rocks and crops in the 21st century. Importantly, we are in a place that supports innovation and right now, we are an infectious disease company in the midst of a global infectious disease crisis. We could choose anywhere to be but there is nowhere we would rather want to be than Australia and we always will be here, Graham says.
  Forum: By Share Code

nipper
Posted on: Sep 8 2020, 01:11 PM


Group: Member
Posts: 7,511

the transformation that FY20 was aimed to be is not complete... The bid for OptiComm OPC at $5.20 has been beaten by a Super Fund coming in at $5.85.

..So, OPC up 10% and UWL down 10% ($1.28 now)
  Forum: By Share Code

nipper
Posted on: Sep 8 2020, 01:03 PM


Group: Member
Posts: 7,511

second player, in with a higher bid, cash too
QUOTE
OptiComm has ... received a non binding and conditional competing proposal to acquire 100% of the shares in OptiComm pursuant to a scheme of arrangement from FSS Trustee Corporation as trustee for the First State Superannuation Scheme. The Competing Proposal includes due diligence and final investment committee approval conditions. The Competing Proposal also includes a condition that the OptiComm Board allow the Competing Bidder to conduct due diligence on OptiComm for the period ending on next Friday, the 18th of September 2020.
The Competing Proposal was unsolicited and prior to receipt of the Competing Proposal, OptiComm had not engaged in any way with the Competing Bidder and no information had been provided to the Competing Bidder. Under the Competing Proposal, OptiComm shareholders would receive 100% cash consideration of A$5.85 per OptiComm share held (less any dividends or distributions OptiComm shareholders may become entitled to after the date of the offer).
- pushed up to $5.70 but settling around 5.58 to 5.60 after the exciement wore off. Will UWL go higher? This offer is from a Super Fund manager, and likely it is the only bid they will make. (treating it as an infrastructure play?!)
  Forum: By Share Code

nipper
Posted on: Sep 7 2020, 08:47 PM


Group: Member
Posts: 7,511

5G Networks Limited (5GN) is a telecommunications carrier operating across Australia. The Company is engaged in the supply of cloud based solutions, managed services and network services. 5G Networks provides the end to end control, responsiveness and upload and download speeds necessary to fully capture the value of cloud based computing systems.

Originally, the Group has 2 operating entities, when it formed in 2017:
• 5G Network Operations Pty Ltd
• Enspire Australia Pty Ltd

These 2 operating entities owned and operated the Networks Business and the ICT Services Business. The Networks Business supplied high speed broadband access to mid market corporate businesses. The ICT Services Business supplied cloud, hosting support and network services to mid market corporate businesses.
By 2019, there was the launch of its high speed managed data network (MPLS) to the Australian market across Australian capital cities; this enabled 5G Networks to extend its fibre and wireless network to its customer base with controlled capital expenditure, swapping out third party services with its own.


According to the company, the fully operational data network with dedicated speeds up to 10gb enabled it to mesh secure and private access to existing cloud, hosting and managed services with seamless connectivity to all 5G Networks data centres (including its Melbourne Data Centre).


By 2020, signed its First Indirect Channel Partner with Servers Australia which offers access (IaaS) to Data Centres in Australia and NZ, mainly NextDC, Vocus and Equinix.
Since then, raised $22mill in May 2020; this fresh capital would be used for M&A opportunities and to expand its fibre networks in Sydney and Melbourne as well as financing new builds in Brisbane and Adelaide, particularly focused on the central business districts of each city.
... and, today, made a scrip offer for the old Melbourne IT MLB then Arg Group ARQ and now WebCentral WCG, which had been a real dog. First
• 5GN acquired a 10.2% strategic interest in Webcentral Group Limited (WCG)
• 5GN plans to leverage 5GNs expertise and asset base to improve the profitability of WCG
• 5GN has previously undertaken detailed due diligence on WCG as part of their recent strategic review process
• 5GN mad an indicative non binding offer for the rest of WCG
. The Proposal includes:
- The transaction would be conducted as an off market takeover bid.
- The pre conditions to the takeover bid are the negotiation and entry into a bid implementation agreement between 5GN and Webcentral and a unanimous Webcentral board recommendation.
- The consideration under the takeover bid would be 1 5GN share for every 12 Webcentral shares.
  Forum: By Share Code

nipper
Posted on: Sep 7 2020, 07:24 AM


Group: Member
Posts: 7,511

ASX futures down 36 points or 0.6 per cent to 5875

AUD +0.1% to 72.82 US cents
On Wall St: Dow -0.6% S&P 500 -0.8% Nasdaq -1.3%
In New York: BHP +1.1% Rio +2.1% Atlassian -3.4%
US markets will be closed Sept 7 for the Labor Day holiday
In Europe: Stoxx 50 -1.3% FTSE -0.9% CAC -0.9% DAX -1.7%
Spot gold +0.2% to $US1933.95/oz
Brent crude -3.2% to $US42.66 a barrel
US oil -3.9% to $US39.77 a barrel
Iron ore -0.9% to $US128.80 a tonne
2-year yield: US 0.14% Australia 0.23%
5-year yield: US 0.30% Australia 0.38%
10-year yield: US 0.72% Australia 0.88% Germany -0.47%
  Forum: Investment Discussion

nipper
Posted on: Sep 6 2020, 04:14 PM


Group: Member
Posts: 7,511

Brian Deer journalist, London, UK briandeer.com

Funding: Brian Deer’s investigation, which led to the General Medical Council inquiry, was funded by the Sunday Times of London and the Channel 4 television network. Reports by Deer in the BMJ were commissioned and paid for by the journal. No other funding was received, apart from legal costs paid to Deer by the Medical Protection Society on behalf of Andrew Wakefield.

Competing interests: The author has completed the
unified competing interest form at www.icmje.org/coi_disclosure.pdf (available on request from him) and declares no financial relationships with any organisation that might have an interest in the submitted work; BD’s investigation led to the GMC proceedings referred to in this report, including the charges. He made many submissions of information, but was not a party or witness in the case, nor involved in its conduct.

Provenance and peer review: Commissioned; not externally peer reviewed.
  Forum: Off Topic Chat

nipper
Posted on: Sep 6 2020, 03:35 PM


Group: Member
Posts: 7,511

We maintain a cautious economic outlook and expect global activity resumption will remain under pressure until a coronavirus vaccine is widely available. Accordingly, the Argo Infrastructure portfolio is modestly defensively positioned with a focus on companies with the balance sheet strength and liquidity to endure a potentially protracted downturn. The portfolio is overweight communications, with the sector remaining the least financially impacted by the global pandemic and an ongoing beneficiary of the remote user trend.

Longer term trends point to an optimistic outlook for global listed infrastructure. Compelling structural drivers, including supportive demographic trends, historic underinvestment and accelerated government expenditure on renewable energy, bode well for the asset class. With a strong balance sheet and no debt, Argo Infrastructure is well‐positioned to capitalise on these prevailing conditions

also ..
QUOTE
Argo Infrastructure is considering offering a Share Purchase Plan to its shareholders in the near future.

An announcement will be made to the ASX when the details are finalised.
..... probably around when it goes ex dividend on 11 Sep or at least by payment date 02 Oct.
  Forum: By Share Code

nipper
Posted on: Sep 6 2020, 03:17 PM


Group: Member
Posts: 7,511

I think the old SMX was delisted late 2017.... ASG Group Limited was successful with an offer of $1.80 in cash per SMS share which was reduced by the cash value of the special dividend paid (being 10.2 cents per SMS share), to $1.698 per SMS share.


Now, and since late 2018, SMX code is for SECURITY MATTERS LIMITED
and is involved in the
QUOTE
... commercialisation of its patented technology that uses a hidden chemical based barcode to permanently and irrevocably mark any object, be it solid, liquid or gas. The barcode is read using the company's unique reader to access the corresponding stored data, recorded and protected using blockchain technology.
Haven't we seen other iterations of such processes? But an Announcement caught my eye..... early August:
Major companies and retailers join BASF's reciChain pilot to improve circular economy and traceability of recycled plastics in Canada

... BASF, CSSA, Layfield, London Drugs, Merlin Plastics, NOVA Chemicals, Recycle BC, ReturnIt, Save on Foods and V.I.P. Soap become part of the stakeholder consortium that enables better sorting, traceability and transparency throughout the value chain
.. For the pilot project in British Columbia, Canada, BASF is also partnering with Deloitte as a strategic advisor
.. SMX technology to be used in reciChain and includes a marker embedded into both rigid and flexible plastic that allows users to access and verify information associated with the material.





  Forum: By Share Code

nipper
Posted on: Sep 6 2020, 12:27 PM


Group: Member
Posts: 7,511

is this an heroic assumption, or will it come to pass?
QUOTE
Oil companies are risking some $400 billion in stranded assets with their focus on petrochemicals production growth that relies on strong growth in demand for plastics, Carbon Tracker has said in a new report. ....

https://oilprice.com/Energy/Crude-Oil/Big-O...ded-Assets.html


QUOTE
While the major displacement of oil demand in the transport sector has yet to materialize as EV penetration has been slower than major projections estimated, the crusade against plastics has begun and will only intensify in the coming years. This would mean more initiatives for banning single-use plastics and more regulation in place for plastics recycling. Without regulation, the crusade will fail.According to Carbon Tracker, however, it will win, not least because of problems inherent in the plastics industry.

Plastics impose a massive untaxed externality upon society which this report estimates is about $1,000 per tonne ($350bn a year) from carbon dioxide, health costs, collection costs, and ocean pollution, the report authors wrote, adding that these can be mitigated through recycling, replacing with alternative materials, and improving the design and regulation.

If demand for plastics falls, then some 80 million tons of new plastics production capacity worth $400 billion will be stranded....
  Forum: Macro Factors

nipper
Posted on: Sep 5 2020, 12:03 PM


Group: Member
Posts: 7,511

I suspect there are more than a few faceless Republican players, quite happy to let the orange buffoon open up various agendas, allowing them to slip through (and profit).

It is hard to be optimistic about many things, these days.
  Forum: Off Topic Chat

nipper
Posted on: Sep 5 2020, 11:50 AM


Group: Member
Posts: 7,511

From their weekly update.
QUOTE
Home shopping is becoming increasingly significant with sales up more than 100% in Victoria, as is scratch cooking, inspired by the Coles sponsored Masterchef and Plate of Origin. Veggie sales, ice cream and home cooking ingredients like flour are up 20%, and coffee capsules and cleaning products are up 30%, as we all focus more on hygiene.

On the fall are beauty products as we spend more time at home, and facial tissues as there is less cold and flu about. If we are seeing more home cooks, with pubs still restricted, we are also seeing the rise of the home happy hour with Gin sales up 80%, and Rose wine and craft beer up 30%. No alcohol drinks are also proving a very popular alternative ... up 170%!
  Forum: By Share Code

nipper
Posted on: Sep 4 2020, 06:09 PM


Group: Member
Posts: 7,511

you missed tattooed. smile.gif
  Forum: Off Topic Chat

nipper
Posted on: Sep 4 2020, 12:24 PM


Group: Member
Posts: 7,511

and I wonder if this will make it to listing, let alone on the ASX?
QUOTE
Macquarie Group controlled forensic software company Nuix has made an impassioned maiden pitch to fund managers, telling them it was a robust and profitable organisation trusted by the world's most discerning customers.

Fronting potential investors for the first time ahead of a potential ASX listing, Nuix boss Rod Vawdrey said his firm was a global success story with more than 1000 clients from the government, law enforcement and legal sectors, spread across 79 countries. He said the group first started selling its software in 2006, had 421 staff and recorded $176 million revenue in the 2020 financial year, most of which was subscription based revenue.
Vawdrey told funds that his company would benefit from an explosion in human generated data, cybercrime and fraud, and the heightened financial and reputational damage arising from non compliance. He said Nuix's software allowed users to process and make sense of huge amounts of data, via various products including search based Nuix Workstation and insights focused Nuix Investigate.

Nuix made 56 per cent of revenue in North America in the 2020 financial year, and advisory firms like Deloitte and Accenture were its biggest customer group at 34 per cent of sales, the presentation said. Revenue was up 16 per cent a year in the past two years, on a compound annual growth rate basis, funds were told, while about half of its revenue came from clients that were also on the books six years ago.

The maiden pitch, put together with bankers Morgan Stanley and Macquarie Capital, comes as Macquarie Group mulls listing the software business on the ASX boards. Macquarie is Nuix's biggest shareholder with a 65 per cent stake.

Fund [managers] said there was little talk about Nuix forecasts or targeted valuation should it push ahead with the initial public offering. The closest comparable stock is arguably San Francisco based Splunk, which sells software for searching, monitoring and analysing data. Splunk is much bigger with $US2.3 billion revenue last year and trades at 12.9-times forecast sales.

What is Nuix worth? It is the $1.5 billion plus question. The other is: will Macquarie find a trade buyer to take it out in the meantime?
https://www.afr.com/street-talk/forensic-so...20200902-p55rjn
  Forum: Off Topic Chat

nipper
Posted on: Sep 4 2020, 10:14 AM


Group: Member
Posts: 7,511

The European Union has issued a plan to cut its dependence on Chinese supplies of rare earths, lithium batteries and solar cell components, as it tries to build a green energy economy that is not largely made in Beijing. Brussels will bring industry, governments and NGOs into a "European Raw Materials Alliance", which will refashion the continent's supply chains for up to 30 critical products, including those used to make wind turbines, fuel cells, solar panels, magnets, drones and batteries for electric vehicles.

Lithium appears on the EU critical list for the first time, in a fillip for the clutch of Australian listed companies looking to mine and process it within Europe.

We cannot afford to rely entirely on third countries; for some rare earths, even just one country, said the EU Internal Market Commissioner Thierry Breton, as he launched the Action Plan on Critical Raw Materials on Thursday.By diversifying the supply from third countries and developing the EU's own capacity for extraction, processing, recycling, refining and separation of rare earths, we can become more resilient and sustainable.

Brussels will look to build sustainable and responsible strategic partnerships with resource rich countries, the Action Plan said, name checking Australia as one of its priorities.

The strategy isn't overtly aimed at China ... there are also dependencies on Turkey, the Democratic Republic of the Congo, and South Africa, but the European Commission analysis shows that in most cases the Asian behemoth is the critical risk factor. The Action Plan's risk assessment notes major concerns about China's quasi monopolistic role in rare earths used to produce magnets for wind turbines, and its dominance of lithium battery production.

https://www.afr.com/world/europe/europe-bri...20200714-p55bqf
  Forum: Investment Discussion

nipper
Posted on: Sep 4 2020, 09:41 AM


Group: Member
Posts: 7,511

The record breaking run in US tech stocks came to a shuddering halt overnight as the Nasdaq Index plunged 5 per cent, its biggest one day fall since March, amid concerns about the sector's lofty valuations.

None of the high profile US tech names was spared: Tesla slumped 9 per cent, Apple tumbled 8 per cent and Google's parent Alphabet slid 5.1 per cent.

Netflix lost 4.9 per cent, Twitter fell 4.7 per cent, and e-commerce behemoth Amazon.com shed 4.6 per cent. Facebook fell 3.8 per cent and China's Alibaba lost 2.3 per cent.

  Forum: Macro Factors

nipper
Posted on: Sep 4 2020, 09:39 AM


Group: Member
Posts: 7,511

Iron ore price benchmarks firmed overnight, with 62% Fe closing above US$130.80/t, and 58% Fe to US$117.35/mt.

Prices rallied on steel mill restocking ahead of holidays in October, which is expected to support prices through September, and on expectations for accelerating construction and infrastructure activity through September and October, said Commonwealth Bank commodity strategists.

The ANZ strategy team said real estate activity is even stronger than it was before the COVID19 crisis began and that is partly supporting iron ore prices. Housing transactions have picked up strongly on the back of pent-up demand, particularly in China, the ANZ strategists said. This sector consumes about 40 per cent of total steel consumption and it also has important implications for downstream demand. We see iron ore benefiting from this over the next six to nine months.

  Forum: Macro Factors

nipper
Posted on: Sep 3 2020, 08:33 PM


Group: Member
Posts: 7,511

Grr, bandwidth shavings
  Forum: Off Topic Chat

nipper
Posted on: Sep 3 2020, 08:33 PM


Group: Member
Posts: 7,511

Swear on an oath?
  Forum: Off Topic Chat

nipper
Posted on: Sep 3 2020, 08:39 AM


Group: Member
Posts: 7,511

37 trading days when markets are open, until the US election.
  Forum: Off Topic Chat

nipper
Posted on: Sep 3 2020, 08:36 AM


Group: Member
Posts: 7,511

Industry background:

Appen is one of the two big players in the artificial intelligence data services industry. It provides the world's biggest technology companies with the crowd-sourced data needed to train the AI algorithms that power everything from search engines to voice assistants and autonomous vehicles.

Its biggest rival is Lionbridge, which was acquired by New York based private equity firm H.I.G Capital in 2016 for $US360 million ($489 million). There is also a range of smaller venture capital-backed players in the market.

Appen has flourished in recent years as the major tech giants, such as Microsoft and Facebook, have invested more and more in AI.

The result: Appen's half year result to June 30 was solid, with the business resilient against the pressures of COVID 19.

Its revenue grew 25 per cent to $306.2 million and its net profit after tax increased to $22.3 million, up 20 per cen

The company's content relevance division, which is data annotated for the purpose of improving search results, is the growth engine of the business, with revenue up 34 per cent to $273.9 million. But its substantially smaller speech and image data segment fell 20 per cent from a bumper first half in 2019, despite being the second strongest half for the segment in the company's history.

Its speech and image results came in below analyst expectations and was the catalyst for an 11 per cent sell-off on the day, undoing share price gains in the week leading up to the result.

Outlook: Despite taking a minor hit from COVID-19 because of smaller customers delaying some projects, Appen reaffirmed its previously-upgraded full-year guidance.

It has forecast underlying earnings before interest, tax, depreciation and amortisation in the range of $125 million to $130 million, at a $1 equals US70¢ conversion rate, having already booked $475 million of revenue, plus orders in hand, as of August.
Over the longer term, the company's future is also bright. It is well positioned to benefit from the acceleration of digital transformation and the boom in e-commerce as a result of the COVID-19 pandemic, with its services required by more and more businesses investing in AI.
  Forum: NZX

nipper
Posted on: Sep 2 2020, 04:26 PM


Group: Member
Posts: 7,511

I saw the release....
QUOTE
While the Board believes that the listed investment company (LIC) structure has many positive attributes, the persistent discount between the Company's share price and its NTA is unsatisfactory. The Board has actively pursued a range of NTA discount control mechanisms including implementing the largest on-market LIC share buy-back in ASX history. The Board acknowledges that the initiatives to date, while significant and moderately enhancing to shareholder returns, have not had the desired effect of sustainably reducing the NTA discount.

The Board also acknowledges that while NTA discounts are influenced by many factors including market sentiment, Manager performance and the size of the Company, it is incumbent upon them to continue to undertake discount control mechanisms to give shareholders the confidence that the share price will better reflect the NTA of the Company over time.

Conditional Tender Offer .....In a new development for the Australian market, the Board has committed to undertake a significant and innovative discount control mechanism by proposing a conditional tender offer program (CTO) to shareholders at the 2020 Annual General Meeting (AGM) which (subject to the condition being triggered) would be implemented in October 2021 being 5 years after the Company listed. The CTO will enable shareholders to exit a minimum of 25% of their shareholding at close to NTA. The CTO seeks to balance the interests of longterm shareholders with those of exiting shareholders and to result in the Company share price more closely tracking its NTA while preserving the benefits of the LIC structure. The CTO will be triggered if the Company's shares trade at a persistent discount to NTA.
The proposed terms of the CTO are as follows:
• The CTO condition is that the Company's closing share price on a daily average basis over the preceding 12-month period to the CTO date exceeds a 7.5% discount to pre tax NTA.
• Shareholders will have the opportunity to tender their shares for sale to the Company via an offmarket buyback.
• The maximum number of shares the Company can buy back will be 25% of the shares on issue at that time.
• Shareholders can tender any number of their shares. Shareholders will be guaranteed that 100% of their tendered shares will be bought back if they tender 25% or less of their total shareholding in the Company.
• If some shareholders do not tender any shares or tender less than 25%, the surplus will be allocated pro rata among shareholders who tender more than 25%.
• The tender offer price will be NTA less 2% as calculated on or around the closure of the CTO offer period.
• The initial CTO offer period will begin soon after the five-year anniversary of the Company's listing date, on or around 18 October 2021.
• The Board intention is for the CTO to occur regularly and for the Company to seek shareholder approval for CTOs on similar terms every three years after the initial CTO

....what do I think?
- I bought to hold this one. I like the ability to pay a dividend. I think value investing has had a bad trot for 10 years and will continue to, as the markets rotate towards C21st realities.
- I am not sure it will solve their problems of deeply discounted trading price to NTA
- there is a logical challenge if a holding is sold down. The 25% reduction becomes smaller and you could be left with an unmarketable parcel.- I wonder if other LICs in the same boat will try this?
  Forum: By Share Code

nipper
Posted on: Sep 2 2020, 03:49 PM


Group: Member
Posts: 7,511

A Doctor was addressing a large audience in Sydney.

The material we put into our stomachs is enough to have killed most of us sitting here, years ago. Red meat is awful. Soft drinks corrode your stomach lining. Chinese food is loaded with MSG.

High fat diets can be disastrous, and none of us realizes the longterm harm caused by the germs in our drinking water.

However, there is one thing that is the most dangerous of all and we all have eaten, or will eat it. Can anyone here tell me what food it is that causes the most grief and suffering for years after eating it?


After several seconds of quiet, a 75 year old man in the front row raised his hand, and softly said, Wedding Cake.
  Forum: Off Topic Chat

nipper
Posted on: Sep 1 2020, 10:55 AM


Group: Member
Posts: 7,511

will post without comment.
QUOTE
Clinuvel board praises "unusual, amazing" CEO Philippe Wolgen
The Clinuvel board reckons CEO Philippe Wolgen is "of a different calibre". We don't disagree.
Joe Aston


There are companies on the fringes of the ASX 200 that are easily mistaken for asylums. One of them is Clinuvel Pharmaceuticals.

Take this excerpt from the remuneration report within its preliminary annual report filed on Thursday. "In recent weeks, the remuneration committee and board has been surprised, impressed but proud to learn that our CEO has waived and rejected his STI awarded to him for achieving 70 per cent of the KPIs for 2020," wrote the committee's chairman, William Blijdorp.

"His decision reflects an unusual and amazing leadership in the industry, awareness of the world and extraordinary sensitivities … in Philippe we have long identified a professional of a different calibre."

Dear God. Is Blijdorp talking about a chief executive whose performance he's supervising on behalf of shareholders, or his favourite child?! "Unusual and amazing leadership in the industry" is certainly an accurate description of Philippe Wolgen's remuneration.

At last year's annual general meeting, Wolgen was awarded performance rights with an exercise price of zero and a face value (on that date) of $43.9 million. This is believed to be the largest ever allocation to the CEO of an ASX 300 company. If fully vested, his new shares will dilute existing shareholders by greater than 3 per cent. Indeed, a whopping 40.1 per cent of Clinuvel shareholders voted against the grant.

Yet for voluntarily forfeiting his STI grant (amount unknown, though in FY19 it was $422,747) the board wants him canonised. It's demented.

In an update to his shareholders on July 22, Wolgen claimed "there is a wide-held belief in our field that this is the most driven and ambitious team one could possibly find among many Asian-Pacific life science companies". We're sure he canvassed widely!

He also warned against "those who disseminate negative and disparaging news on us". "We at Clinuvel play a role to point … authorities in the jurisdictions where our shares are traded in the direction of these market participants and stock bashers and all those who distort the Clinuvel narrative openly." These must be those "extraordinary sensitivities" the board recognised.


https://www.afr.com/rear-window/clinuvel-bo...20200831-p55r06
  Forum: By Share Code

nipper
Posted on: Sep 1 2020, 09:49 AM


Group: Member
Posts: 7,511

it seems like the Internet of Things, with its sensors and finicky set ups, may only be interim technology

I genuinely don't think I am exaggerating when I say this is simply the most exciting technology to ever come out of Australia.

— Bevan Slattery, FiberSense chairman

QUOTE
Rich Lister's latest tech play could be bigger than 5G

A new Bevan Slattery backed deep technology start up that uses telecommunication fibre optic cables to detect vibrations is emerging from so-called "stealth mode" with a suite of big-name enterprise clients and millions of dollars in investment under its belt.FiberSense, started by former sonar research scientist Dr Mark Englund in 2015, created and patented a new wide area sensor system for recording, labelling and visualising objects and events in real-time called VIDAR (vibration detection and ranging).

VIDAR is capable of capturing and analysing the tiny vibrations of nearby objects, such as cars, drills or even pedestrians, across large geographical grids using fibre optic cables. The vibration readings are then analysed and categorised on FiberSense's digital platform SuperSoniQ, which it provides to clients as a subscription cloud based service.

Just like your ears, SuperSoniQ is able to use vibrations to detect and recognise objects and events in real time over wide areas, but it can not see faces or things. It also cannot hear voices.

The technology, Dr Englund said, will transform the way critical infrastructure assets such as power grids, telecommunication cables and sewerage pipes are managed, as well as be used to help enable autonomous vehicles.

If you can access the fibre in the city grids ... think of it like a street map ... we could detect and then classify what we are seeing across the whole footprint of the CBD in real time, he told The Australian Financial Review . We already own fibre first and foremost, then we have fibre partners and then we have clients in asset protection that provide us the fibre in their assets. We can go to a telco whose pipes have been relegated to limping, impaired assets ... and show them they can take those fibre cables and they're no longer just dumb pipes, but they can be used as a source for real time, relevant data for the operation of cities.

The first focus has been asset protection and it has 10 enterprise clients paying thousands of dollars a month signed up across the Asia Pacific region, including Superloop, Transgrid, Basslink and submarine cable operators Southern Cross Cable Networks.

Unlike internet of things businesses offering a similar service, no specialised equipment such as sensors is needed.

Customers use the SuperSoniQ platform to gain real-time intelligence on any event that could damage their assets.

Dr Englund said the platform so far had detected, classified and notified customers of more than 26,000 events (such as drilling or water leaks nearby) and has a false negative detection rate of 0.011 per cent. Our capability has matured and our patent has been granted, so it is time to build the brand. We have made a lot of direct connections, but there is a bigger game here. We are not selling sensor boxes, we are selling this as a service and it is deployed from data sensors and you can deploy it in any city.

Before FiberSense, Dr Englund started a business called Redfern Optical Components in the late 1990 and had also led the Optical Fibre Sensors Laboratory in his early career with Defence Science and Technology in Adelaide.

He became connected to Mr Slattery (who is set to debut on this year's Rich List with a net worth of more than $520 million) while working with a submarine cable manufacturer in the US. Having provided angel funding for FiberSense, Mr Slattery is now also the company's chairman.

When I first saw this, I knew it was special, but as we have seen improvements in AI, DSP [digital signal processing] capabilities of advanced GPU [graphics processing unit] and cloud, this whole FiberSense capability envelope keeps lifting to another level, Mr Slattery said. I genuinely don't think I'm exaggerating when I say this is simply the most exciting technology to ever come out of Australia. This will be bigger than 5G, in fact, I'm starting to wonder if this could become as big as the cloud.

The company's milestones for the coming years include to "significantly cover" all critical infrastructure in the top 120 cities of the world and then to keep expanding the "objects and events" detection capabilities of its platform.

Our vision at the end [is] to have a total 2D grid of those cities, with substantially all objects and events digitised in real time. That is where the whole gear shifts significantly, Dr Englund said. Then in the autonomous vehicle space we think we have unprecedented capabilities to offer the likes of Tesla, Zoox, Uber, Ford etc and what we provide is the ability to look at an individual vehicle, monitor its maximum and minimum speeds, the route it took and use it to do a risk-analysis behaviour prediction. In driver assisted tech, with the ability to look at all vehicles ... if you are coming up to a corner and can't see what's around it, we'll be able to show you digitally. If there is a car on the road, we will see it.


https://www.afr.com/technology/rich-lister-...20200827-p55pz8
  Forum: Investment Discussion

nipper
Posted on: Sep 1 2020, 08:50 AM


Group: Member
Posts: 7,511

Revenue continued to improve simultaneously due to growing product lines and expanded sales channels, particularly large governmental agencies.

Operating expenses remain relatively the same as last year with continued focus on allocating resources to marketing of sales channels and the continued development of the WhiteHawk online exchange.

- very much focused on the US
QUOTE
[WHK operates the] first online Cybersecurity Exchange based on a platform architecture that is Artificial Intelligence driven, with a focus on identifying, prioritizing, and mitigating cyber risks for businesses of all sizes. WhiteHawk continually vets and assesses risk focused technologies, methodologies, and solutions that are impactful, affordable, and scalable to stay up to date on current cyber threat vectors to businesses, organizations, family offices, and individuals. The Corporation has an online approach to determining key cyber risks through a Cyber Threat Readiness Questionnaire, and as appropriate, a cyber risk assessment. Using this information, Companies and Organizations are then matched to tailored risk mitigation solution options, based on current threat trends across key sectors. Cyber Consultants on staff help build a tailored cyber maturity plan customized to meet business or mission objectives.

As part of the Corporations portfolio of cyber risk online platform and services, WhiteHawk has architected and implemented Cyber Risk Radars and Cyber Risk Programs at U.S. Federal Departments and Fortune 500 Enterprises. Cyber Risk Radars address supply chain risks via Software as a Service (SaaS) platforms. Cyber Risk Programs allow a comprehensive outside-in approach to assess an Enterprise's ongoing cyber risks. WhiteHawk leverages global open data sets integrated with deep cyber and digital age business risk tradecraft. The Corporation brings risk trends to light, providing automated, customized reporting on individual suppliers, companies, and across an entire enterprise portfolio. First and foremost, WhiteHawk enables companies to identify and mitigate their priority cyber risks on an ongoing basis with demonstrated cost and time savings.


and it ties in with what is said below (does not mean they will not make money):
The trick is the auditors don't actually fix the issues they find: they turn around and sell bog standard cyber insurance wrapping in a shiny fintech coating.
  Forum: By Share Code

nipper
Posted on: Aug 31 2020, 08:47 PM


Group: Member
Posts: 7,511

Key Highlights
● FY20 Financial Objectives achieved:
-- $43.8M Revenue per annum run rate achieved in FY20
-- Achieved quarterly EBITDA profitability for the FY20 June quarter
-- Cash flow from operations positive during the FY20 June quarter
● Acquisitions:
Phase 1 Acquisitions Completed: Rivium (completed FY20) , Pure Security (completed FY20) , North Security (completed FY20) , Seer Security (completed FY21)
Phase 2 Acquisitions Announced: Airloom (SPA signed FY21) , Ludus Cybersecurity (SPA signed FY21)
● First Acquisition Integration milestones achieved, including:
.. First cross-sales achieved
.. Single Finance Platform, Oracle NetSuite, rolled out across the Group
.. Rivium and the Tesserent MSSP/SOC absorbed into Pure Security

Including the new acquisitions, at the time of publishing this document, the Company:
- has an FY21 forward gross revenue runrate of circa $80M
- is cashflow positive;

and,
- is operationally profitable on a month to month basis
- has an ambition to get gross revenue runrate to in excess of $100M by December 2020
  Forum: By Share Code

nipper
Posted on: Aug 31 2020, 04:54 PM


Group: Member
Posts: 7,511

IPO at 20c, came on at 40c and closed at 36c on Day One
QUOTE
The rise of home cooking in COVID19 lockdowns and the increasing interest by consumers in plant based foods have combined at the right time, say the founders of Forbidden Foods.

Chief executive Marcus Brown said all of the group's main brands;– Forbidden, Sensory Mills and Funch, are entirely plant based across a range of products including black rice, protein balls, organic baby food and puree, and specialist flour and powders. A lot of the home eating trend has come right through, he said.

Forbidden Foods products are sold in about 3500 retail outlets across Woolworths, the IGA independent retail stores supplied by Metcash, Drakes supermarkets and Costco. The company also supplies items to fast food chains including Hero Sushi and Zambrero.

Mr Brown said Forbidden Foods, established in 2010, ran a ''capital-light'' model where it outsourced production and packaging. E-commerce sales have also been rising fast in the past six months as consumers bunkered down at home. Mr Brown said online sales had climbed tenfold in the past six months and were expected to keep accelerating. "That's a big part of the business in the future,'' he said. "It's easy to scale.''

Forbidden Foods mainly uses Australia Post for its deliveries and Mr Brown said in the latest stage four lockdowns in Melbourne there had been some slight delays. But customers were very understanding about delivery logjams, he said.


Forbidden Foods sells about 10 per cent of its products overseas, with New Zealand the main export destination. Some product also goes to the United States and Britain. He said China would be a future target once the trade spat between Canberra and Beijing settled down.

  Forum: By Share Code

nipper
Posted on: Aug 31 2020, 04:51 PM


Group: Member
Posts: 7,511

New to market today

Forbidden Foods (ASX code FFF) is a diverse multi‑brand food and beverage company focusing on the wellness and organic markets, with various national and international sales channels.

The Company produces healthy food products under three primary brands .... Forbidden, Sensory Mill and Funch.

Forbidden Foods was established in 2010 with a vision to provide Australia with the very best health foods and to meet growing consumer demand for differentiated, health orientated products. Forbidden Foods recognised the demand for healthy, better‑for‑you food products and its brands are attractive to health conscious consumers who demand premium products.

By 2016, Forbidden Foods had expanded its operations, establishing a New Zealand distribution centre and supplying a variety of rice and rice flour products. In 2018, Forbidden Foods successfully expanded the existing Australian rice flour accessible market from 3 types of flour to 35. Today, Forbidden Foods has a diverse health foods retail and food service range and exports to customers in New Zealand, Ireland, Singapore and the United States.

Forbidden Foods has a diverse range of customers within the Food and Beverage Industry operating within retail (major and independent), food service, food manufacturing and quick service restaurants. Through its distribution channels, the Company has access to over 3,500 retailers, 500 food service and QSR
  Forum: By Share Code

nipper
Posted on: Aug 31 2020, 08:39 AM


Group: Member
Posts: 7,511

ALI today announces an increased fully franked final dividend of 4.5 cents per share. The Company reports a full year accounting loss of $9.3 million as a result of the downward revaluation of the investment portfolio to market value at 30 June 2020.


SUMMARY OF FINANCIAL RESULTS .....2020 ......... 2019
Profit/(Loss)* ............................ 2020 .. ($9.3 million); 2019 ........... $44.9 million
Final dividend per share (ff) ............ 2020 .. 4.5 cents ; 2019 .............. 4.0 cents
Net tangible asset (NTA) backing per share.......2020 ... $2.27 ; 2019 ..... $2.50
Shareholders ..................................2020 ... 9,495 ; 20119 ................. 9,206

COVID‐19 IMPACTS ON INFRASTRUCTURE
Global listed infrastructure was not spared the effects of the global pandemic and induced downturn delivering a total return of ‐6.2%. However, within the asset class performance varied considerably, as some sectors were impacted by social distancing measures more than others.
Transportation related sectors fell sharply in response to travel restrictions and reduced trade, with airports, marine ports, toll roads and to a lesser extent, railways, all declining.
Midstream energy stocks also fell, hit by the combination of supply and demand shocks in energy markets during the second half.

In stark contrast, the communications sector (towers and data centres) advanced strongly as working and learning from home drove a surge in data usage.
Water and electric utilities also outperformed, with their essential service nature translating into stable cashflows.


INVESTMENT PERFORMANCE
During an extremely volatile and challenging period for investment markets, the portfolio delivered a total return of ‐2.9% for the 12 months to 30 June 2020, well ahead of the benchmark which fell ‐6.2%. The portfolio also outperformed Australian shares (‐7.7%), underscoring the global diversification benefits offered by Argo Infrastructure.

Importantly, at the height of the volatility in global equity markets, Argo Infrastructure demonstrated resilience in a crisis. During the March quarter when Australian shares plummeted ‐23.1%, ALI's portfolio return fell by just ‐6.5%, assisted by a sharp drop in the Australian dollar and outperformance by the portfolio manager, Cohen & Steers.
  Forum: By Share Code

nipper
Posted on: Aug 30 2020, 06:26 PM


Group: Member
Posts: 7,511

interested to read your comments. The 5G implementation will create a large footprint, for sure; much more than 4G due to the shorter range of the frequency. Coming at it from another angle, have a look at Redflow RFX Investor presentation dated 11 June on p16. Is that a fortified telco tower (powered by remote battery, rather than grid), or what?

What with the theft challenge plus the flat earthers, there should be a whole lot of protection going on smile.gif
  Forum: By Share Code

nipper
Posted on: Aug 30 2020, 09:30 AM


Group: Member
Posts: 7,511

222nm UV light ??

https://www.ted.com/talks/david_brenner_can...s=172BB350-0003
  Forum: Off Topic Chat

nipper
Posted on: Aug 30 2020, 08:52 AM


Group: Member
Posts: 7,511

I am wondering if this will take the transport industry by storm. It is an interesting advance.

QUOTE
Private plane travel could be coming to the masses. A US company has unveiled a futuristic aircraft billed as an alternative to executive jets which can be hired for the price of an airline ticket. Developed in secret for a decade, the bullet-shaped plane, the Celera 500L, has intrigued the aviation world since it was spotted at Victorville in the Mojave high desert in 2017. Otto Aviation unveiled its creation during the week, saying the revolutionary plane had made 31 test flights since November and proved itself to be "the most fuel-efficient, commercially viable aircraft in existence".


The makers claim performance that seems incredible by conventional standards. Driven by a 12-cylinder diesel engine that turns a "pusher" propeller on its tail, the plane is said to fly at 450mph (724km/h), the speed of light jets, with operating costs of £250 ($453) an hour, six times lower than similar-sized business jets. Fuel consumption at 18 to 25 miles (29km to 40km) a gallon (about 3.8 litres) is an eighth of that of a small jet. The wide bullet shape of the six-passenger, fixed-wing aircraft promotes laminar flow, meaning that the oncoming air passes around its fuselage and wings smoothly without the turbulence that causes drag in more conventional craft. Bill Otto, a veteran aerospace scientist who founded the company, said the Celera was due to enter service in 2023. It was the ideal plane for the post-coronavirus world, he said. It would serve as a long-distance air taxi for families or small groups with seats costing no more per person than a commercial flight. "Of course, we didn't anticipate Covid-19 but there are enhanced market opportunities in being able to afford to fly with only those you choose to," he told CNN. Unlike the slow, short-range drone-style air taxis under development, the Celera will have a relatively long range and will be able to fly non-stop anywhere in America, for example, its makers claim. "Our goal was to create a private aircraft that would allow for direct flights between any city pair in the US at speeds and cost comparable to commercial air travel," Mr Otto said. While other plane-makers are racing to build electric or hybrid aircraft, the Celera is betting on internal combustion. Its German-made Red Aircraft A03 powerplant can burn jet fuel or bio-diesel, producing more than 550hp. The company is planning a second model, twice the size of its 500, which may use a hybrid electric and internal combustion engine.
The Times
  Forum: Off Topic Chat

nipper
Posted on: Aug 29 2020, 08:38 PM


Group: Member
Posts: 7,511

(wrong cut and paste ...)
Copper Nickel and Potash. Where BHP is heading. Definitely not coal.

try.... https://www.australianmining.com.au/news/mo...ormula-bhp-ceo/
  Forum: By Share Code

nipper
Posted on: Aug 29 2020, 07:49 PM


Group: Member
Posts: 7,511

Copper, Nickel and Potash

https://www.rollingstone.com/politics/polit...impression=true
  Forum: By Share Code

nipper
Posted on: Aug 29 2020, 07:11 PM


Group: Member
Posts: 7,511

One for you, Mark. Plenty of self loathing on display.

https://www.rollingstone.com/politics/polit...impression=true
  Forum: Investment Discussion

nipper
Posted on: Aug 29 2020, 05:06 PM


Group: Member
Posts: 7,511

QUOTE
Metcash competes through its affiliate IGA network with Woolworths, Coles and Aldi in groceries in a sector that we understand is aggressive but rational. In liquor, IGA is the number 2 player behind Woolworths, but ahead of Coles. In hardware, Mitre 10 competes directly with Bunnings, with both chains currently benefiting greatly from the extra spend on renovations as many people working from home take the opportunity to fix up their homes and gardens.


Our confidence in Metcash's prospects strengthened in recent months when after significant research we undertook including various channel checks and talking to many independent retailers, it became apparent to us that Metcash was not only growing its sales, helped by the increase in grocery and hardware sales during the pandemic, but that the IGA network had also picked up substantial market share from the major supermarket chains as the company benefitted from new localised shopping trends by consumers across all its businesses.


On our estimates for the company, we calculate that Metcash should report a net PROFIT after tax of slightly over AUD200 million for FY2021. As a result of all this and given that Metcash was trading on a P/E of around 14 times earnings and a 4% dividend yield (while also experiencing good growth), we have been a fairly large buyer across our funds in recent months, as we believed the company offered great value given the strength in its underlying businesses. Through our thorough research process, we also learnt that the IGA network had made significant progress in reinvesting in its stores and reducing its prices to be more competitive with Woolworths and Coles.

So when Metcash announced at its AGM on Wednesday 26 August that food sales were up 15% and liquor sales were up 11% and that its hardware sales were up 19%, we were delighted and felt vindicated by our positioning in the portfolios. These sales numbers were well above our estimates and market expectations. However, Metcash's resulting 2% share price rise on the day underwhelmed us, as the focus of investors seemed to be on more 'exciting' sectors in the market as opposed to real companies with real earnings
Anton Tagliaferro from IML
https://www.sharecafe.com.au/2020/08/28/jus...id-sharemarket/
  Forum: By Share Code

nipper
Posted on: Aug 29 2020, 10:31 AM


Group: Member
Posts: 7,511

The $15 billion private hospital giant Ramsay Healthcare underlines the dilemma for investors trying to navigate the year ahead in what is usually a steady, defensive sector. With a vast network of hospitals in Australia and Europe, it is well positioned to capitalise on the ageing demographic and rising demand for elective surgeries in normal times.
QUOTE
But the pandemic has temporarily upended its business model and triggered a situation where bottom line net profit tumbled almost 50 per cent to $248 million in fiscal 2020 and a final dividend vanished completely. That hurt, given shareholders were paid a 62.5c first half dividend.

Ramsay chief executive Craig McNally is convinced, however, there will be an eventual comeback in elective surgeries once the pandemic is under control. The Nordics are coming out of summer holidays, and we are optimistic about surgery coming back, he says.

Ramsay had to rapidly pivot in virus hotspots of Italy and France, and struck agreements with governments around the world to deliver extra capacity from its private hospitals in the fight against the pandemic. It has treated about 7000 COVID patients during the pandemic.

The Ramsay share price was sailing along in February at close to $80, but it crashed to $50 in March in the rapid sharemarket sell off ; its lowest point in six years.

Mr McNally believes there will be a pickup in elective surgery, which is already happening in states outside of Victoria, and that should help momentum, but the company is not making any forecasts.
  Forum: By Share Code

nipper
Posted on: Aug 29 2020, 09:52 AM


Group: Member
Posts: 7,511

A tale of three indexes !?

The gains keep piling up on Wall Street, and the S&P 500 rallied again on Friday to close out its fifth straight winning week.
The benchmark index rose 23.46, or 0.7%, to 3,508.01, setting another record high and several more superlatives. It was the seventh straight day of gains for the index. It also capped a 3.3% rally for the week to cement its longest weekly winning streak since December, before the coronavirus pandemic swept the world and sent economies tumbling into recession.

The Dow Jones Industrial Average rallied 161.60, or 0.6%, to 28,653.87 and clawed its way back to a tiny gain for the year. It’s just 0.4%, but it's the first time the Dow has been up for 2020 since late February.

The Nasdaq composite climbed 70.30, or 0.6%, to 11,695.63 to set another record. It has lapped the other U.S. stock indexes many times over, thanks to market leading gains for big technology stocks, and it's up 30.3% for 2020 so far.
  Forum: Investment Discussion

nipper
Posted on: Aug 29 2020, 08:52 AM


Group: Member
Posts: 7,511

Five years since a post .... but, reading this about the most common form of brain cancer, it shows just how hard these cancers are to treat. I had a friend who died of glioblastoma this year; the last 18 months, from diagnosis to passing, was terrible for him.

With A 'Ticket To Ride', Kazia Wows Investors With Its Rare-Cancer Story
By Tim Boreham
https://www.sharecafe.com.au/author/tim-boreham/
QUOTE
As the political schisms in the US widen there's one element that does not discriminate between the major parties: the most common form of brain cancer. Known as glioblastoma, the condition claimed the life of Beau Biden, son of Democrat Oval Office aspirant Joe Biden. It also killed former Republican presidential candidate John McCain.

In the US, more than 13,000 Americans will receive a glioblastama diagnosis this year, with the disease accounting for about half of all primary malignant brain tumors. Sufferers can expect to live for only 12 to 15 months after diagnosis, with a five year chance of survival of less than 5 per cent.

Enter the ASX and Nasdaq listed Kazia Therapeutics, which has been trialling its lead drug paxalisib (formerly GDC0084) to treat the aggressive and complex disease. Paxalisib inhibits a signalling pathway called PI3K which is expressed in 85 per cent to 90 per cent of glioblastoma tumours.

After years of quiet development, Kazia in August achieved two key milestones.

On August 7 the company announced the US Food & Drug Administration had awarded the company a rare paediatric disease designation (RPDD) to treat Diffuse Intrinsic Pontine Glioma (DIPG).

DIPG is another rare and aggressive brain cancer, with a survival rate of less than one per cent. Annually it affects around 400 children in the US and 40 here, typically between the ages of four and 11. The average survival from diagnosis is around 9 to 10 months, says Kazia CEO Dr James Garner. This is the absolute definition of unmet medical need.

The paediatric news was followed swiftly by the August 20 revelation that the FDA had granted fast track designation for paxalisib in relation to glioblastoma. Fast track status is designed to expedite development of pharmaceutical products which demonstrate the potential to address unmet medical needs in serious or life threatening conditions.

A glioblastoma treatment currently exists, the generic drug temozolomide. Administered after surgery or radiotherapy) it's effective in only one-third of cases with a 'methylated' form of the condition. The remainder are 'unmethylated', the difference being the genetic makeup of the tumors.

Investors have latched on to the double dose of good news, with Kazia shares almost doubling since the start of August, on elevated volumes. While the company's Nasdaq listed equivalent shares have accounted for most of the activity in the past, recent trading has been locally oriented. Our quietest day in the last few months would have been our busiest day a year ago, Dr Garner says.There's definitely a sense the Australian market is waking up to the stock – and not before time.

At least part of the $45 million valuation uplift relates to the 'rare paediatric disease priority review voucher' (PRV) that's attached to the RPDD.

Awarded on approval of the drug, PRVs are tradeable assets that have changed hands between $US68 million ($94m) and $US350m. More recently the values have converged to $US150-200m.

A review voucher shortens the FDA review period for a future marketing application of any drug from 12 months to six months. But it's most relevant for more advanced stage developers; hence the fungibility. If you can launch a $1 billion a year drug six months earlier it is worth half a billion dollars, Dr Garner says. The idea is not so much we use it but sell it to someone else.

The "cleverly designed" PRV scheme is scheduled to end in September and maybe extended depending on who wins the keys to the White House. At the very least there will be a hiatus with the issue of these vouchers and perhaps eventually there will be no more of them, Dr Garner says.

While the vouchers have a clear market value, the fast-track status given to glioblastoma program arguably is no less valuable, despite being less tangible.

The fast-track designation confers a number of benefits over the more snail-paced route, such as face-to-face meetings with the regulator. Post new drug application an expedited review may result in faster approval, with fast-track applications likely to be more successful.

It is like flying on a business class ticket rather than economy, Dr Garner says. We get a lot of extra support from the FDA and a quicker turnaround in many steps of the review process. Rather than submitting all documents at the end of development, it can be done over time and discussed and signed off as needed.

Despite the fast-lane benefits, any drug candidate needs to be supported by data proving its genuine potential. We could not be going for fast track designation in athlete's foot; there is no evidence the drug works for that, Dr Garner quips.

Kazia's next step in proving up paxalisib's efficacy is a so called pivotal clinical trial, designed directly to support a regulatory application.

Interim results from a phase II study showed paxalisib provided five months' median extension in patients' overall survival (they lived longer) and three months extension for progression free survival (the tumors did not get bigger).

Kazia is taking an unusual approach to the phase III (pivotal) trial, by joining a global study called GBM Agile. (GBM is shorthand for glioblastoma).

Created independently of any individual drug company, GBM Agile seeks to standardise the clinical approach and undertake joint research, thus reducing costs and producing data in a format the FDA prefers to see.

Paxalisib will be the second drug to join the study, behind a Bayer candidate called Stivarga (regorafenib). We expect to have up to 200 patients and roughly the same number of control group patients, Dr Garner says. We hope to start the study by the end of this year. ....That will take a couple of years to run its course but at the end of that we hope to got to regulatory agencies like FDA and obtain a marketing authorisation.

Kazia, meanwhile, is in a sound financial position, having 'beaten the rush" by raising $7.8 million in an oversubscribed placement in April. This was followed by a $1.8 million share purchase plan. We have money well into next year at this stage. We are in the nice position that we are not under pressure to do anything, Dr Garner says. After all, it's still a very uncertain market. The coronavirus isn't going away in a hurry, we have the US presidential election and some of the implications of the pandemic are yet to register.

After years of effort to build the credentials of paxalisib, an endgame is in sight for Kazia and its patient shareholders.


https://www.sharecafe.com.au/2020/08/24/wit...e-cancer-story/
  Forum: By Share Code

nipper
Posted on: Aug 28 2020, 06:39 PM


Group: Member
Posts: 7,511

Saw some article talking about this eventuality happening over 10 years... but first, it is policy from a position of weakness. Deflation until it isn't?


At present, it is more the symbolism of dumping long-standing policy.
The king is dead, long live the king.
  Forum: Investment Discussion

nipper
Posted on: Aug 28 2020, 04:46 PM


Group: Member
Posts: 7,511

Beach Energy (BPT) has opted to defer growth and prioritise its balance sheet, ensuring it can withstand weak oil prices going into 2021. Brokers assess Beach Energy has reconfigured its development expenditure well, in order to reflect the current market.

FY21 production guidance is now below the prior target because of delays to the Otway Basin (Victoria) and Western Flank (Western Australia). Attributable production is forecast to grow to 37-40mmboe by FY25.

Guidance is lower than most brokers expected because of the deferred production at Otway and Western Flank and given the 2020 oil price decline. Still, around $2.1bn in free cash flow is expected to be generated over the next five years despite $3.3bn in cumulative capital expenditure.




https://www.sharecafe.com.au/2020/08/18/bea...es-development/


  Forum: By Share Code

nipper
Posted on: Aug 28 2020, 09:24 AM


Group: Member
Posts: 7,511

ORE is raising approximately A$126 million / US$91 million from a Placement and will issue approximately 50.0 million new fully paid ordinary shares, representing 18.1% of the existing shares on issue.


Proceeds from the Equity Raising will be used to allow the Company to fully fund Olaroz Stage 2 and deliver the Olaroz Stage 1 ramp up through a range of operating, COVID19 and pricing environments, as well as capital for future growth initiatives.
The Placement issue price of A$2.52 per share represents a 13.1% discount. Plus a SPP with a discount IF the VWAP drops too low!!
  Forum: By Share Code

nipper
Posted on: Aug 28 2020, 08:45 AM


Group: Member
Posts: 7,511

The Federal Reserve has dumped its policy of deploying monetary policy to maintain 2 per cent inflation and will now turn a blind eye to greater price pressures in an effort to stoke spending, employment and investment.Inflation will now be allowed to run modestly above the Fed's goal for "some time" if it has persistently fallen short, Fed chairman Jay Powell told this year's Jackson Hole symposium on Thursday (Friday AEST).

QUOTE
In seeking to achieve inflation that averages 2 per cent over time, we are not tying ourselves to a particular mathematical formula that defines the average, Mr Powell said. Thus, our approach could be viewed as a flexible form of average inflation targeting.


Simultaneously, the Fed expanded its definition of maximum employment in order to allow any future rise in hiring to run for longer before it taps the interest rate brakes to prevent a wage-driven inflation outbreak. Implicitly acknowledging the Fed has largely failed to reach its 2 per cent inflation goal over the post GFC decade, Mr Powell said it was time to change course.

QUOTE
Because the economy is always evolving, the FOMC's strategy for achieving its goals - our policy framework - must adapt to meet the new challenges that arise, he said.

The new policy emphasises that maximum employment is a broad-based and inclusive goal, he said. This change reflects our appreciation for the benefits of a strong labour market, particularly for many in low- and moderate-income communities.
  Forum: Investment Discussion

nipper
Posted on: Aug 28 2020, 08:37 AM


Group: Member
Posts: 7,511

The Fed announcement is a big one; basically inflation of 2% is no longer a target
QUOTE
The S&P 500 ticked further into record territory on Thursday after the Federal Reserve made a major overhaul to its strategy, one that could keep interest rates low for longer.

The benchmark index rose 0.2%, to another all-time high, but it veered through a jumbled day of trading to get there. Prices for stocks, bonds and gold all made several U turns after Fed Chair Jerome Powell gave a highly anticipated speech. In it, he essentially said the Fed may continue efforts to prop up the economy even if inflation rises above its target level of 2%, as long as it had been weak before then.

The change in the Fed's strategy is a huge deal for markets. The central bank has been the superhero repeatedly rescuing them from crises through the years, by slashing short-term interest rates and buying all kinds of bonds. The momentous announcement was widely expected on Wall Street, if not on Thursday then later this year, but trading was nevertheless erratic following it......

  Forum: Investment Discussion

nipper
Posted on: Aug 27 2020, 03:58 PM


Group: Member
Posts: 7,511

Calix came out with a solid FY report today. Getting a bit more money in the door
QUOTE
... acquisition in December 2019 of USbased Inland Environmental Resources Inc. contributed significantly to growth ($9.7m), along with organic Sales Revenue growth of 34% to $4.4m compared to the prior year
.
Total Revenue and Other Income .... up 75% to $A24.4m
Core Product Sales ...... up 327% to $A14.1m
Other Revenue ......... down 2% to $A10.4 m
EBITDA ................... up 224% to 1.5m

Strong financial position with a closing cash balance of $11.1m, cash flow positive, zero debt and with significant pipeline of grant funding to execute further R&D.
Speaking of which, no hiccups reported. Significant progress for what appears to be their big one; CO2 carbon capture for cement and lime:
o LEILAC 1 PILOT PLANT successfully commissioned mid 2019, and test runs since have proven the technology concept, and increasing operational robustness and throughputs.
o LEILAC 2 COMMERCIAL DEMONSTRATOR (four-fold scale-up of LEILAC 1) received €16m (~A$27m) in EU funding in December 2019, and a further €18m (A$30m) in cash and in kind committed from industrial partners, as final project agreements were executed in March 2020.


Up to 90c, during the day. The best since Covid
  Forum: By Share Code

nipper
Posted on: Aug 27 2020, 01:48 PM


Group: Member
Posts: 7,511

Is it a crazy world? How does a loss making new kid on the block get valued? Now bigger than ANZ Bank; & well into the Top 20 on ASX
QUOTE
With brokers reluctant to put a forward price earnings multiple on the company, one of the few measures for comparing Afterpay with other global tech companies is revenue to enterprise value. Afterpay lost $22 million in the year to June taking accumulated losses to $142 million. Some will argue this exercise is ridiculous given that Afterpay is a tiny niche player in the global payments system and it cannot be compared with companies involved in social media, search-based advertising, video streaming, online retail or software collaborative tools.

Afterpay comes out on top in a comparison of enterprise values as a multiple of forward revenue based on consensus broker data collected by S&P Global Market Intelligence.
QUOTE
Afterpay has a multiple of 28 compared to multiples for the following companies: Netflix 9.33, Facebook 9.2, Apple seven, Google five, Amazon four. For the record Atlassian comes in at 23 times and Tesla comes in at 11 times. The only company that comes close to matching the revenue multiple of Afterpay is Zip Co (Z1P) .

There are a couple of caveats to the Afterpay revenue multiple. First, brokers may, based on the latest financial results, upgrade their revenue numbers for 2021. Second, the share price spiked another 5 per cent on Thursday morning which would mean the multiple should be higher.

Revenue multiples became de rigueur as the measure of success in the last tech bubble in 1999/ 2000. ... But in March 2000 following the publication of comprehensive cash burn rates in Barrons weekly newspaper share prices began to plunge.

There does not appear to be any danger of Afterpay running out of capital to cover its losses given its recent successful capital raising, strong balance sheet and extensive funding lines. But a switch in market sentiment in relation to the amount investors were willing to pay for growth could be devastating for the valuation of highly rated stocks.

The Afterpay results published on Thursday had mostly been prereleased. Two of the numbers investors were hanging out for were the receivables impairment expense which rose from $58.7 million to $94.5 million and late fees as a percentage of income which fell from 18.7 per cent to 13.7 per cent. The Afterpay gross loss rate is the receivables impairment expense expressed as a percentage of underlying sales. This improved by 24 per cent from 1.1 per cent to 0.9 per cent. The company said payment defaults were at record lows in April and May and this trend was sustained in June and July.

Shareholders in Afterpay will be pleased to see the company has revamped its remuneration framework to put greater emphasis on equity rewards and encourage key management personnel (KMP) to focus on getting the share price up.

The long term incentive for Afterpay executives has two equally weighted hurdles: growth in gross merchandise value, which is underlying sales, and increase in net transaction margin assessed over three years. Delivery of the LTI in options also encourages a focus on the Group's share price performance as the LTI will only deliver value to executive KMP if both the share price increases above the exercise price and the performance measures are met, the company remuneration report said.
https://www.afr.com/chanticleer/afterpay-sm...20200827-p55pry
  Forum: By Share Code

nipper
Posted on: Aug 27 2020, 12:55 PM


Group: Member
Posts: 7,511

too true.
QUOTE
• Lake appoints respected Novonix Battery Technology Solutions in Nova Scotia, Canada, to produce high-performance lithium-ion battery test cells using Lake’s lithium carbonate samples compared to industry leading materials.

• Data from battery technology and materials company Novonix will allow potential users and offtakers of Lake’s high purity, responsibly sourced product to make direct comparisons of its performance

LKE up 15% and NVX up 10%
  Forum: By Share Code

nipper
Posted on: Aug 27 2020, 10:32 AM


Group: Member
Posts: 7,511

my two gold index holdings up again, today .... PMGOLD and GDX
the sector has been in a bit of tizz for the last few weeks after hitting highs and getting lots of press at start of August. About a 10% retrace.
I hold the above for insurance
  Forum: Macro Factors

nipper
Posted on: Aug 26 2020, 06:17 PM


Group: Member
Posts: 7,511

Net profit for MNF climbed 20 per cent to a record $11.95 million as demand for voice-over-internet network soared. The company has experienced three years of demand growth from blue chip customers such as Skype, Zoom and Google Meet during just a few weeks in March 2020, CEO Rene Sugo said.MNF customer usage data suggests that unified communications as a service (UcaaS) platforms such as Microsoft Teams will be the permanent winners from COVID19, potentially at the expense of Zoom or Slack.

Unified comms is the one shooting out of the gates right now, he said. In some ways, when the lockdown happened, people just reached out for whatever they could grab. We saw mobile traffic and audio conferencing traffic go through the roof and of course at collaborative platforms [like Skype and Zoom]. Now as the new normal settles down, we're seeing a lot of IT managers and CEOs going back to their organisations and going, 'how do I improve my business communications to allow working from home or another lockdown?

According to Mr Sugo, the post COVID future will be UcaaS, where messaging, video conferencing, voice over internet, collaboration tools and file sharing are offered on one cloud based platform.... From my point of view, everyone will have a UcaaS tool installed on their desktop. What a lot of UcaaS providers are now doing is allowing guest access from people outside your network. So with Microsoft Teams, I can now invite people outside my organisation into a team and video call. So that precludes the need to install other software like Zoom. My prediction is the specialist collaboration providers will eventually be absorbed into the unified all encompassing service providers. .. It is almost like the proof of concept has been successful. Everyone now understands the benefit of having unified comms via my desktop or laptop that I can take to home, work, or travel.

The physical internet infrastructure also allows Uber or Lyft customers to call drivers over the internet by connecting a mobile user handset to an online server, before initiating a separate connection to the driver, with both then joined in the cloud. As MNF sits between the two, there is never a connection between the consumer and business. The software provides the counterparties with temporary phone numbers to protect privacy and security. It also lets vehicle traders on carsales.com obtain temporary numbers. Revenue is generated by charging Uber or Carsales for every phone number in their inventories. During financial 2020, MNF's revenue climbed 7 per cent to $230.9 million.

Mr Sugo said he viewed MNF as more a software than internet infrastructure company; 85 per cent of the employees in its technology division are software engineers.
  Forum: By Share Code

nipper
Posted on: Aug 26 2020, 03:12 PM


Group: Member
Posts: 7,511

The splitting of Apple shares via a reverse four for one division has triggered a historic change in the Dow Jones average ... oil giant Exxon Mobil is out, as is drug group, Pfizer and defence manufacturer Raytheon Technologies. Cloud based customer relations management software group Salesforce replaces Exxon Mobil in something of a surprise, biotech drugmaker, Amgen replaces Pfizer and industrial group, Honeywell will replace Raytheon.

Apple split will have a dramatic impact on the ranking of the companies in the 30 stock Dow. Apple will fall from Number one to Number 17 because the Dow is a price weighted index). The top three stocks will become UnitedHealth Group Inc., Home Depot, and Amgen in that order.

The ousting of Exxon is a historic move as it has been a Dow member for 92 years. It joined in October 1928 (a year before the Great Crash), when it was called Standard Oil of New Jersey. For decades the company was one of the 10 most valuable publicly traded companies, and for six straight years—from 2006 through 2011—it was the most valuable company in terms of market value.

S&P Dow Jones said the changes were prompted by the Apple four for one split which happens after the close this Friday (Ie from trading next Monday) will reduce the index's tech-sector weighting in the Dow, hence the rebalancing.

The announced changes help offset that reduction. They also help diversify the index by removing overlap between companies of similar scope and adding new types of businesses that better reflect the American economy, said S&P

Apple joined the Dow back in 2015 not long after a seven for one stock split.

The changes won't disrupt the level of the index, S&P Dow Jones said in a statement. The divisor used to calculate the index from the components' prices on their respective home exchanges will be changed prior to the opening on Aug. 31, 2020.

While that is true, American market analysts point out that there is another, very good reason, for Exxon Mobil to be punted ... underperformance. Its shares traded for more than $US104 in June 2014, against $US41 today. Even taking dividends into account, it has underperformed the Dow since 2014 by 21%.

The last venerable US company to be punted from the Dow was General Electric back in 2018. It has underperformed the Dow since then at an annual rate of 21% while the Dow has risen at an annual rate of 9%.
Apple shares closed Tuesday at $US499.30 valuing it at $US2.15 trillion. It hit an alltime high of $US515.14 last Friday in trading. If the $US500 level holds, the theoretical value of the new shares post-split will be around $US125.
https://www.sharecafe.com.au/2020/08/26/app...c-dow-shake-up/
  Forum: Macro Factors

nipper
Posted on: Aug 26 2020, 02:33 PM


Group: Member
Posts: 7,511

QUOTE
Resilient American householders more inclined to tackle a plumbing job rather than call in a plumber helped offset a sharp fall in sales in Europe for Reliance Worldwide Corp during Covid.

Chief executive Heath Sharp said there was still high volatility in the market after a partial rebound in sales in July/ August, but making predictions about customer behaviour in the UK and Europe, in particular, was fraught. But buoyant results out of Reliance's US market helped trigger a 17 per cent surge in the share price [following release of FY results].

The US makes up about 50 per cent of the plumbing supplier's overall business and the impact of COVID19 that market was in stark contrast to Europe, which comprises about 35 per cent of the operations.

In the June half, sales in the Americas region jumped 19 per cent as plumbers headed to hardware stores to stock up on items they were having trouble sourcing from wholesalers, while DIY enthusiasts also spent up as they had a go at home plumbing jobs themselves.

But in the UK and Europe, sales fell 20 per cent because of harder lockdowns by the British government and ''cultural'' and licensing issues, which mean professional plumbers are virtually the only avenue for repairs and renovations. There is more of a mindset in the United States to tackling those DIY projects, Mr Sharp said. While there had been some pent up demand in the UK, there was still major uncertainty. The UK business is not back to normal by any stretch, Mr Sharp said.

Orders were happening at the last minute in some cases, while some players appeared to be expanding stock levels of plumbing items in case there was a renewed wave of COVID-19 cases. Forecasting was almost impossible. Quite frankly, we just do not know, Mr Sharp said.

Net profit fell 33 per cent to $89.4 million, even though net sales revenue rose 5 per cent to $1.16 billion.

The company will on October 9 pay a final dividend of 2.5¢, which is half the payout a year ago.

Reliance is also scrutinising its global supply chain and Mr Sharp said the company would rely less on output from China in the future. There's a lot to be said for making close to the market, he said. We are looking globally at our supply chain and where we are making our products.

Reliance made a big bet on the UK market in May 2018 when it paid $1.2 billion to buy the John Guest business.

It makes plastic push to connect plumbing fittings, similar to the Sharkbite brass fittings range which has slowly been penetrating the US market as a younger generation of plumbers chase time savings and steer away from welding and soldering of traditional fittings. Mr Sharp said synergies from the John Guest acquisition were $31.3 million at June 30, and outside of the impacts of COVID19, that business had been seamlessly integrated.
  Forum: By Share Code

nipper
Posted on: Aug 26 2020, 11:40 AM


Group: Member
Posts: 7,511

The philanthropic listed investment company Hearts and Minds Investments delivered a portfolio return for 2019-20 of 26.1 per cent, ahead of the MSCI World's 4.8 per cent in Australian dollar terms.

The board will consider a dividend payment following the realisation of the 2019 conference portfolio which will occur at the end of 2020, the LIC said.

The 2019 conference portfolio contributors , with a 35 per cent allocation, were Tesla (Catherine Wood from ARK Invest), Spotify (Hamish Corlett from TDM Growth Partners), GDS Holdings (Beeneet Kothari from Tekne Capital), The Trade Desk (Nick Griffin from Munro Partners), The A2 Milk Company (Jun Bei Liu from Tribeca) and Mineral Resources (Emma Fisher from Airlie).

The core portfolio return leaders, with 65 per cent allocation, were Appen, Zillow, Microsoft, Alibaba and Alphabet Inc (selected by Caledonia, Cooper, Magellan, Paradice, Regal and TDM).

Only two stocks in the 2018 conference portfolio were sold at a loss.
  Forum: By Share Code

nipper
Posted on: Aug 26 2020, 11:35 AM


Group: Member
Posts: 7,511

TNT continuing its acquisition path.

Acquires Airloom kicking off Phase 2 of acquisition strategy

QUOTE
Airloom is a Sydney-based cybersecurity firm with a focus on security architecture and supporting organisations secure their journey to the cloud. The firm has a strong management team and an excellent operating record, with FY20 gross revenue in excess of $27M. Airloom is immediately earnings, cash flow and EPS accretive to the TNT Group, having achieved in excess of $2.7M EBITDA in FY20. Strong revenue and earnings are expected to continue into FY21. Importantly, the firm’s financial position is underpinned by multiple locked in, recurring multiyear annuity based contracts.

The acquisition is fully funded through Tesserent Acquisition Debt Funding Facility with PURE Asset Management (announced 20 July 2020). The consideration for the acquisition of Airloom is a mix of cash and TNT shares, being $6M cash and 40M shares, issued at a 30 day VWAP, subject to any necessary shareholder or other regulatory approval. The cash payment will be split over two payments, with $5M payable on completion and $1M upon achieving agreed key financial milestones.


  Forum: By Share Code

nipper
Posted on: Aug 26 2020, 11:18 AM


Group: Member
Posts: 7,511

described as under the radar, OCL continues to get runs on the board

results were in line with the Trading Update provided on 15 July 2020.
QUOTE
Group revenue for Financial Year 2020 (FY2020) grew by 13% to $70.0 million (FY2019: $62.1 million); EBITDA grew by 22% to $17.2 million (FY2019: $14.1 million)

Net Profit After Tax (NPAT) increased by 22% to $11.0 million (FY2019: $9.1 million)
Perpetual (upfront) licence fee revenue in FY2020 represented less than 7% of total revenue, demonstrating consistent and continuing progress in transitioning to subscription software contracts.
Overall recurring revenue increased to 75% of total revenue (FY2019: 70%). Annualised Recurring Revenue (ARR) increased to $56.6 million at 30 June 2020, an increase of 22% over the balance at 30 June 2019 ($46.6 million).
We delivered significant annual recurring revenue growth in all core subscription software products including ECMaaS (101% growth over FY2019); Connect (34% growth over FY2019); Keystone (8% growth over FY2019); Trapeze (51% growth over FY2019) and AlphaOne (49% growth over FY20191).

In FY2020, the Company invested $15.7 million in Research and Development (R&D) (FY2019: $13.2 million) representing 22% of revenue. The company fully expenses all R&D expenditure in the year that it is incurred.

In November 2019, Objective Corporation acquired Master Business Systems (MBS), a developer of software and services that enables local governments in New Zealand to more efficiently process building consent applications and manage their software environments. The total acquisition consideration for MBS comprised of NZ$4.0 million in upfront cash consideration and a further payment of NZ$1.2 million deferred over three years. The last twelve months revenue for MBS to 30 November 2019 totalled NZ$3.1 million with Annualised Recurring Revenue (ARR) of NZ$2.5 million as at 30 November 2019.
... Overall operating costs increased by 11% in FY2020 to $54.6 million (FY2019: $49.3 million) driven largely by the addition of the cost bases of acquired businesses (partial year contribution of MBS and the full year contribution of Alpha Group, after a partial year contribution in FY2019). Operating costs excluding the impact of acquisitions increased by 3% over FY2019.
... Group operating cash flow in FY2020 was $29.2 million (169% of EBITDA) in FY2020, an increase of $5.8 million over FY2019 operating cash flow ($23.4 million).
... Total cash balance at 30 June 2020 was $51.0 million. The Group has no external borrowings.

Directors declared a fully franked dividend of 7.0 cents per share.
  Forum: By Share Code

nipper
Posted on: Aug 26 2020, 10:39 AM


Group: Member
Posts: 7,511

Outlook
Whispir remains focused on executing its longterm growth strategy : sustainably increasing its geographical footprint, acquiring new customers, diversifying channel partners and enhancing its platform functionality and capability.

QUOTE
In addition to acquiring new customers in our three key markets of ANZ, Asia and North America, we are confident that we can continue to consistently grow platform usage within our existing enterprise customer base.

The need for our communications workflow platform is universal across all industries and regions and the COVID19 pandemic has highlighted the need for secure and auditable communications software that does not require IT expertise to use and can be quickly deployed at scale across multiple delivery channels.

Acknowledging the high level of uncertainty in the current economic and business environment, Whispir provides the following outlook guidance for FY21:
• Year end ARR: $51.1m to $55.3m
• Revenue: $47.5m to $51.0m
• EBITDA: $(6.2m) to $(4.8m)
• R&D cash investment: $9.2m to $9.8m
  Forum: By Share Code

nipper
Posted on: Aug 26 2020, 10:27 AM


Group: Member
Posts: 7,511

patience is a virtue, Mick biggrin.gif
  Forum: By Share Code

nipper
Posted on: Aug 26 2020, 10:11 AM


Group: Member
Posts: 7,511

Those that use it love it. And Covid times has been good for business
QUOTE
Outstanding growth numbers for FY20 that reflect our successful year.
• Active traders have increased 235% from 13,856 to 46,445
• Annual trade numbers are up over 299% from 164,999 to 659,131
• Revenue increased significantly in line with the large increases in clients and trading volumes to finish 188% up from $2.81m to $8.08m
• Operating cashflow saw a reduction in cash burn from $3.2m to $147,000.


The growth exhibited by your Company has resulted in SelfWealth's first-ever quarterly positive cash flow from operating activities during the fourth quarter of FY20. We are confident of further growth in FY21. A healthy balance sheet, no debt and a positive cashflow leave the Company in an excellent position to execute its growth strategy in a dynamic marketplace that is changing actively
  Forum: By Share Code

nipper
Posted on: Aug 25 2020, 03:53 PM


Group: Member
Posts: 7,511

No. Had a look; while it is an attractive concept, I do not see any unique ability to own its market. Competition with deeper pockets and better connections?
  Forum: By Share Code

nipper
Posted on: Aug 25 2020, 02:49 PM


Group: Member
Posts: 7,511


Quite often companies can have great products and technology, suggesting great potential with share prices that boom but without delivering on those expectations the share price comes screaming back to earth. More often than not, they become largely forgotten. One that has come storming back is Elsight (ELS) with a series of contract wins for its Halo product that is opening the door for a serious increase in earnings.

This is a company that has transitioned itself from development to commercialization. And now that it is delivering the share price is also moving in accordance. That can often lead to a significant re-rating.

The Halo product allows for the distribution of real-time data and video across networks with significantly lower use of bandwith to still be able to deliver that content uninterrupted. This is naturally crucial in environments of military, security and health applications. Its specific benefit is in areas where communication networks are underrepresented but key information still needs to be communicated.

The recent contract announcements with Kinetx Prime and Alrena show that health services are significant market for the company and these two contract alone is US$1.9 million with potential for additional orders. This is clearly validation of their technology in the real world and as a result I would expect that more contract wins will be delivered. Furthermore, the lead time to additional contract wins will be shortened as ELS has more devices in use.

These contract wins helped lift the share price from its doldrums in the sub-50c mark up to as high as 73c recently. Currently it is sitting at 60c with a market cap around $63 million. The more exciting aspect is looking at the longer-term profile of the company since it listed with 2017 being the exciting year where its share price rocketed from 20c to $1.75. We know that when ELS hots up it can really motor.

Given the recent move coming off the back of actual delivered contract wins, it won’t take many more wins before the same level of interest and excitement about the earnings potential for its technology returns back to those 2017 levels.

I continue to think that ELS has finally come into to its own, delivering on the potential that the market could clearly see, but was unwilling to wait for. Now that contract wins are coming in relatively quick succession it’s hard not to think that there are more in the near future. ELS had been on my watch list for over 18 months and I had refrained from buying because I wanted to see that validation with contracts. Now it’s here and I am buying. Once 75c is cleared I think there is every potential this is returns to a $100 million + market cap.





https://www.sharecafe.com.au/2020/08/21/els...-its-potential/
  Forum: By Share Code

nipper
Posted on: Aug 25 2020, 10:57 AM


Group: Member
Posts: 7,511

the post war generation has risen with increased affluence and material well being. Being of this cohort, I am glad I did not have to go through Depression and War, character-forming such events may have been (for those that may have survived)
The media does try to play off one generation against another. I certainly reacted against the straight laced society that informed my parents. But there was never any sense of entitlement, which seems to be an attribute becoming more apparent among younger folk.
.x.x.x.x.x.x.x.x.x.x.x...
Apropos of everything, this morning I was reading about and even delved into Anna Akhmatova's Requiem. To help with some context, this was a poem cycle written by her as a response to Stalin and the Terror of 1936/37. So terrified she was, the work was memorised, passed secretly in small groups and never written down until 1963, published in the USSR only in 1987.. Its introduction, its genesis, was when waiting to see her imprisoned son (husband had been executed/ murdered prior)
QUOTE
During the frightening period of the Yezhov terror, I spent seventeen months waiting in prison queues in Leningrad. One day, somehow, someone "picked me out". On that occasion there was a woman standing behind me, her lips blue with cold, who, of course, had never in her life heard my name. Jolted out of the torpor characteristic of all of us, she said into my ear (everyone whispered there) "Could one ever describe this?" And I answered, "I can." It was then that something like a smile slid across what had previously been just a face.


So, basically, stop whingeing, people. We will get through this. As Bertrand Russell said Remember your Humanity.
  Forum: Off Topic Chat

nipper
Posted on: Aug 24 2020, 06:07 PM


Group: Member
Posts: 7,511

US allows emergency use of blood plasma treatment for coronavirus patients
  Forum: By Share Code

nipper
Posted on: Aug 24 2020, 05:14 PM


Group: Member
Posts: 7,511

Ava Gardner never said On the Beach is a story about the end of the world and Melbourne sure is the right place to film it
  Forum: Investment Discussion

nipper
Posted on: Aug 24 2020, 04:50 PM


Group: Member
Posts: 7,511

27 bucks. Selloff did not last long when the results came out
https://arichlife.com.au/pro-medicus-asx-pm...y-2020-results/
QUOTE
Yesterday, Pro Medicus shares dropped as much as 7.5% on delivering its results for FY 2020. While the record profit of $23 million was an increase of about 20% on the prior year, the second half profit was actually down on the immediately preceding half. Happily, free cash flow was very strong at $23.7m and the company finished the year with cash reserves of $43.4 million.

The main reason for the reduced half-on-half profit was the impact of the coronavirus pandemic, which the company estimated reduced second half profit by $1.2m. Without that impact, the second half would have been mildly better than the first half, but not a lot better.
However, there were a number of drivers of lower profit growth in FY 2020 compared to FY 2019. The biggest single reason was that the company received a $3m point in time payment for a German installation in FY 2019, and this was not repeated in FY 2020.

Comparing the first and second halves, European and Australian revenue was largely flat, half-on-half, while the biggest hit was felt in the USA, where sales actually dropped for the first time since 2018.


and he has a say
QUOTE
...At the current price of around $24.50, Pro Medicus trades on a price to earnings ratio of 110. This implies that it can at least 5x its profit before reaching maturity, preferably in the next few years. Given the nature of its business, Pro Medicus does receive system growth even once mature, but clearly it will need to increase its number of customers by 3x or 4x. On the conference call, CEO Sam Hupert said that they were far from saturating their market and were closer to the beginning than the end. This implies that there is at least a 2x gain possible in terms of image viewing customers, but I would hope it would be more than that. In any event, we can reasonably expect some uplift from the open archiving product, and if it were a priority I’m sure they could build out the RIS product for a north American customer base.

In terms of costs, I think the company will be in a good position as the world undergoes the digital transformation even faster, and it should end up saving on marketing costs as the big RSNA conference it attends will be online this year.

.

  Forum: By Share Code

nipper
Posted on: Aug 24 2020, 02:50 PM


Group: Member
Posts: 7,511

Mainfreight is a NZX listed Company, so it does not feature too highly in the consideration of many Australian investors. Which is a shame, as it has been doing well, and doing right.
It is now the biggest holding in Mirrabooka (MIR) portfolio, at 5.5% with the shareholding around A$20million

QUOTE
Mainfreight is a 42 year old transport and logistics business based in Auckland run by executive chairman and founder Bruce Plested and Don Braid.Even a quick scan of the $4.2 billion group's recent NZSX announcements tells you this company is a bit of an outlier, in the best possible way.

Lots of companies talk about culture, but very few live it as vividly as Mainfreight appears to.

Despite posting a record profit in the year to March 31, Plested's address at the group's recent annual general meeting spent exactly 77 words on financial results, before quickly moving on to weighty matters including climate change and the importance of social housing.

And every few months, Mainfreight publishes a report on the exchange written entirely by its team members, talking about the business and their roles. July's document was 72 pages long. All this might sound a little corny, but it clearly translates to strong performance. Mainfreight's share price has more than trebled over the past five years.

So when Prime Minister Jacinda Ardern put the country in an aggressive lockdown in March as New Zealand tackled the pandemic, Mainfreights first thought was for its people.

Braid says he watched turnover sink between 40 per cent and 50 per cent in the initial weeks of the crisis, and the fear was that such conditions could continue. With the New Zealand government supporting businesses through the lockdown with generous wage subsidies, Mainfreight hesitantly applied ... but only after putting through wage cuts for senior staff, and stipulating only those earning less than $NZ200,000 ($182,000) would be able to tap the subsidies.

It did not sit right, but we thought if this might save jobs, let's take it, Braid explains.

The money , some $NZ10.6 million for 1526 staff , arrived much faster than expected. But Braid and Plested still were not comfortable, so they put it in a separate bank account and thought of it as a sort of emergency buffer.

Happily, the business started to turn around quickly as New Zealand adjusted to life under lockdown, and the Mainfreight geographic spread across 26 countries provided welcome diversification. Revenue in New Zealand and Europe was down across April and May, but it was stronger in Australia and stable in the US. Braid said in late May he was cautiously optimistic about the year ahead.

So Mainfreight decided to hand back the untouched wage subsidies. It was the most important thing we do. We felt we did not deserve it, Braid says.

The logic was simple. The New Zealand government had done the right thing by Mainfreight and the country, and the executive team were unanimous in their view that other businesses needed assistance more than they did.

It's about integrity and it's about what we stand for. ...We are a pretty proud business and we see those things as important, Brad says.

Hilariously, the idea was easier said than done. In this case at least, the bureaucracy was geared up for giving, not taking. It was harder to give it back than it was to take it ... they did not know what do with it, Braid laughs. He's suitably diplomatic when asked for his views on those companies that have taken JobKeeper and still paid healthy dividends. Each to their own. But I know what's important at Mainfreight.

https://www.afr.com/chanticleer/why-this-fr...20200823-p55ofk
  Forum: NZX

nipper
Posted on: Aug 24 2020, 11:54 AM


Group: Member
Posts: 7,511

QUOTE
FY20 was wholly transformational for Uniti, having completed three substantial acquisitions in the first half, namely LBNCo, OPENetworks and 1300 Australia, each of which therefore contributed to Uniti’s FY20 earnings for part of the year.

The organic growth achieved in the second half of FY20 by the now substantially enlarged Uniti business, combined with an effective integration program, resulted in the Company upgrading its underlying EBITDA0 guidance for the second half of FY20 and its forecast June 2020 underlying EBITDA runrate on three separate occasions, twice in February and again in June.


Uniti finished FY20 with an annualised underlying EBITDA exit runrate of approximately $41M, a 24% increase in the second half of FY20 on the same measure as at December 2019, generated entirely organically.

Very pleasingly, Uniti continued to convert operating earnings into free cash flow with Net Operating Cash Flow in Q4 FY20 of $10.1M providing Uniti with the ability to fund any growth capital expenditure out of operating cash flow. Capex as a percentage of underlying EBITDA for FY20 was 31%, and for Q4 of FY20 was 38%.
  Forum: By Share Code

nipper
Posted on: Aug 24 2020, 10:28 AM


Group: Member
Posts: 7,511

well, it is not a capital raising. So, that would be encouraging
QUOTE
wait for new news
  Forum: By Share Code

nipper
Posted on: Aug 24 2020, 10:15 AM


Group: Member
Posts: 7,511

eat my words .... up 100%++
QUOTE
Mastercard and Identitii sign five-year agreement Overlay+ enables the secure and auditable collection and sharing of information related to financial transactions.
Highlights:
• Identitii has signed a five-year Agreement with Mastercard
• Agreement enables Identitii to sell to and work with any Mastercard business globally
  Forum: By Share Code

nipper
Posted on: Aug 23 2020, 05:11 PM


Group: Member
Posts: 7,511

It is a funny one. Partner of my brother works in a dementia ward in a home, up on the Tweed. She calls the old bints My second family.
She would pull in more a week if on JobKeeper .
  Forum: Off Topic Chat

Poll: Politics
nipper
Posted on: Aug 23 2020, 01:34 PM


Group: Member
Posts: 7,511

just look upon them as your personal case worker
  Forum: Off Topic Chat

nipper
Posted on: Aug 23 2020, 12:29 PM


Group: Member
Posts: 7,511

Announcement was after closing time on Friday afternoon....

  Forum: By Share Code

nipper
Posted on: Aug 23 2020, 12:29 PM


Group: Member
Posts: 7,511

CEO Frank Houllis has had his employment terminated, effective immediately. Chair and a Director will run the company for a while. !!
  Forum: By Share Code

nipper
Posted on: Aug 23 2020, 12:11 PM


Group: Member
Posts: 7,511

CEO Dr Malcolm Parmenter said COVID19 accelerated the closure of some of the company network of pathology collection centres, which experienced a rapid and sharp decline in base testing services as the virus hit in March and April.... At their worst, volumes were down more than 30 per cent; they were down more than 40 per cent in Healius imaging units because of restrictions during the height of the pandemic.

Healius closed 30 collection centres over fiscal 2020, and plans to close more of the 2150 sites in the coming year. It also plans to rationalise some community imaging facilities, its fleet of couriers and warehouses.

Dr Parmenter said the lockdown in Victoria was significantly affecting its imaging unit, given its private hospital contracts and elective surgery had stalled. Imaging volumes in the state fell 17 per cent in July, and fell further in August, but were up in the rest of the nation, he said.. There is a natural hedge [in pathology] but imaging does not have that, so it's more about controlling the cost base while volumes are down, he said.

The $2 billion healthcare giant swung to a $70.5 million loss in the 12 months to June 30 from a net profit of $55.3 million in the prior year. Underlying net profit from continuing operations was down 21.2 per cent to $55.4 million, while revenue from continuing operations crept up to $1.58 billion from $1.56 billion.

Underlying earnings before interest and tax was at the lower end of guidance at $102.7 million, or $76 million on a reported basis, against $126 million in 2018/19. During the COVID19 crunch in the second half year, Healius received $6.6 million in rental concession from landlords, as well as nearly $13 million in government assistance and JobKeeper subsidies.

Dr Parmenter said without the assistance, there would have been further service and labor cuts. All up, $37 million was saved by cutting costs across the business. The imaging business was hit hardest during 2020, with sales down 3.7 per cent and earnings tumbling 41 per cent. Pathology volumes were down 1.5 per cent, or 3.5 per cent excluding COVID19 testing.

Dr Parmenter said Healius had completed 1 million COVID19 tests, with more than half completed since June 30, while the group also won a number of commercial contracts from the government and the AFL.

The board cut the final dividend, but decided to pay the deferred February dividend of 2.6¢ per share, on October 15. It is also reviewing its capital structure, and may consider an special dividend after it completes the sale of its medical centres to BGH Capital, which is is on track to complete this year.

Healius is the nation's second-largest pathology service provider after Sonic Healthcare.

https://www.afr.com/companies/healthcare-an...20200820-p55nsx


  Forum: By Share Code

nipper
Posted on: Aug 23 2020, 11:42 AM


Group: Member
Posts: 7,511

PainChek Ltd (PCK) backed into another carcass in Jan 2018. Had a bit of a run last year ... 5c to 35c but bumped back down to 10c.

It is engaged in the development and commercialization of mobile medical device applications, that automate intelligent pain assessment of individuals who are unable to communicate their pain with carers. PCK is involved in provision of pain management and better medication for residents living with dementia and other communication difficulties. The company has obtained regulatory clearance in Australia and Europe.


The PainChek Technology:
QUOTE
The company uses cameras in smartphone and tablets to analyze facial recognition software to detect presence of facial microexpressions that are indicative of pain. The technology has been TGA and CE Mark cleared for use as a class 1 medical device to assess pain in people who are unable to verbalise, such people with dementia.
The caregiver uses PainChek to record observations of pain related behaviours, the software then calculates an overall pain score and stores the result allowing the caregiver to monitor the effect of medication and treatment overtime.


Picked up Govt R&D tax incentive ($800k; Feb), Bed Milestone incentive ($1.25mill; March); granted patents and regulatory clearances (various countries); raised $10mill in placement (Aug); Has launched in Aust and Europe/ UK, in enterprises (Hospitals/ Age care facilities) and likely to launch for Home Care soon (5 x the market), plus likely in USA and Canada in 2021/22 ..


The use of an App on a mobile phone gives portability, especially in these Covid times. Elimination of subjectivity would be a core issue, and having SaaS and digital access to records would be a great advance in access to information. From the 08 Aug investor Presentation:
- Using video/AI to automate the facial expression assessment – eliminating subjectivity & improving accuracy
- Eliminating paperwork – all digital 42 data points with prompts = faster assessments
- Automatic logging of pain scores over time – monitor trends
- Integrates into medical records
- Helps care homes meet accreditation standards & protect income & revenues

Also from the Presentation; startling advantage if true:
QUOTE
1. Attractive pricing for rapid enterprise adoption, $4 per bed per month
2. Patent coverage & no direct competition – PainChek has first mover advantage for 15 years+
3. Some 80-85%+ gross margins – very low cost of goods sold

there is a new 15 minute webinar available:
https://www.sharecafe.com.au/2020/08/21/pai...r-presentation/
  Forum: By Share Code

nipper
Posted on: Aug 23 2020, 10:48 AM


Group: Member
Posts: 7,511

it would be fair to say Aged Care is a sector worth staying out of, as an individual choice (definitely) and probably as an investment.
QUOTE
... Such is the scale of death and infection in the nation's aged care homes, industry players and advocates for older Australians say the pandemic must be the spark for meaningful reform of the sector... worth the equivalent of 1.1 per cent of GDP.Nearly 300 residents have died so far, mostly in Victoria, and already acute workforce shortages are compounded by more than 1000 infections among staff. Divided accountability between state and federal governments and a sector splintered among private, public and non-profit operators is struggling to cope.
and then some.
QUOTE
The [Corona]virus is a symptom. The overall state of the sector is a longterm chronic disease.

That's the assessment of Terry Barnes, a wellknown consultant and author of the Howard government aged care policy for the 1996 election victory.
It is not any one government's fault. The way I see it, in terms of the politics and the policy, aged care politically has been the Cinderella of the health care system, forever. It does not matter who is in government federally, the squeaky wheels are public hospitals and Medicare. The squeakers of the wheels are powerful lobbies like the Australian Medical Association and the Pharmacy Guild, he says.

He says efforts to reform a system that cares for about 1.3 million people and costs the federal government $20 billion a year usually fail because of the complexity and the fact most voters have other priorities. Aged care lobby groups don't have the pull of their competitors.

Nursing homes are things most people don't want to know about until they absolutely have to, Barnes says. For him, it's a matter of a national culture increasingly subcontracting care for the elderly to the state. A set and forget mindset.
The sector has an historically low paid workforce and faces persistent calls for higher qualifications and staff-to-resident ratios. As of 2019, about 240,000 people live in permanent care around the country, with another 65,000 receiving respite care. More than 106,700 people are cared for through inhome support services, a growing part of the aged care puzzle.


and the players:::::

QUOTE
Non-profit organisations manage almost about 60 per cent of residential aged care services in Australia, followed by private at about 30 per cent and government organisations at about 10 per cent.

The biggest players, including BUPA, Opal, Regis, Estia, and Japara dominate the sector, with the trend to larger facilities for economies of scale. Federal government spending is expected to pass $23.6 billion by financial year 2022, while about a quarter of costs are covered by customers.

One industry analyst says aged care isn't a good way to make money, with more than half of centres not profitable, including those run by churches and charities and not seeking to make money. About 80 per cent of providers revenue comes from the government, with a shrinking pool available, despite a growing cost base. Nursing costs, compliance costs, personal protective equipment costs are all rising but earnings are contracting.

However, a report by the Centre for International Corporate Tax Accountability this month found big operators claiming hardship are also generating large cash surpluses. It said four out of five of the largest non-profit residential aged care operators claimed losses last year while producing at least $26 million in net cash flow.....


https://www.afr.com/politics/federal/austra...20200820-p55npv
  Forum: Off Topic Chat

nipper
Posted on: Aug 23 2020, 10:27 AM


Group: Member
Posts: 7,511

and of course, as an investment house that has a Value tilt in its approach, Platinum are squirming a bit as Growth, especially tech, challenges heir model.


Current Platinum boss Andrew Clifford has a few things to say (5 min vid):
QUOTE
Markets have rebounded strongly from their March lows, despite entering one of the deepest economic downturns in history. But that's not the whole story.
There are two very different markets; a speculative market in growth stocks and the rest. With 30+ years investment experience, CEO and CIO, Andrew Clifford explains why he believes there is a need for caution.


https://www.sharecafe.com.au/2020/08/20/spe...se-for-concern/
  Forum: By Share Code

nipper
Posted on: Aug 22 2020, 08:55 PM


Group: Member
Posts: 7,511

Preliminary Final report out:

Overall investment return was negative 3.5% for the year ended 30 June 2020, as measured by its pre tax net tangible asset backing per share. The negative return from the Company's investment portfolio resulted in a net loss after tax of $10.1 million for the 2020 financial year.


The Company's investment performance during the 2020 financial year can be broken into two distinct periods:
... The six month period from 1 July 2019 to 31 December 2019, during which the Company portfolio delivered an investment return of 7.2%.
... The six month period from 1 January 2020 to 30 June 2020, during which Company investment return was negative 10.0%. The cautious positioning resulted in significantly reduced investment returns during this period, mostly attributable to losses on its short positions.

The Company declared a fully franked 2020 final dividend of 3 cents per share. This brings the full year fully franked dividend to 6 cents per share representing a grossed up yield of 6.9% based on the closing share price of $1.25, demonstrating the value of the Licensed Investment Company Structure and the Company's dividend smoothing strategy.
  Forum: By Share Code

nipper
Posted on: Aug 22 2020, 06:54 PM


Group: Member
Posts: 7,511

Headquartered in Melbourne, Australia, PayGroup Limited (ASX: PYG).
QUOTE
The Group is a provider of Software with a Service (SwaS) payroll solutions and APP enabled Cloud (Software as a Service or SaaS) Human Capital Management (HCM) platform for multinational companies. Clients are typically medium to large multinational companies with employees in multiple countries across Asia Pacific.

The Group operates as a trusted partner to perform the outsourced payroll process for the client employees, contractors , banking, treasury, lodgement of statutory submissions including taxation, superannuation, pension, provident funds, and other social benefits.

Beyond its SwaS Payroll Services, the SaaS HCM software platform supports clients in managing aspects of their employees life cycle, plus regional and mobile-enabled workflows for critical processes (such as employee and manager self service, leave management and expense management).


paygrouplimited.com

The company started in Asia has maintained its Pan Asian focus, utilising India and Philippines to grow the business. The first leg is PayAsia group of companies, including an Aust presence.... it has 875 client entities across the Middle East, subcontinent and SE Asia.

Listed on ASX in May 2018 and acquired Astute One at end of that year.. Astute is the second leg of the biz; it is a leading SaaS platform provider to workforce management companies and the corporate sector, with over 300 clients in Australia and New Zealand.

There is a fifteen minute webinar available:

https://www.sharecafe.com.au/2020/08/21/pay...r-presentation/
  Forum: By Share Code

nipper
Posted on: Aug 22 2020, 02:54 PM


Group: Member
Posts: 7,511

The MD Ben Cole ... comes across as a pretty smart guy
Existing protein ... beef and lamb. Quality branded product (Dirty Clean Food) that was sold to restaurants has moved to online during Covid and they are selling it all. Also moving into pork and chicken.

Plant Based: Europeans are eliminating soy and almond milk (about 10 minutes in) so they state .... oat milk is a way to go.

Lupins have an inability to gel. New technology they have developed in refining the product allows it to disrupt soy protein market

........ the WOA share price has surged in the last few weeks. Up 250% in a month (now $1.39) !!
  Forum: By Share Code

nipper
Posted on: Aug 22 2020, 02:38 PM


Group: Member
Posts: 7,511



Webinar ... 15 minutes long
https://www.sharecafe.com.au/2020/08/21/wid...r-presentation/
  Forum: By Share Code

nipper
Posted on: Aug 21 2020, 06:37 PM


Group: Member
Posts: 7,511

Australia has a new golden triangle for aviation, with Brisbane to Cairns & Townsville now seeing more flights and passengers than Sydney.. Melbourne .. Brisbane.

Qantas CEO Alan Joyce revealed on Thursday that Brisbane to Cairns had become the airline’s best performing route in the COVID crisis, with demand for flights exceeding that before the pandemic.

In the space of a few weeks, Qantas has increased services from 22 return flights a week, to 53 in response to demand, with the potential for more when state border restrictions are eased.

Brisbane-Townsville is the second most popular route nationwide with 44 return services a week across three airlines, and Brisbane-Mackay third, aided by the ongoing demand from the resources sector.

In contrast Sydney Melbourne Brisbane are each seeing just a couple of return flights a day between those cities, due to border restrictions limiting travel to essential workers or returning residents.

It’s a state of affairs Cairns Airport chief executive Norris Carter is well aware of, with ten flights a day from Brisbane delivering around 1500 people to the far north Queensland city.
QUOTE
Pre COVID, Brisbane to Cairns was the country’s 11th more popular route, now it’s the first, Mr Carter said. It means the airport is operating at about 25 per cent of pre COVID passengers across all the routes so we have still got some tourist activity happening.

A number of hotels in the city remained closed and a lot of businesses were hamstrung until international borders reopened, such was the reliance on foreign visitors.

In addition to the Brisbane to Cairns flights, the city was also seeing regular flights to Adelaide and Darwin, and looking forward to recommencement of Gold Coast services from September 1.

Townsville has also seen some recovery in recent months, with 58,490 passengers in July. more than the previous three months combined.

Owner Queensland Airports Limited which also operates Gold Coast, Mount Isa and Longreach Airports, was encouraged by the improvement.

Mr Joyce also highlighted the popularity of Perth-Broome flights, which the West Australian tourism spot welcomed.

Broome Chamber of Commerce president Peter Taylor said a deal by the state government with Qantas had delivered additional flights at cost effective rates, which had been hugely successful in getting tourists into Broome.
  Forum: Off Topic Chat

nipper
Posted on: Aug 21 2020, 03:45 PM


Group: Member
Posts: 7,511

and we cannot travel and enjoy foreign climes @ cheap rates
  Forum: Macro Factors

nipper
Posted on: Aug 20 2020, 02:17 PM


Group: Member
Posts: 7,511

the PFD acquisition .... paying $552million for a 65% share. It is a business with about $2.2 billion in revenue and earnings before interest, tax, depreciation and amortisation of $57 million. The company has maintained modern facilities; it has just completed a $100 million upgrade of its distribution centres.

Woolworths chief executive Brad Banducci admits Woolies is paying a full price for PFD Foods at 11 times EBITDA. But he is unapologetic. He says the quality of the asset, its national distribution footprint, its position as the second largest player in the sector, and its reputation for offering the best service means it will be a really valuable part of Woolworths Group.
QUOTE
Banducci has been expert at extracting efficiencies from the Woolies supply chain. He has been good at installing world-leading technology for managing logistics, and the company's data analytics is best in class.

But this size and scale is actually an impediment to lifting the products and services it offers people living in different urban localities.

This is where the PFD Foods acquisition is a potential game changer for Woolies shareholders. The deal is not about buying a business and squeezing it for synergies or turning the screws on managers to boost margins. The transaction will allow Woolies to use the PFD Foods distribution network to offer specialised food services on its supermarket shelves. It is recognising that everything is local.

Banducci says that combining capabilities of both companies will enable Woolies to enhance the range in its stores. He says there will be synergies through better route and capacity optimisation across the Woolies network. Woolies expertise in data analytics, its digital capabilities and its commodity sourcing will be made available to PFD Foods.

Tying up all sectors ..... just like the Marley (MMM) stake
  Forum: By Share Code

nipper
Posted on: Aug 20 2020, 01:16 PM


Group: Member
Posts: 7,511

another essentially positive Covid story

https://www.entrepreneur.com/article/354999
  Forum: Off Topic Chat

nipper
Posted on: Aug 20 2020, 12:13 PM


Group: Member
Posts: 7,511

seems that this company may be escaping its former self
17 Aug: IMEXHS enters global agreement with Vital Images, Inc., a Canon Group company.
Highlights

• IMEXHS signs global partnership agreement to license leading healthcare imaging company Vital Images' advanced visualisation Vitrea® software
• Vitrea advanced visualisation will now feature on IMEXHS's AQUILA platform via an affordable on-demand subscription model
• Vitrea suite of applications will now be available in the cloud thanks to the IMEXHSVital collaboration

19 Aug :IMEXHS Chief Sales Officer Alejandro Varettoni is leading IMEXHSs expansion into the USA, with an initial focus on the major markets of Florida and Texas. The Company intends to expand into California in the first half of 2022.
Mr Varettoni said,
QUOTE
Establishing our office in the US is an important milestone for IMEXHS growth strategy. The Company will bring its disruptive, innovative and competitive business model initially to the important markets of Florida and Texas. Our fully cloud based SaaS solution will benefit the largest healthcare IT market in the world. The Company also announced it has appointed a new US Branch Director and is currently recruiting a Senior Sales Manager.
IMEXHS strategic approach is to target small and medium sized clinics and medical imaging centres with an innovative and affordable offering. IMEXHS's competitive advantage lies in its cloud-based, multi-modal technology which will benefit the Florida and Texas markets.


and in the quarterly
QUOTE
IMEXHS has had a solid second quarter with annualised recurring revenue 20% higher on a constant currency basis compared to the same period last year.
Despite the challenges presented by the COVID-19 pandemic, revenue growth remained strong and was up 58% on a constant currency basis. Our strategic focus on recurring revenue was again evident and represented 96% of total revenue in the quarter.

"During the quarter, we continued to invest in product and technology. Our new Aquila in the Cloud offering is generating significant interest across Latin America and the USA, with our first purchase order received from a new customer in Ecuador. "We have also been able to leverage our strategic contracts, most notably with RIMAB-Colsubsidio, to further develop Artificial Intelligence (AI) tools that address immediate needs created by the COVID19 pandemic. Using our large image library, we are beta testing promising AI tools that could assist radiologists in the diagnosis of COVID-19.
  Forum: By Share Code

nipper
Posted on: Aug 20 2020, 11:44 AM


Group: Member
Posts: 7,511

Exopharm's Big Idea Heading For A Big Business In EV Medicines

By Chris Baldwin

QUOTE
Big ideas can also become big businesses in biotech; the only difference is, they might not quite become household names.

Dr. Ian Dixon, an engineer and biotechnology entrepreneur, had a big idea back in 2013. Dixon was looking at regenerative medicine, and the promise of stem-cells. In particular, he was looking at the exosomes that stemcells secrete.

And this was his Eureka moment.

All cells produce exosomes, which are an essential component of cell to cell signalling: they are small particles that deliver therapeutic cargoes, such as protein and nucleic acids, to other cells to reduce inflammation and promote regeneration. Exosomes (also known as extra-cellular vesicles, or EVs) are plentiful in our youth but decline with age: one of the most important roles of exosomes is in slowing the ageing process.

Dixon realised that the exosomes released by stem cells could have a powerful rejuvenating effect on the cells that take them up. In fact, he realised that the EVs produced by stem cells could be a simpler product, and eclipse the use of stem cells as medicines, for many practical reasons.

Back in 2013, the promise of stem cells as a new form of regenerative medicine was still on the rise. Doctors were excited about placing stem cells in the patient's body and waiting for the cells to secrete the therapeutic material into the patient's body.

But Dixon's breakthrough was to realise that the exosomes/EVs were the therapeutic material from the stem cells, and that this active material itself could be extracted and placed in the patient's body, thus accelerating the therapeutic effect.

Dixon reasoned that these exosomes/EVs could represent a completely new type of medicine.

But first he had to solve the problem of how to purify EVs as large-scale proprietary therapeutic products, but using manufacturing equipment that is standard in the bioprocessing industry. Dixon defined the problem, and what success would look like, as the first critical step. He could envision success: it would be a chromatography process, of the kind already used in typical GMP (Good Manufacturing Practice) drug manufacturing – which would ensure that it was inexpensive and scalable – but modified to both capture EVs, and, with a slight change in conditions, release them.

Having defined the problem very specifically, Dixon and his team worked over three years, with many failures. Persistence is a virtue (if it leads to success), and in 2016 Dixon lodged a patent application on a purification technique that could mass-produce exosomes/EVs. This technique, known as ligand-based exosome affinity purification (LEAP), is the central IP behind the ASX-listed company Exopharm.

Since patenting the LEAP technology in December 2016, further patent applications have been lodged and the technology and know-how has been further refined and improved. Today, Exopharm is a leader in EV purification for therapeutic products and has already commenced clinical trials with EVs from platelets.

In 2020 Exopharm inlicensed (exclusive worldwide and all uses) two technologies (called LOAD and EVPS) that enable it to design and manufacture a range of "engineered" EVs (or EEVs). EEVs use the natural properties of EVs as a way of delivering a 'payload' of drug (small molecule compounds, nucleic acids etc) into selected cells, while avoiding the limitations of liposomes and other artificial carriers that people have tried in the past. Researchers can load the drugs into the EEVs and targeting the EVs to certain cell types. EEVs are an ideal way to implement precision medicines .... one of the hottest fields in medicine today

Through LEAP, Exopharm is now a world leader in the purification of EV medicines, and is a clinical-stage company. Through holding the exclusive rights to LOAD and EVPS, Exopharm can make advanced EEV medicines.

Over the past few years, several companies in the EEV field have struck billion-dollar deals (for example, Codiak, EVOX, and Carmine). In the same vein, Exopharm is positioning itself for deals in the EEV field, in areas such as neurology, inflammation, cancer and anti-virus. Exopharm can design and make custom EEVs for partners, and is talking to a range of potential partners.

EVs are a far better way to harness the regenerative power of stem cells as a regenerative medicine than stem cells themselves. This science can be applied to a range of conditions where medicine is desperate for a new approach – for example stroke, cardiac disease, neuro-degeneration, auto-immune disease, Type 2 diabetes, acute respiratory stress disorder and arthritis. EVs are poised to become important new medicines in both regenerative medicine and precision medicine ... each multi-billion dollar areas.

As a serial biotechnology entrepreneur, Dr Dixon does not just develop technologies or products. He wants to build long lasting businesses based upon big ideas. Over the past three years, the Exopharm team has been carefully curated to bring in people with diverse backgrounds, skills and experience; successful biotechnology is very much a team sport. Further, Exopharm has sought, and in licensed, extra intellectual property to ringfence the business in the EEV field. Other IP is being developed in-house – solving problems that others haven't even thought about yet.

That is definitely a big idea, and the only listed pure play exposure to it on the ASX is Exopharm.


https://www.sharecafe.com.au/2020/08/19/exo...n-ev-medicines/
  Forum: By Share Code

nipper
Posted on: Aug 20 2020, 11:02 AM


Group: Member
Posts: 7,511

FY20 SUMMARY
• Highest full year profit in the company history.
• Record Metal Detection and Communications sales
• Annual dividend of 18.5 cents, fully franked; 11 cents today
• Strong balance sheet continues ... $93 million net cash
• Invested in excess of $30 million in product development


SP has hit all-time record high of $10.10 this morning... over 12% up today
  Forum: By Share Code

nipper
Posted on: Aug 20 2020, 10:27 AM


Group: Member
Posts: 7,511

Wesfarmers reported a 7.4 per cent increase in underlying net profit from continuing operations to $2.08 billion as strong profit growth at Bunnings and Officeworks offset weaker earnings from Target and the industrials businesses.

Wesfarmers slashed the value of Target by $525 million, or $437 million after tax, and booked $110 million or $83 million net in restructuring costs. It also booked a $310 million impairment ($298 million net) against the value of the industrial and safety businesses. These large one off items were partly offset by a $290 million gain on the sale of a 10.1 per cent stake in Coles and a $220 million revaluation of its remaining 5 per cent stake.

Revenues grew 10.5 per cent to $30.85 billion, beating consensus of $30.3 billion, underpinned by strong sales growth at Bunnings, Kmart, Officeworks and online retailer Catch Group. Bunnings and Officeworks sales soared as consumers forced to spend more time at home stocked up on home office equipment, educational needs, and hardware and gardening supplies, while Catch has benefited from the acceleration in online spending during the pandemic.

Bunnings profits rose 13.9 per cent to $1.8 billion, and Officeworks profits were up 13.8 per cent to $190 million, but Kmart Group profits fell 23.5 per cent to $413 million despite the Catch acquisition. Kmart delivered solid sales growth of 5.4 per cent despite volatile trading conditions, but Target sales fell 2.6 per cent.
In the chemicals, energy and fertilisers business, earnings fell 9.2 per cent to $393 million, while industrial and safety profits plunged 53.5 per cent to $40 million.

Online sales across the group rose 60 per cent to $1.5 billion, or $2.1 billion including Catch, which is part of the Kmart Group.

Plans were announced in May to close between 10 to 25 large format Target stores, convert between 10 and 40 large format stores into Kmart, swap 52 Target Country stores to small format Kmart stores, and significantly reduce Target store support office staff.

Wesfarmers kept most of its retail stores open during the first national lockdown in April and May, when strong demand for hardware, homewares and home office equipment boosted sales. However, Kmart and Target have been forced to close in Melbourne during stage 4 restrictions and Bunnings and Officeworks are open to trade customers only for six weeks, forcing the retailers to rely on online operations to generate sales.

Wesfarmers did not receive material Australian government support payments and is not currently part of the JobKeeper program. One small entity was eligible for JobKeeper but this application was withdrawn. Wesfarmers received approximately $40 million in wage subsidies outside of Australia, almost entirely in New Zealand, where it was forced to temporarily close Bunnings stores to the public.


Wesfarmers will also pay a final dividend of 77¢ a share, plus a special 18c dividend arising from the sale of the 10.1% share of Coles.
  Forum: By Share Code

nipper
Posted on: Aug 19 2020, 03:30 PM


Group: Member
Posts: 7,511

QUOTE
EML Payments says COVID19 has prompted it to accelerate its diversification strategy to ensure it is not overly reliant on supplying gift cards in shopping malls. This includes making equity investments in fintechs that could use its payments as a service offerings. EML, which operates in 28 countries and was an ASX darling before the pandemic struck, saw revenue hit hard in gift cards provided to retailers in physical shopping centres across Europe and the United States.

Gross debit volume plunged by 90 per cent in April as shops were shuttered and over the fourth quarter was down 33 per cent on the comparable period.

Despite signs of recovery in June and July, the approach to mall reopenings has been a "mish-mash" which makes it very difficult to predict Christmas trading, chief executive Tom Cregan said on Wednesday. We did not want to come out of COVID as the largest mall card provider in the world. We have taken the opportunity to reimage what the business will look like in three years and we have hit the ground running., he said.

EML has created an accelerator, called FinLabs, that will invest $10 million to $15 million over the next two years in disruptive fintechs, which EML can integrate with or cross-sell to. Its first, $2 million investment is in interchecks, a US-based disbursement tool. It will also look for investments to help it tokenise transactions on Visa's network.

EML has been seeking to diversify for several years, including through the acquisition of Prepaid Financial Services, which was finalised in April. This propelled EML to record levels of revenue, transaction value, EBITDA and net profit for the full year, despite the pandemic also curtailing disbursement volume in its sports betting operations and reducing global travel, pushing down multi-currency services.

Gross debit volume was up 54 per cent to $4.23 billion, EBITDA was up 10 per cent to $32.5 million and net profit was 17 per cent higher at $24 million, on revenue up 25 per cent to $121.6 million. Shares in the $1.1 billion company fell 4 per cent to $3.14.

EML has been pushing into general purpose reloadable cards which are being used by corporates and government departments for payroll or salary packaging services.

It has also got a longterm ambition to become fintech to the fintechs by creating a variety of as..a..service solutions, including for the buy now, pay later sector, where it counts ASX-listed Sezzle, and soon to list Laybuy as customers. These multiregional fintech partnerships are what we want to see more of, and what we want to compete more often for, Mr Cregan said. We will generate long-term shareholder value by partnering with fintechs disrupting their own industries who will be using EML, in part, to support the payments aspect of their business and that disruption.

EML is also working with MoneyMe, Coinjar, revsto, Hammock, Paygo and Scalapay.

A key risk for EML is its reliance on revenue from breakage, or the unused amount left by consumers on reloadable gift cards. EML can share this with retailers, although it is possible regulators may require unspent funds to be returned to shoppers. EML said breakage continues to fall as a percentage of group revenue, now comprising 23 per cent, down from 33 per cent in FY19, and it is expected to represent a lower percentage of group revenue in FY21 with further growth in the [general purpose reloadable card] segment.


the last para about sums this mob up.


EML is working with MoneyMe, Coinjar, revsto, Hammock, Paygo and Scalapay (!) No wonder the banks are scared!!
  Forum: By Share Code

nipper
Posted on: Aug 19 2020, 01:35 PM


Group: Member
Posts: 7,511

some steady buying of PKS over the last few days, and hitting an all time high of 26.5c today . No news, but I guess results are due soon.

Together with Alcidion ALC and newly floated Jayex JHL in this sector, I wonder of there is consolidation brewing?
  Forum: By Share Code

nipper
Posted on: Aug 19 2020, 01:21 PM


Group: Member
Posts: 7,511

softly, softly

CSL has 5 Covid related projects, the first being the partnership with the University of Queensland and the Coalition for Academic Preparedness and Innovation. This is in a Phase One study, and CSL has agreed to manage Phase two and Phase three registration and to manufacture the vaccine should the trials be successful.
I am pleased to advise that we now estimate first doses of the UQ vaccine will be available for ... emergency use by the middle of 2021," CEO Paul Perreault told a news conference. "This revised timeline is a result of further planning to align clinical and regulatory with the manufacturing activities and the obvious public health need to accelerate development as much as possible.

The second area of research is through the CoVIg-19 Plasma Alliance, which is a partnership of the world's leading plasma companies – Biotest, BPL, CSL Behring, LFB, Octapharma and Takeda. Perreault says this potential plasma-derived hyper immune therapy is beginning patient trials in the US and Europe this month.
The third option is a similar plasma product for the Australian market to be known as COVID19 immunoglobulin. This is being developed at the CSL Broadmeadows facility in Melbourne in a partnership with the Australian Red Cross, which has arranged for 500 donors to support the first batch of the product from the clinical trial.
The fourth option is a partnership with SAb Biotherapeutics to deliver a novel immunotherapy targeting COVID19.

The fifth program is a trial with the current CSL pipeline product Garadacimab to see if it has effect for patients suffering from respiratory distress or serious consequence of COVID19.

There is a sixth option in relation to COVID19 and that is the AstraZeneca vaccine proposal, which has the support of the federal government. Perreault said CSL was involved in discussions to advance this project and may be involved in the manufacture of the vaccine.

QUOTE
With all of these projects, whether it is preventative with the vaccine or preventing progression with a hyper immune or using a monoclonal antibody like Garadacimab, there is a risk of failure, even when we have selected opportunities we think make sense both scientifically and [for] efficacy, he said.

It is important that the public understands these risks and that no single vaccine or therapeutic approach is going to solve this global health crisis.

We are heartened by the extraordinary amount of scientific collaboration happening across the industry, academia and government, including many initiatives we are proud to be a part of and we remain cautiously optimistic.
  Forum: By Share Code

nipper
Posted on: Aug 19 2020, 11:00 AM


Group: Member
Posts: 7,511

Shekel Brainweigh Ltd (SBW) has been developing, manufacturing and distributing advanced weighing systems for the retail and healthcare markets. Shekel Brainweigh IP includes unique digital weighing technology innovations together with highly advanced Deep Learning and Artificial Intelligence algorithms and models.

Retail: SBW produces and sells the weighing components annually for the retail OEM market with customers including Datalogic, Diebold Nixdorf, Toshiba and Fujitsu. TheShekel Brainweigh OEM solutions consist of POS systems such as checkout scanner scales; and security scales for self-checkout systems, Innovendi, The Bay and The Promotional Bay.

Healthcare: The healthcare weighing systems are distributed via two channels: the OEM channel for incubator and baby warmer manufacturers; and the Company's own branded Healthweigh products, sold to medical centres, clinics, hospitals, long term care and fitness centres mainly via distributors.

Retail Innovation Division:The division has defined its mission To digitize onshelf events in valuable retail insights, expressing the division strategy to focus on software, algorithms and data monetization of its expertise in digital weighing systems. Its product line includes:
PAS (Product Aware Shelf) ...the basic building block of their technology,
PAB (Product Aware Bay) .... a commercial Smart Bay to be used by retailers,
Innovendi ... A smart cooler using smart shelves and functioning as independent Micro Market,
SOTER ...A non-cooler solution for DIY retailers,
The CAPSULE ... a full Autonomous Micro Market framework that allows retailers to provide full24/7 autonomous frictionless shopping solution.


Israeli firm, ASX listed. In with some big hitters.
  Forum: By Share Code

nipper
Posted on: Aug 19 2020, 10:15 AM


Group: Member
Posts: 7,511

the plasma biz is the powerhouse... Covid interrupted collections but having some 6 month supply helped smooth over things
It will be interesting with any virus vaccine. Might be some shift work coming up at Broadie, if the Oxford trials work.
  Forum: By Share Code

nipper
Posted on: Aug 19 2020, 09:46 AM


Group: Member
Posts: 7,511

tale of market bifurcation? (or, why indexes can be misleading)

QUOTE
The key Wall Street index, the S&P 500 closed at a record high on Tuesday, completing a rebound from the huge losses of February and March triggered by the coronavirus pandemic and fears of a deep recession.

Tuesday's rise in the index was small; just 7.7 points as it edged up 0.23% to 3,389.78.

Since hitting the pandemic low on March 23 the index has surged about 55%. Reuters said that gain is the largest in the shortest period of time. Just 103 days.

Trillions of dollars in fiscal and monetary stimulus have pushed commodities, shares, bonds higher and millions of investors, stuck at home in lockdowns have entered the market as day traders.

But there has been another major factor many analysts have ignored ... the weakness in the value of the US dollar which touched a 27 month low on the US Dollar Index, a measure of the greenback's value against a basket of major currencies.

The dollar hit two lows against the euro and the Japanese yen. The Australian dollar trade around 72.44 Wednesday morning in Asia, the highest in 20months (since January 2019).

That has been helping drive commodity prices higher, led by gold and silver.

The slide in the US dollar saw Comex gold top $US2,000 an ounce for the second time in a month. It rose $US14.40 or 0.7% to settle at $US2,012.10 an ounce, after the metal climbed 2.5% on Monday. Oil though dipped a fraction to $US42.51 a barrel.

Apple, Netflix, Amazon, Facebook, Microsoft, and other high growth technology related stocks have become the dominating stocks on Wall Street, replacing the so-called blue chip banks and other industrials.

That rotation has seen the tech heavy Nasdaq surge to a series of record highs in the past month. On Tuesday it rose 81 points to end at 11,210.84, up 81.12 points and a new high, its 18th since early June. The Tuesday record was its 34th record close so far this year compared with 31 record closing highs in 2019 and 29 in 2018.

The Dow has lagged the other two measures lately. It fell 66.84 points, or 0.24%, to 27,778.07
ASX futures traders weren't as excited and the overnight numbers were showing a weak to flat start at 7 am this morning for the local market.
  Forum: Macro Factors

nipper
Posted on: Aug 18 2020, 12:59 PM


Group: Member
Posts: 7,511

got me thinking about this sector, Mick.
There are big pure play pathology stocks, but most seem tied up either with hospitals/ medical centres, or diagnostics, or software (or any combination).
Because driving most in this sector is a push towards digitalisation, in what I see as an attempt to bring efficiencies and greater insights (plus keep a lid on spiraling costs in what is a complex and expensive sector)

I have put a bit of a list together; feel free to add. Most seem to come under Health Care, Health Care Equipment & Services, but this is a huge sector, running from the big pharma companies through to diagnostics and minnow Phase 1 drug trial cures for everything
RHC, SHL, HLS,

IDX ...main activity is providing Diagnostic Imaging Services to general practitioners, medical specialists and allied health professionals (Referrers) and their patients. IDX provides services through a network of 45 sites, including 12 hospital sites, and operates under different brands
CAJ is a provider of diagnostic imaging services to the Australian healthcare market. Headquartered in Melbourne, the Company owns and operates clinics throughout Metropolitan Melbourne, Regional Victoria, Tasmania and Western Australia.
VHT is a MedTech SaaS company and is a provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer.
LBT is a developer of clinical and diagnostic technology, based in Adelaide, South Australia. The Company has product named Automated Plate Assessment System in microbiology automation.

IMR is a US based medical device company that seeks to address the current issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology.

EMV is primarily focused on research and development of medical imaging and diagnostic technology, for the purpose of commercialising a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs.

4DX is a Melbourne based software technology company commercialising its patented imaging platform, 'XV Technology'. This four-dimensional lung imaging technology utilises mathematic models and algorithms to convert X-ray scans into quantitative data .. to manage patients with respiratory diseases and diseases of the lung.

M7T is a provider of enterprise image management systems that allow healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence where and when needed.
  Forum: By Share Code

nipper
Posted on: Aug 18 2020, 12:06 PM


Group: Member
Posts: 7,511

Small cap darlings' merger challenge
QUOTE
Each time telco entrepreneur Vaughan Bowen fronts institutional investors, he can usually count on one question: what will you do differently this time around?
Bowen is well known to investors after founding M2 Communications, a company that delivered strong returns for investors, mainly by growing through scrip fuelled acquisitions, until it ultimately merged with Vocus deal that quickly went sour.
That regular question is particularly pressing right now as Bowen's $790 million Uniti Group, which lays fibre in new developments and then charges internet providers access to the networks, finalises its cash deal to buy Opticomm, a smaller $500 million rival that has gradually been moving into Uniti's space of laying fibre to apartments and high rise buildings rather than its traditional housing estates market.

It's a deal that both critics and supporters say is right on form for Bowen, a Uniti executive director.

The critics see it as proof that he's a deal junkie, who knows how to ride a hot market and ask how long the run can last.

His supporters say he has a track record of creating value through acquisitions in the telecommunications space by identifying trends ahead of the pack and this is bang on target.

Uniti Group listed in 2019, attracting plenty of backing from institutional small cap investors, after its management was replaced by Bowen and Mick Simmons, who had also worked with Bowen at M2.

The investors liked the segment, and hoped the new team would repeat their earlier success.

Uniti has delivered ... its share price has risen from 18¢ back in February 2019 to closer to $1.60. Opticomm has been a similar success ... it also listed in 2019, and its shares have grown from $2 a share to $5.20, largely through organic growth.

So how does Bowen answer that persistent question?

He tells investors that he is more focused on integration. It's undoubtedly the right answer, as it was the integration with M2 and Vocus Group that turned things sour. But it will be put to the test with the Opticomm deal, which is Uniti's biggest acquisition to date and has a distinctly different culture.

Bowen, who declined to be interviewed, is right alongside the investors with this Opticomm deal ... he bought $3.7 million worth of shares in the latest Uniti capital raising to fund its Opticomm deal.

Like M2, Uniti has grown through acquisitions, funded by regular capital raisings.

Last May, it raised $15 million at $1 a share to buy inbound voice services business Call Dynamics. By August, it had agreed a $100 million deal to buy private fibre networks company LBNCo and raised another $100 million at $1.20 a share to help fund it.

In October it acquired OPENetworks for $27.5 million in cash and shares and raised another $85 million to buy 1300 Holdings Pty Ltd, which owns priority phone numbers and is affiliated with Telstra, in December. That raising was at $1.62 a share.

The Opticomm deal – for which the company has raised $270 million – is its biggest yet, and is expected to catapult this small cap favourite into the S&P/ASX200, a move that tends to bring index buying along with it.

Uniti has been in talks with Opticomm, a company that has had equally impressive growth from IPO – though it has relied on organic growth, rather than acquisitions – for more than a year, sources said.

But Opticomm finally agreed to a deal as COVID-19 hit, negotiating a cash deal without any face-to-face meetings, including the due diligence phase.

COVID is regularly offered up as the reason that Opticom's board was willing to strike a deal on little premium and not scrip based, although there are options for investors to take some scrip.

Others see it as a sign the board was happy to take the money and run.

Much of Uniti's register owns shares in Opticomm ... roughly 30 per cent ... and those investors were prioritised in the latest Uniti capital raising, in order for them to increase their scrip holding if they chose, in some cases by selling down shares in Opticomm. There are plenty of reasons that investors like the deal, including that it will limit the two players moving in on the other's territory.

It is effectively them and the NBN... and they were both [Opticomm and Uniti] starting to compete a little bit more head to head, which had the potential to impact returns," says Tribeca Investment Partners portfolio manager Simon Brown.

"This was manifesting itself in developer contributions with some price pressure in green field agreements and multi-apartment market, where in some cases contributions had been cut to zero.

Ultimately, Brown says, the real focus should be on customer activation and utilisation, rather than developer contributions which were not the core earnings base.

Opticomm and Uniti both provide an alternative to the NBN .... and, while they don't offer Telstra or Optus on their platforms, they do provide more than a standard NBN option. They can provide developers with pay TV so there's no need for dishes, lay out Wifi stations around new developments and other options, often at no extra cost.

One of the bigger concerns is whether a COVID-19 recession will impact housing development and slow new builds.

There were some early concerns about this, that have now abated to a degree. Another factor that is soothing investors is the gap between the combined business' connected and activated lots. In other words, the houses that have been built but not connected, either because they are still under construction or the owners have opted not to get broadband yet.

Reporting season updates from developers will be an important data point.

It's a significant number because the increase in activated units is where the earnings come from, the per month fee per household. It makes money by charging internet providers to access the networks and the customers, and by providing support and maintenance services to the networks.

The combined group will have 109,500 active connections, and an additional 78,000 connected premises. Then there's another 188,000 contracted lots ... the ones that could be considered at risk if either developments slow or developers go under, though both companies say they work with the major players.

This deal will deliver the scale for both in other areas apart from connections. For example, using one another's facilities. Opticomm has a new control centre in Melbourne, and that can roll through the Uniti systems, reducing capital expenditure. There's also been talk about stranded assets in Queensland the new group might buy together.

There are smaller issues as well, including weaning both groups off China's Huawei ... referred to in the scheme documents as the country of origin issues relating to network equipment. It is a process that has already begun, and one that does not really concern investors who point out there are plenty of rival offerings.

Ultimately, the big challenge is putting the two businesses together. The acquisition is due to complete in September.

After that, the real work integrating the two businesses will begin.


https://www.afr.com/companies/telecommunica...20200812-p55kzk
  Forum: By Share Code

nipper
Posted on: Aug 18 2020, 11:54 AM


Group: Member
Posts: 7,511

QUOTE
Livewire Markets: Okay. Now it's that time of the episode where our guests tell us about one secret stock they've bought. Arden, what have you got that is a structural growth story with a legendary management team?

Arden Jennings (Ausbil): Yeah, so probably changing tack a little here with Lifestyle Communities, with ticker LIC. So they provide lifestyle villages, not to be confused with retirement or aged care villages. These are fantastic villages. They operate in Victoria, which I think may be an opportunity at the moment, given the pandemic down there at the moment.
But really the management are fantastic, led by James Kelly, an entrepreneur. He has skin in the game. He is the founder as well. So fantastic management, ageing population is a great structural trend that we are seeing that will continue, aided with great management. The recurring revenue is really what is attractive here. It's pregnant with cashflows. So we think from a longterm perspective, it's a great addition to our portfolio. BUY.
  Forum: By Share Code

nipper
Posted on: Aug 18 2020, 11:52 AM


Group: Member
Posts: 7,511

[]
  Forum: By Share Code

nipper
Posted on: Aug 18 2020, 11:18 AM


Group: Member
Posts: 7,511

Holiday park and retirement village developer Ingenia says its poised to jump on acquisitions in both sectors arising from COVID-19 stress, as it reports a 25pc jump in annual profit.

Handing down its full year results, Ingenia said it had notched profit of $59.1m, with record earnings of $71.9m driven by an increase in rental sites and higher average new home sale prices ... even with a heavy hit from holiday park closures and reduced settlments due to COVID-19.

The group decalred a 4.4c per share dividend, taking the full year dividend to 10c, down from 11.2c last year.

Chief Simon Owen said acquisition opportunities were emerging, and the group was well capitalised and ideally positioned to benefit from any market dislocation, with proceeds from the group’s $178m equity raise to be progressively deployed over the next 12 to 18 months.

He added that the second half of the year was marred by bushfires and COVID 19 restrictions, but that the bounce back better than expected.
QUOTE
What was particularly encouraging was the way Australians responded to domestic holidays when restrictions were lifted, with an uptick in forward bookings. Due to the nature of the pandemic, there remains uncertainty over further COVID 19 disruptions.
  Forum: By Share Code

nipper
Posted on: Aug 18 2020, 11:12 AM


Group: Member
Posts: 7,511

In an update for the fourth quarter, Coles said COVID 19 factors continued to have an impact on both the level and mix of supermarket sales as customers made fewer trips to supermarkets, while basket size increased significantly.

QUOTE
Following a subdued and socially distanced Easter, sales improved as a result of increased in-home consumption. Home cooking categories such as meat and poultry benefited, partially offset by declines in impulse, food to go and prepared salads.

However, the mix of sales evolved following the initial period of panic buying and pantry filling, with April and May seeing a degree of destocking in canned and ambient pantry lines. As social distancing eased towards the end of the period, customer demand again evolved with signs of increased demand for home entertaining resulting in uplifts in categories such as gourmet cheese and flowers.


COVID 19 also had an impact on Coles Online and demand for home delivery, the company said.

QUOTE
Online demand and sales grew strongly in May and June with growth rates above 30 per cent supported by substantial increases in capacity both for store pick and delivery vehicles and the rollout out of contactless Click & Collect to more than 400 stores.
  Forum: By Share Code

nipper
Posted on: Aug 17 2020, 10:13 PM


Group: Member
Posts: 7,511

Beach Energy saw annual profit fall 18 per cent on lower energy prices sparked by the COVID 19 slowdown, but it avoided writedowns and plans to send gas from its giant Waitsia field in Western Australia to the North West Shelf plant.

Underlying net profit after tax for 2020 fell to $461m from $560m, just ahead of a RBC forecast of $457m for the reporting period.

Revenue fell 17 per cent to $1.73bn while the oil and gas operator will pay a final dividend of 1c per share, steady on last year.

Beach, 30 per cent owned by the Seven Group, said underlying earnings before interest, tax, depreciation and amortisation fell 19 per cent to $1.108bn, after the company had guided to earnings marginally below $1.175bn.
  Forum: By Share Code

nipper
Posted on: Aug 17 2020, 08:42 PM


Group: Member
Posts: 7,511

Talks with AstraZeneca include CSL potentially producing its vaccine under a licensing deal at its advanced manufacturing facility at Broadmeadows in the Melbourne northern suburb.
QUOTE
Development of the UQ vaccine candidate remains CSL's priority, a company spokeswoman said.

However, we are currently in discussions with AstraZeneca and the Australian Government to assess whether it is possible to provide local manufacturing support for the Oxford University/ AstraZeneca vaccine, should it prove successful, while protecting our commitment to the UQ vaccine.

We are assessing the viability of options ranging from the fill and finish of bulk product imported to Australia through to manufacture of the vaccine candidate under licence
.
  Forum: By Share Code

nipper
Posted on: Aug 17 2020, 04:15 PM


Group: Member
Posts: 7,511

In Oslo, the city is introducing two dozen electric Jaguar taxis that will be able to wirelessly recharge on special pads embedded under the road while they wait for their next fare.
QUOTE
We think that wireless charging is a potential game-changer, said Sture Portvik, a manager for electromobility in the Oslo city government, and we are happy to assist by helping taxi drivers keep moving and not adding cable clutter to the city. By improving infrastructure and providing better charging to the taxi industry, we are confident that by 2024 all taxis in Oslo will be zero emission.

  Forum: Investment Discussion

nipper
Posted on: Aug 17 2020, 03:51 PM


Group: Member
Posts: 7,511

meantime it is trading 3.06 to 3.07 nearly all day. I wonder which side is going to blink?


with 3.065s going through as well, the one minute chart is like a set of Bar Codes
  Forum: By Share Code

nipper
Posted on: Aug 17 2020, 02:22 PM


Group: Member
Posts: 7,511

Argo says 2021 could be even worse for Banks

The managing director of $5.5 billion Argo Investments is worried that financial markets are factoring in only a short pandemic as he likens it to only being in the first quarter of an Australian Football League match which still has a long way to run. Jason Beddow said the big four banks are likely to be in for an extended tough time and will be hamstrung by banking regulators, and that will in turn flow through to consistently lean times for bank shareholders.

He said there is a perception among many investors that once 2021 arrives there will be a more positive outlook. But he is bracing for the prospect of an extended pandemic and economic damage, coupled with the extra volatility which may stem from huge uncertainty and unpredictable events which may follow on from the US election.

Argo, which is now underweight in bank stocks after steering clear of capital raisings and dividend reinvestment plans, was forced to cut its final dividend to 14¢ from 17¢ a year ago after a 32 per cent drop in net profit after tax to $199 million for 2019/20.

Argo relies heavily on dividend payments from the 200 different ASX companies it invests in, but the big banks have either been deferring dividends or reducing them heavily. Argo last cut its dividend payout a decade ago during the Global Financial Crisis.Mr Beddow said the Australian Prudential Regulation Authority would be keeping a very close eye on the big banks and the extent of payout ratios for a long time. APRA will still be vigilant on what the banks can do, he said.

The Argo overall return for 2019 -2020 from its portfolio went backwards by 10.1 per cent after all costs and tax. Mr Beddow said the group had taken an ultraconservative approach when the sharemarket plunged in late March, and this had hurt its performance. It had stayed away from some of the companies in ecommerce which had delivered a huge rebound in share price in the following months. It had also steered clear of FMG which hurt performance. In hindsight we were a bit too conservative, he said. But Mr Beddow said that safe approach may prove to be a big plus over the longer term.


INVESTMENT PORTFOLIO
In an extraordinary year for the share market, a majority of sectors posted negative returns, with bank stocks among the worst performers. Ongoing industry specific headwinds and broad exposure to Australia's rapidly weakening economy weighed on the banking sector. As a result, Argo portfolio exposure to the banks has fallen from 17.4% to 13.8% and remains underweight relative to the broader Australian share market.

During the financial year, Argo purchased $243 million of longterm investments which included adding to new positions. Over the same period, Argo received $127 million from sales and takeovers of longterm investments
. The larger movements in the portfolio were:

Purchases
AP Eagers (Automotive Holdings takeover)
Downer EDI
Freedom Foods Group
Oil Search
Ramsay Health Care
Suncorp Group
Treasury Wines * (new position)

Sales
AMP
Ansell
Automotive Holdings Group (AP Eagers takeover) **
Corporate Travel Management **
Dulux Group (Nippon Paint takeover) **
Milton Corporation
Nufarm **
** Fully exited position and removed from portfolio.

Together with other stocks exited, the total number of stocks in Argo's investment portfolio decreased from 95 to 89.
  Forum: By Share Code

nipper
Posted on: Aug 17 2020, 02:11 PM


Group: Member
Posts: 7,511

QUOTE
any other path stocks they favour?
path ways: IDX (not CAJ)
  Forum: By Share Code

nipper
Posted on: Aug 17 2020, 01:28 PM


Group: Member
Posts: 7,511

Adelaide, a major hub of the Australian defence industry (ships, research, etc) has a disproportionately large PRC consulate, with 10 Chinese govt officials attached.
Guess they will be busy cultivating their new charges.
  Forum: Off Topic Chat

nipper
Posted on: Aug 17 2020, 11:25 AM


Group: Member
Posts: 7,511

SPP extended. tracking sideways. out on the hustings.
QUOTE
Locally-listed small cap Prescient hopes to shift the conversation around cancer from treatments to cures, as it invests in a new-age technology showing early success in helping terminal patients called CAR-T.On Friday the company announced a research collaboration with the world renowned Peter MacCallum Cancer Centre to develop new cell therapy technologies to treat cancer, including CAR-T technologies. Under the terms of the research contract, Prescient will own any resultant intellectual property (IP) from the research program, which is being led by Peter Mac’s Professor Phil Darcy.

CAR-T is a new technique for fighting cancer that trains a patient's own immune system to recognise and attack cancer cells that have resisted standard treatments like chemotherapy or radiation. Using this approach, a person's T-cells are extracted and modified outside the body to produce special structures called chimeric antigen receptors (CARs) on their surface. These receptors are able to recognise and latch onto a specific antigen on a patient's tumour cells when they're re-injected into the body, allowing them to destroy the cells.

There's no question in my mind that it's the future. It's weaponising your own cells. Cells are the problem with cancer and they will be the answer. It's the ultimate killing machine, Prescient chief executive Steven Yatomi-Clarke said. We're the only listed company in Australia doing CAR-T... and it will be the next generation cell therapy.

Earlier this year 11-year-old Kamm Denieger's five-year battle with a rare leukaemia ended, when he became the first person in NSW to receive CAR-T therapy and a month later was deemed cancer free.

To date, CAR-T has been particularly successful in treating blood cancers. But due to the uncontrollable nature of the therapy in its current form, some cancer patients have died from CAR-T, at the same time as their cancers are killed.

T-cells can swallow up a 2 kilogram organ within a week, that's the capability of a T-cell, Mr Yatomi-Clarke said. With some end-stage cancer patients, they have no other option. But it's akin to a type of massive inflammatory response that kills COVID patients. This can be overcome though if you titrate it safely, rather than crossing your fingers and hoping a dose kills the cancer but not the patient."

There are some major barriers to CAR-T's broad adoption, which Mr Yatomi-Clarke is determined to tackle. These flaws include the fact that the treatment is extremely expensive, so far hasn't worked as well treating solid tumours (compared to blood cancers) and it's also inherently risky with patients needing to be placed in intensive care when undergoing the treatments due to the inability to control the modified T-cells while in the patient.

To help solve these flaws, Prescient is developing a platform called OmniCAR, based on technology licensed from University of Pennsylvania and Oxford University. This platform has a mechanism to allow clinicians to control the modified cell activity after infusion, including turning them off. It also enables CAR-T cells to be directed against a variety of tumours and could work with "off-the-shelf" T-cells, as well as a patient's cells.

OmniCAR is still in a preclinical phase, but Mr Yatomi-Clarke is optimistic about its future.

Anyone looking to make their CAR-T programs more controllable and safer should be speaking to us. We're going to look to monetise this sooner rather than later through collaborations and licensing. We want to be the Intel chip to others' computers, he said.


While still an emerging field, there's already been plenty of deal activity surrounding CAR-T therapies.

In 2017Gileas bought KitePharma for $US11.9 billion, ($17 billion) while in 2018 Celegne bought Juno Therapeutics for $US9 billion and in November last year Bristol Myers Squibb bought Celegne for a whopping $US74 billion.

CAR-T is not Prescient's only bet on next generation cancer therapies.

The company also has two compounds (PTX100 and PTX200) which are already in clinical trials.


PTX 100 blocks a cancer growth enzyme known as geranylgeranyl transferase-1 (GGT1), which was the first gene discovered that drives cancer development. Last week the company released results from a phase 1B dose escalation study which showed the therapy was safe in small amounts, letting the company progress to higher doses.

https://www.afr.com/policy/health-and-educa...20200803-p55i66The interesting part was even at the lowest dose, of the three patients we saw, one [person's cancer] stopped growing, and another had a partial response and their tumour actually reduced. We didn't expect to see that with the first cohort, Mr Yatomi-Clarke said.

While both PTX 100 and 200 are still early in their development, Mr Yatomi-Clarke said thanks to clever study designs (and the fact that these treatments are for patients who are dying) it would be possible to bring products to market in a relatively short amount of time, potentially after completing phase two trials. ..With refractory patients you can get to market with comparatively much smaller, much shorter development timelines, he said.

Loxo Oncology pioneered this one trial to launch... and a few guys involved in the development of their drug now work for us. It is the equivalent of doing a phase three because you're smarter with patient recruitment, he said.


https://www.afr.com/companies/healthcare-an...20200814-p55lro












  Forum: By Share Code

nipper
Posted on: Aug 17 2020, 11:13 AM


Group: Member
Posts: 7,511

yeah, I was thinking of cutting that out. There is a link about the assertion in the valuewalk article
Also, TSLA went for a 5 for 1 share split last week
  Forum: Investment Discussion

nipper
Posted on: Aug 17 2020, 10:07 AM


Group: Member
Posts: 7,511

Tesla Set To Lose Money Again In 2020


We remain short Tesla Inc. (TSLA), which I still consider to be the biggest single stock bubble in this whole bubble market.
The core points of our Tesla short thesis are:
  • - Tesla has no moat of any kind; i.e., nothing meaningfully proprietary in terms of electric car technology, while existing automakers, unlike Tesla­, have a decades long experience moat of knowing how to mass produce, distribute and service high quality cars consistently and profitably, as well as the ability to subsidize losses on electric cars with profits from their conventional cars.
  • - Excluding sunsetting emission credit sales, in 2020 Tesla will again lose money, as it has every year in its 17 year existence.
  • - Tesla is now a busted growth story; quarterly revenue has declined since Q4 2018, while unit demand for its cars is only being maintained via massive price cutting.
  • - Elon Musk is a securities fraud-committing pathological liar.

https://www.valuewalk.com/2020/07/teslas-pr...n-credit-sales/
  Forum: Investment Discussion

nipper
Posted on: Aug 16 2020, 01:43 PM


Group: Member
Posts: 7,511

Is 5G all hype or real investable opportunity?

QUOTE
The impact 5G will have on a wide range of industries is likely to be bigger than we have seen with any previous generation of mobile telecoms. Each previous new generation of network has produced a big jump in speed. And we will certainly see this with 5G, which is estimated to be between 10 and 100 times faster than 4G. But 5G is about much more than quicker phone downloads. It brings lower latency, greater network capacity, and significantly extends battery life. In time, this will produce a robust network in which millions more devices will communicate with one another remotely 10 to100 times faster than at present, and it is what opens the door to 5G full potential: the capacity for machine to machine communication.

What is the timeframe for 5G?

The initial impact will be gradual. Most countries are not yet actively rolling out 5G infrastructure. However, there has been initial build in the US, the UK and other parts of Europe, and much more extended implementation in China, South Korea and Australia. China now has at least partial 5G networks in 50 cities and is accelerating 5G implementation. Part of its unannounced fiscal stimulus as a result of COVID19 could be accelerated spending on 5G infrastructure, and there may also be 5G phone subsidies.
Why is global adoption slow? To some extent, this is an inevitable lag... it took 4G six years to achieve 90% penetration. In the case of 5G rollout, it is partly down to physics: 5G is a high performance network because of its high frequency, but its shorter wavelengths are more readily absorbed by objects, meaning that the 5G signal doesn't travel well through buildings and is even absorbed by plants and rain. In practical terms, it needs more base stations much closer together.

Putting a 5G system in place will take some time. It's not going to be the immediate revolution that some expect.

So what are the opportunities in 5G at the moment? Is it really investable?

Three levels of 5G beneficiaries
A helpful framework for the journey through 5G investment over the next five years is to think of 5G companies in three layers:
5G providers

These are the telecom companies that provide 5G services. While research suggests incremental revenues for telecoms will grow, they are expected to remain relatively small in dollar terms until the middle of the coming decade, when a real acceleration is anticipated, which could in principle be attractive.

But there is a problem: building the infrastructure to access those revenues is going to require massive, upfront capital expenditure, compressing the margins of telecom companies and making them a less than compelling 5G investment.

5G enablers

This second layer comprises the organisations building infrastructure and providing the components necessary to take part in 5G. I believe this is currently a much more attractive area than the providers. The demand for cell towers, network equipment, devices, components and data storage requirements over the next few years could see very significant growth.

Examples of the enablers include tower providers, which supply sites to telecom companies for their infrastructure. The logistics behind providing a vast interconnected network, particularly in cities, is a huge undertaking...

The semiconductor industry is likely to be another beneficiary of 5G. High performance applications such as 5G require even smaller semiconductors. The essential technology required to manufacture these semiconductors is highly specialised... . Device and component makers that produce memory chips, OLED display screens, mobile phones and consumer electronics (or the Internet of Things) are positioned to benefit from the increased connectivity of 5G. Companies like Samsung have been leading the market developing end-to-end 5G offerings.

Data centre providers are also likely to see growing demand from 5G adoption. These data storage centres allow enterprises to take advantage of 5G mobile networks when accessing cloud infrastructure, while improving network and application performance over low latency connections.

5G users These comprise the third level of beneficiary, and this is the area where 5G is potentially a gamechanger because it will enable devices and machines to talk to each other with accuracy and speed. Known as Machine Type Communication (MTC), this technology comes under two main headings.

Massive MTC is where lots of devices exchange large amounts of data but do not necessarily require exceptionally fast response times. Applications could include logistics or smart agriculture. The second category is critical MTC, where not only ultra-reliability is needed but also speed ... think of factory automation, autonomous vehicles and traffic safety.

While some of these themes such as factory automation are already familiar to the market, 5G could accelerate the trend. Similarly, autonomous vehicle development is already making significant headway, but 5G could enable autonomous vehicles to start communicating with one another more effectively, allowing greater safety, efficiency and reducing emissions.

Across industries, 5G is expected to lead to a flood of innovation. In health care, it could allow not just online consultations with doctors but monitoring health conditions and remote surgery. In the energy sector, 5G could enable remote facility inspection or repair, and smart grids.

Virtual and augmented reality, VR and AR,are usually associated with entertainment, but they have massive potential in the maintenance of industrial facilities, where they could improve efficiency through faster repairs.

Where are the possible investable opportunities?
There are a number of listed companies that fall under the 5G enabler category. Importantly, though, they are positioned not just for the growth associated with 5G but for wider secular growth trends around digital disruption. We believe many of these companies represent attractive investment opportunities right now for long-term future growth.
While the real game-changing opportunity could be among the companies that become the ultimate 'users' of 5G, this segment is still in its infancy. That means we must be very careful about how we invest in 5G and for that reason, the concept of a fund overly reliant on 5G has limited appeal. The ability to flexibly invest across different themes and ensure that the investment theme evolves over time, just as the investment opportunity evolves, should be more robust.


Capital Group New Perspective Fund (AU) focuses on investing in companies benefiting from a range of secular trends, and one key theme is digital disruption. This includes companies across industry sectors that are using technology to disrupt their markets, and 5G comes squarely under that heading.


https://www.firstlinks.com.au/article/is-5g-all-hype-or-real-investable-opportunity
  Forum: Off Topic Chat

nipper
Posted on: Aug 16 2020, 12:39 PM


Group: Member
Posts: 7,511

and a webinar from ShareCafe series:

https://www.sharecafe.com.au/2020/08/14/lin...r-presentation/

been a while since any posts. I wonder if LNU does the same thing?
LNU is a video streaming company situated in Australia. They are involved in development of technology products, software development and the commercialization and licensing of its computer software, the Linius Video Virtualization Engine. The Company moved to a communication methodology of outlining NTGs to the market.

Video Virtualization Engine: The Video Virtualization Engine Automatically unlock, expose and index the digital DNA code within a video file and create a virtual video. It will programmatically extract, splice, merge and manipulate video content in transit to its destination and reassemble the video file instantaneously at its destination.
Hyper-Personalized Video solutions: Linius VVE powered Video Hyper Personalization and Search Solution enables anyone to instantly search the data within video, from across an infinite number of sources, and automatically assemble the results in a single stream on the fly. No human hands required.
  Forum: By Share Code

nipper
Posted on: Aug 16 2020, 12:25 PM


Group: Member
Posts: 7,511

has a webinar in the ShareCafe series:

https://www.sharecafe.com.au/2020/08/14/jay...r-presentation/


FY2019 was a pivotal year for Jayex as we commenced phase 1 of our transformation from a product-based business to a cloud-based SaaS model. Central to this transition has been the launch and rollout of our Jayex Connect Platform. By the close of 2019, the Jayex Connect Platform was being used by 727 customers. In Financial year 2019
• We saw an increase in revenue of 6.5% from $6.75 million to $7.18 million in 2019
• Revenue from SaaS made up 26% of total revenue
• Expenses reduced 17% and as a result we saw significant improvements in the margins and profitability of the company compared with prior periods.

now its all about Jayex Connect
Jayex Connect is the first all-in-one patient engagement platform. Utilising the cloud based platform, it allows increased productivity, efficiency and profitability for both the healthcare service providers and Jayex alike. The company now has a platform that provides appointment booking, patient calling, patient check-in, health messaging and script management. We will continue to innovate and add new product to the platform, for example – remote patient monitoring is a growth area, that we intend to leverage with the platform.

Phase II of the Jayex Connect Platform development has commenced in 2020 and it is growing from strength to strength. We are seeing existing Jayex customers transitioning to the new platform, new customers taking it up as well as increasing our capability offering to existing and new customers. Jayex now has 959 customers using the platform up 47% from last year.

Web-mobile check-in
Central to our growth strategy is creating new and innovative products to add to our platform. During Q2 we launched a new module, web-mobile check-in. This module enables you to efficiently check-in from your mobile device which supports social distancing behaviour, helps to reduce queues and reduces congestion in waiting rooms. We are really pleased with the rate of take-up of this product, it has been well received by our customers (healthcare providers) and patients under the current COVID19 constraints. Pleasingly the product has been sold ahead of the planned roadmap timetable.
During the quarter we have also been installing our Queue Management System (QMS) in both Australia and the UK. In Australia, we installed the system at the North Sydney Local Health District and it was the first project completed in Australia with the Jayex/Cerner partnership. Additionally, Jayex UK delivered a QMS in a state-of-the-art new build project located in the Alfred Barrow Health centre in Barrow-in-Furness.

QMS integrates community and primary care services, focusing on helping people stay healthy within the local community.

In June this year, we entered into a Software Licence Agreement with Lifespot Health Ltd for technologies which allow patients to monitor chronic disease and critical conditions with their mobile device. The data can be shared in real time with healthcare professionals allowing for conditions such as chronic diseases, post operative recovery and COVID19 to be monitored remotely.
  Forum: By Share Code

nipper
Posted on: Aug 16 2020, 12:23 PM


Group: Member
Posts: 7,511

Jayex Healthcare Limited (JHL) is a provider in the United Kingdom and Australia of integrated healthcare services delivery platforms, incorporating the Company's four interconnected and proprietary technologies.

Enlighten: A patient management system that focuses on the workflow of patients through a GP clinic or hospital. Key functionality includes patient self-arrivals and patient calling, permitting clinic and hospital staff to refocus from administrative functions to providing a higher quality of patient care.

Appointuit: A proactive and comprehensive 24/7 patient engagement solution that optimises clinic workflow, avoids costly inefficiencies of manual appointment systems, enables staff to engage with patients to provide tailored healthcare services, and provides patients with an online appointment booking function.

Pharmacy Delivery 2 U: P2U will allow patients to take control of their pharmaceutical prescription by either requesting express pickup at a participating pharmacy or by having medicines delivered directly to their home, office or other location.

BluePoint: BluePoint is a pharmacist controlled ATM style terminal capable of installation almost anywhere, that remotely processes prescriptions and provides on the spot dispensing of standard pharmaceutical products.

Jayex Connect: The Jayex Connect is the complete cloud-based Patient Engagement Platform which provides appointment booking, patient calling, patient check-in, health messaging, and script management
  Forum: By Share Code

nipper
Posted on: Aug 16 2020, 12:17 PM


Group: Member
Posts: 7,511

ShareCafe webinar series:


https://www.sharecafe.com.au/2020/08/14/pre...r-presentation/
  Forum: By Share Code

nipper
Posted on: Aug 15 2020, 01:51 PM


Group: Member
Posts: 7,511

Afterpay is hiring an Influencer Marketing Associate, based in New York City, according to a filing on LinkedIn.

QUOTE
Afterpay is looking for a freelance contractor to help us maintain and grow our influencer network. We're looking for someone who has at least 3-6 years of experience working on influencer campaigns, and can dedicate at least 25 hours per week to this program. This role will be a 6 month contract, the company says.

Key responsibilities include selecting monthly influencers via the company's partner influencer platform; assisting with managing the brand ambassador program; and ensuring activations happen in timely fashion.
QUOTE
If you are brave, if you are committed to doing the right thing, if you always keep it real, and your background matches the description above then please apply today!, the company says.

Afterpay is continuing to hire for all open roles with all interviewing and on-boarding done virtually due to COVID-19. All new team members, in addition to current staff, will temporarily work from home until it is safe to return to our offices.


.... (sounds more like keeping it unreal, to me)
  Forum: By Share Code

nipper
Posted on: Aug 15 2020, 12:55 PM


Group: Member
Posts: 7,511

Q4 Highlights:

• Free cash flow generated of $3.6M for Q4 and $4.5M for FY20
• Cash on hand at 30 June 2020 $48.9M, boosted by the raising to fund the acquisition of Client Outlook completed in July
• New sales orders of $9.2M for Q4 and $19.4M for FY20
• Two customers go live on Mach7 Platform during quarter
• FY20 results expected 27 August, with >$18M of revenues, positive EBITDA


The Company raised $22.9 million (net of costs) in the quarter. This includes the recent placement ($3.7 million) and institutional component of the entitlement offer ($19.7 million), less costs ($1.0 million), together with proceeds from the exercise of options ($0.5 million). Next quarter result will include funds received from the retail component of the entitlement offer of $10.9 million (net of costs).

Company announced on 14 July it had completed the acquisition of Canadian company, Client Outlook Inc. for A$40.9 million.

Immediately post acquisition, Mach7 had $19 million cash on hand, after allowing for estimated acquisition costs which have yet to be paid. Client Outlook provides a unique zero-footprint viewing and integration platform distinguished as the first healthcare Smartviewer, known as eUnity. By combining Mach7's suite of solutions (including Mach7's vendor neutral archive, universal worklist, and workflow engine) with the industry leading eUnity diagnostic and enterprise viewer, the Company will provide one integrated end to end platform for the entire healthcare enterprise. Mach7's long-standing partnership with Client Outlook has, over time, resulted in the development of seamless integrations between the companies' respective platforms.

Mach7 intends to continue its investment in R&D to further tighten this integration and enhance the capabilities of the new enterprise imaging solution so it will help customers adapt more quickly to the challenging and rapidly changing healthcare environment.
  Forum: By Share Code

nipper
Posted on: Aug 15 2020, 12:52 PM


Group: Member
Posts: 7,511

Mach7 Technologies Limited (M7T, formerly 3D Medical Limited) is a global provider of enterprise image management systems that allow healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence where and when needed. M7T develops data management solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes.

Management Studio: Management Studio helps healthcare delivery organizations meet business and patient care goals by empowering them to own, archive and communicate all imaging data from across the enterprise and seamlessly connect that data with the Electronic Medical Record (EMR).

Clinical Studio: Clinical Studio puts authorized clinical staff, physicians, and patients in control of medical imaging data. It helps to view, navigate, review, and share patient medical data over the web and across the enterprise.

Diagnostic Studio: Diagnostic Studio provides a suite of solutions designed to drive specialty workflow. With the ability to load balance across critical resources, manage and monitor service level agreements, enable technologists to QC imaging studies across disparate visualization solutions and more, Mach7 Diagnostic Studio advances traditional PACS functionality with intelligent vendor neutral workflow and data management capabilities.

Archive Migration Service: Archive migration services utilize a traditional DICOM C-MOVE migration, or a rapid DICOM media migration. If image attribute normalization is needed during the migration, Mach7 Migration Engine is used to modify DICOM attributes as the study is being sent to the target system
  Forum: By Share Code

nipper
Posted on: Aug 15 2020, 10:35 AM


Group: Member
Posts: 7,511

Boom time for biotechs

COVID 19 has thrust the Australian biotech sector into the spotlight, but the potential big rewards come with high risk.

http://www.smh.com.au/business/not-for-the...55l93.html?btis

QUOTE
Thecoronavirus pandemic has fuelled extraordinary volatility in the markets but the fight against the virus has also thrust relatively obscure companies into the spotlight and turned some into multibillion-dollar businesses.
The biotech sector, which includes diagnostics, novel drug development and medical devices, is big business. The top 10 healthcare companies on the ASX are worth more than $200 billion alone. Australia is renowned for its cutting edge research, and its largest life sciences companies such as CSL and ResMed have grown into multibillion-dollar exports with sustained share price growth.

Beyond these household names, there are more than 80 listed smaller pharmaceutical and medical device companies working, often under the radar, to turn brand new therapies into reality.

And there are big rewards on offer for investors but as Silvio Itescu says, the sector also presents significant risks. Investors should understand that biotech is a highly regulated field ... it requires patience, diligence and ultimately you're in the hands of regulators.

Having said that, there's got to be more of an understanding of the hurdles but also the rewards, if the tech works and it is patented and has an exclusive area of focus, really if you can make substantial differences to patients and their outcomes, you have the ability to create a new industry, Itescu says.

While the sector has not traditionally been on the radar of many investors, experts say the pandemic has generated awareness of the role of drug and treatment supply chains, which has in turn led to money flowing into the sector.

Atomo Diagnostics experience since listing on the ASX in April illustrates the new found enthusiasm of investors in punting on stocks involved in testing, treating and eradicating COVID 19.

The rapid diagnostic testing startup pitched itself to the market with a test for HIV but quickly shifted its focus to developing a COVID19 test. Atomo's rapid antibody test was approved by the Therapeutic Goods Administration last week, launching it into the Australian market. As the pandemic put biotech companies front and centre, its share price jumped. Sitting at 38¢ on Friday, the business is trading 90 per cent above its initial public offer price.

Managing director John Kelly says the swift pivot has served the company well and while investor interest in biotechs is welcome, it's what happens once the virus is contained that will be crucial for the sector.

"I think for a company like Atomo it's a bit of a double-edged sword, it's increased interest in the sector, but at the same time there has been such a level of media saturation. We'd rather grow a steady share price over five years rather than spiking over one year.

Atomo is not the only small biotech that has rocketed in recent months. Real-time lung function tracking company 4D Medical soared on its ASX debut in the second week of August, up 117 per cent on its 73¢ offer price to $1.59...

Even fund managers that have benefited from the growth of vaccine stocks in recent months urge caution about evaluating investment opportunities in the space.

Platinum Asset Management's international healthcare fund portfolio manager Bianca Ogden has been watching companies like Moderna for years, and invested since the company's IPO in 2018, when it bought in at $US23.

Ogden says there has been a lot of money flowing through US biotech stocks, but she is also watching closely for when the fuel of vaccine enthusiasm wears off. I wonder if the next data point is where they run out of puff.

The global pandemic has given local investors a better insight into research processes and medical products, particularly around diagnostics and tests, she says. But cautions that despite there being strong companies both here and abroad, investors shouldn't be jumping into stocks without considering their long-term risks and rewards. You have to take the emotion out and look at 'what can this company realistically generate in sales?', she says.

Ogden says there are plenty of up and coming Australian-founded biotechs that will grow beyond the pandemic but the challenge will be competing with some of their cashed-up US peers. I think there are some good companies — one of the issues here is the funding environment, it's sometimes a bit challenging. For larger trials, for example, you often need $20 million-$50 million.

Her team is currently focused on finding investment opportunities with inventions that will be of use beyond the pandemic. We tend to gravitate to things that are less discovered, less in the headlines.

Securing the research pipeline
However, investors believe Australia has the power to further capitalise on rising appetite for biotechs post COVID, although there will be some hurdles.
Melbourne was ranked among the top 40 startup ecosystems in the world this year by global research firm Startup Genome. Its debut on the list was based largely on the strength of the life sciences sector, which Startup Genome believes generates close to $17 billion in economic activity each year.

There's going to be great careers in being a research scientist, because more than any time perhaps in history, we will find funds being dedicated to this area, Alex Waislitz says.

However, Paul Kelly, who oversees the $170 million healthcare fund at OneVentures, says the country will have to face up to local challenges. COVID19 has hit Australian universities incredibly hard, having implications for research projects that might one day be spun out into successful companies. That significant impact runs the risk of really gutting research and development. There may be impacts we won't see for the next five to 10 years.

Atomo's Kelly agrees that Australia's challenge will be improving the commercialisation pipeline. The research is brilliant, we could do better at turning that research into businesses that can grow globally, he says.

Despite the commercialisation challenges, he's hopeful the pandemic has reframed the sector. It has been a bit unloved in Australia at times — the appetite is not always patient enough and sophisticated enough, Kelly says. With the pandemic, one positive that might come out of it is these types of businesses are more investable.
  Forum: Investment Discussion

nipper
Posted on: Aug 15 2020, 08:16 AM


Group: Member
Posts: 7,511

QUOTE
The Ascent is Not a Recent Phenomenon Gold's ascent began five years ago, with interest rates low and question marks beginning to be asked about the world economy. Interest rates were kept low during and subsequent to the GFC, as a means of accelerating and maintaining economic growth, but have never been allowed to return to 'normalised' levels. There are inherent dangers in keeping interest rates too low for too long, as they create asset bubbles and lead to artificially high equity markets, as investors chase returns.


https://www.sharecafe.com.au/2020/08/14/gold-price-overview/
QUOTE
Uncertainty is really driving the gold price now .... concerns about economic growth, do central banks have enough firepower to fix the economic mess, will it make a difference, and how long COVID19 will last. If we reference the last major economic crisis, the GFC, we didn't see gold's peak until three years later. If gold prices continue to rise for another three years, predictions of $3,000 do not seem unreasonable at all.


- nice graphs too
  Forum: Macro Factors

nipper
Posted on: Aug 14 2020, 09:05 PM


Group: Member
Posts: 7,511

There is an interesting article, see link, that might add to the story. The 50% rise of the US S&P 500 index from its lows in March has been driven by a narrow number of titans. In fact, 5 stocks have increased their market cap by the same amount as the other 495 have lost since the beginning of the year.
https://www.sharecafe.com.au/2020/08/13/is-...levant-anymore/
based around the thesis of: Is an Index Relevant Anymore? which comes to the conclusion:
QUOTE
Do not buy the index, buy value for long term investing, and capital preservation. There are cheap stocks in an expensive index. The index at the moment is an irrelevant benchmark in finding value
... but only gets there via a series of charts and graphs (and sometimes, a picture can tell a thousand words graduated.gif ).



  Forum: By Share Code

38 Pages (Click to Jump) V   1 2 3 4 > » 

Cant find what you are looking for? Show all active topics from the last 3 months


New Posts  New Replies
No New Posts  No New Replies
Hot topic  Hot Topic (New)
No new  Hot Topic (No New)



TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING